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Modulation of exercise-induced gene expression in human skeletal muscle by exercise 
intensity, training status and short-term endurance training 
Brendan Egan 
 
A single bout of exercise generates a robust, but transient, increase in mRNA abundance for a 
multitude of genes, which is thought to contribute to the recovery from and adaptation to 
exercise. Adaptation to exercise training is mediated by the accumulation of pulses of elevated 
mRNA after individual exercise bout within a training program, leading to longer term increases 
in protein abundance that culminate in physiological adaptations. Several signalling pathways 
involving cytoplasmic protein kinases, transcription factors and their coregulators are 
recognised as regulators by which activation transduces physiological stimuli into transcriptional 
adaptations. 
This thesis examined the modulation of gene expression in human skeletal muscle under 
varying physiological conditions, including divergent exercise intensities, untrained and trained 
muscle, and short-term endurance training. 
Compared to low intensity isocaloric  exercise (400 kcal, 40%VO2peak), a single bout of high 
intensity exercise (80% VO2peak) resulted in greater activation of the signalling kinases AMPK 
and CaMKII, coincident with a larger increase in mRNA abundance of PGC-1α and FOXO1A 
during recovery. A single bout exercise induced an increase in PGC-1α. FOXO1A, and PDK4 
mRNA abundance in both untrained and trained muscle. This may form part of a transcriptional 
response that contributes to exercise-induced alterations in skeletal muscle metabolism such as 
glucose sparing and increased fat oxidation during recovery from exercise. Fourteen 
consecutive days of endurance training resulted in the accumulation of mRNA and 
corresponding protein for some (ERRα, COXIV), but not all (FOXO1A, PDK4), reportedly acute 
exercise-responsive genes. This suggests that certain genes are involved in the restoration of 
homeostasis after acute exercise, whereas others are involved in adaptation to regular exercise. 
Our results illustrate the well-described phenomenology of skeletal muscle plasticity and 
suggest that transcript level adjustments underlie modulation of skeletal muscle metabolism and 
phenotype by regular exercise. 
1 
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All living organisms possess the inherent capacity to alter the structural and functional 
properties of their organ systems in accordance with the environmental conditions imposed on a 
particular system; i.e. systems are malleable in the presence of physiological stimuli. Phenotypic 
plasticity thus refers to the property of a given genotype to produce different phenotypes in 
response to distinct environmental conditions (Pigliucci, 2001), ultimately yielding phenomena 
observed in living beings. To the exercise physiologist, phenotypic plasticity is most obviously 
observed in the remarkable exercise performance capacity of elite athletes after years of 
exercise training (Coyle, 2005a), or the ability of regular exercise to prevent or ameliorate 
pathophysiological disease states to which physical inactivity contributes (Hawley, 2004). 
1.1 Metabolic dysfunction in human skeletal muscle 
Skeletal muscle is a tissue richly endowed with mitochondria and strongly reliant on oxidative 
phosphorylation for energy production. Quantitatively, it is the largest organ in the body, 
contributing 30–40% of the resting metabolic rate in adults (De Lange et al., 2007). One of the 
striking physiological characteristics of skeletal muscle is metabolic flexibility, expressed by a 
high capacity to modulate rates of energy production, blood flow, and substrate utilization (Saltin 
& Gollnick, 1983). Impaired metabolic flexibility is manifested as reduced insulin-stimulated 
skeletal muscle glucose uptake, increased intramuscular triglyceride accumulation, elevated 
respiratory exchange ratio at rest and an inability to switch between fuel sources appropriately 
when challenged by feeding or fasting (Kelley et al., 1999). These phenomena are closely 
associated with chronic metabolic diseases (Storlien et al., 2004). 
Impaired mitochondrial function and reduced oxidative capacity in skeletal muscle contribute to 
the pathophysiology of insulin resistance, type 2 diabetes mellitus and obesity (Storlien et al., 
2004;Lowell & Shulman, 2005). A coordinated downregulation of genes involved in 
mitochondrial oxidative phosphorylation and a reduction in oxidative metabolism has been 
demonstrated in skeletal muscle of obese (Kelley et al., 2002), insulin resistant (Patti et al., 
2003), and type 2 diabetic (Mootha et al., 2003) individuals and insulin resistant offspring of type 
2 diabetic patients (Petersen et al., 2004). However, the causative or compensatory nature of 
this pattern of expression is not established and is debated (Pospisilik et al., 2007). In rats 
selectively bred for divergent endurance exercise capacities, rats with high intrinsic aerobic 
fitness levels and commensurate elevation in resting skeletal muscle mitochondrial oxidative 
capacity have reduced cardiovascular risk factors (Wisloff et al., 2005) and exhibit resistance to 
development of insulin resistance when challenged with a high fat diet (Noland et al., 2007), 
when compared to rats with lower intrinsic aerobic capacity and reduced skeletal muscle 
mitochondrial oxidative capacity. 
1.2 Exercise as therapeutic intervention for metabolic dysfunction 
Therefore, therapeutic strategies that increase oxidative capacity and the expression of 
mitochondrial genes in skeletal muscle are essential for the amelioration of metabolic 
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dysfunction and insulin resistance associated with obesity and type 2 diabetes mellitus. 
Fortunately, skeletal muscle shows a remarkable malleability to remodel its phenotype and to 
adapt functionally in response to contractile stimuli (Hood et al., 2006;Fluck, 2006). A single 
bout of exercise is known to acutely increase lipid metabolism and glucose disposal in skeletal 
muscle (Wasserman & Cherrington, 1996) and improve whole body insulin sensitivity (Richter et 
al., 1989). Repeated myofibrillar contraction associated with physical activity and exercise 
training is a potent stimulus for physiological adaptation. For instance, exercise training can 
improve indices of metabolic flexibility in both obese and type 2 diabetic individuals (Toledo et 
al., 2006;Menshikova et al., 2007). Regular physical activity is therefore a critical tool in the 
treatment and prevention of these chronic diseases (Booth et al., 2002;Hawley, 2004), although 
the molecular mechanisms underlying these benefits are still being elucidated. However, a 
direct association between chronic physical activity, increases in oxidative capacity and 
improvements in mitochondrial function has long been established (Holloszy, 1967). As little as 
six sessions of exercise training can almost double the endurance capacity of untrained 
individuals when completing a cycle to exhaustion at a fixed workload (Burgomaster et al., 
2005). Importantly from a metabolic perspective, this is accompanied by an increase in muscle 
oxidative capacity and mitochondrial protein expression (Gibala et al., 2006). 
1.3 Regulation of skeletal muscle gene expression 
The expression of genes encoding proteins regulating skeletal muscle mitochondrial 
metabolism is under control of an increasingly well-defined subset of transcription factors and 
their coregulators. Peroxisome proliferator-activated receptor (PPAR) γ co-activator 1α (PGC-
1α) is a transcriptional coactivator that is critical in controlling many aspects of cellular 
metabolism in a variety of tissues and thought to be a “master regulator” of transcriptional 
processes (Finck & Kelly, 2006;Handschin & Spiegelman, 2006). In muscle cells, altering the 
transcriptional activity of PGC-1α affects physiological responses that equip the cell to meet the 
energy demands of a changing environment including augmentation of mitochondrial 
biogenesis, cellular respiration rates and energy substrate uptake and utilisation (Wu et al., 
1999;Michael et al., 2001;Lin et al., 2002;St-Pierre et al., 2003;Wende et al., 2005;Rohas et al., 
2007;Wende et al., 2007). The molecular mechanism underlying these functional adaptations 
may be the ability of PGC-1α to coordinate alterations in the expression of genes involved in 
carbohydrate and lipid metabolism, oxidative phosphorylation and mitochondrial biogenesis in 
response to metabolic stimuli. 
In recent years, it has become clear that transcriptional coregulator proteins, apart from being 
crucial to the regulation of gene expression in response to cellular signals, can actually be 
primary targets for signal transduction pathways (Gerhart-Hines et al., 2007;Jager et al., 2007). 
This characterisation provides a framework for understanding the continuity between signalling 
events affecting cellular energetics and the expression of both nuclear- and mitochondrial-
encoded genes that dictate skeletal muscle phenotype (Scarpulla, 2008). Therefore, 
transcription factors, nuclear receptors and their transcriptional coregulators are key players in 
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integrating signals from physiological stimuli into adaptive tissue responses to coordinate 
metabolic processes (Spiegelman & Heinrich, 2004;Desvergne et al., 2006;Feige & Auwerx, 
2007). Transcription factors and coregulator proteins can be activated in response to specific 
cellular signals, cocomplex with a variety of other factors and demonstrate selective activation 
of only certain gene promoters containing binding sites for the given transcription factor. These 
highly regulated functions suggest that the coregulator proteins play a crucial role in selecting 
the subset of genes that make up a given biological program (Spiegelman & Heinrich, 
2004;Desvergne et al., 2006). Regulation of transcriptional activity occurs via change in the 
amounts (protein content) or activities (e.g. posttranslational modifications) of transcription 
factors (Spiegelman & Heinrich, 2004). 
1.4 Contraction-mediated regulation of skeletal muscle gene expression 
Of particular interest is the fact that the activation of these cellular signals and the expression 
and/or function of these transcriptional regulators can be markedly and rapidly induced by acute 
exercise. A single bout of exercise presents multiple stimuli to and within the contracting muscle 
mass, which underlines the difficulty in delineating the signalling pathway from the exercise 
signal and ultimately the molecular mechanisms linking exercise to the transcription of 
metabolic genes. Acute contractile activity increases calcium flux, ATP turnover, mechanical 
stress, glycogen utilisation, catecholamine concentration and oxidative stress (Fluck, 
2004;Freyssenet, 2007;Coffey & Hawley, 2007). Any one of these changes may, in principle, 
activate a signalling pathway that may ultimately alter the expression of downstream gene 
targets (Williams & Neufer, 1996). Exercise-induced phenotypic alterations are generally 
accepted to involve the sensation and transduction of contraction-induced stimuli through 
intracellular signal transduction pathways including protein kinases, phosphatases and 
deacetylases, their integration into physiological processes by downstream targets including 
transcription factors and transcriptional coregulators (Fluck, 2004;Hood et al., 2006;Freyssenet, 
2007). The consequent alterations in mRNA abundance and protein accretion result in 
functional and structural adaptations localised to the exercised muscle. 
These functional adaptations to exercise training have been well characterised and include 
proteins involved in mitochondrial ATP production (Holloszy, 1967), mobilisation, transport and 
oxidation of fatty acids (Bonen et al., 1999), glucose transport and glycogen synthesis 
(Houmard et al., 1993), antioxidant defences (Ookawara et al., 2003), and oxygen delivery to 
and extraction from skeletal muscle (Hickson, 1981). These adaptations have long been known 
but many of the detailed molecular mechanisms remain to be identified. Contraction-induced 
changes in skeletal muscle gene expression and activity of key metabolic and mitochondrial 
proteins are largely responsible for the pleiotropic effects of exercise on skeletal muscle 
metabolism. A widely accepted hypothesis is that adaptation is mediated largely at the level of 
transcription (Mahoney & Tarnopolsky, 2005). A single exercise session carries a “molecular 
signature” which is typical for the type of stimulus (i.e. the nature of the exercise session) as 
well as the actual condition of the muscle tissue (i.e. untrained, trained) (Hoppeler et al., 2007). 
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This signature is evident as rapid, transient changes in mRNA abundance and protein 
expression during recovery from exercise. The transcriptome response to a single bout of 
exercise includes an upregulation of mRNAs involved in carbohydrate and lipid metabolism, 
oxidative phosphorylation and mitochondrial biogenesis (Pilegaard et al., 2000;Hildebrandt & 
Neufer, 2000;Pilegaard et al., 2003;Hildebrandt et al., 2003;Russell et al., 2005;Cartoni et al., 
2005;Cluberton et al., 2005;Pilegaard et al., 2005;Mahoney et al., 2005). Repeated exercise 
sessions thus lead to concerted accretion of expressed mRNAs which upon translation results 
in a corresponding protein accretion. This process has been identified as the major molecular 
strategy of muscle for governing structural and functional adaptations with exercise training 
(Booth & Baldwin, 1996;Williams & Neufer, 1996;Hood, 2001;Fluck & Hoppeler, 2003). 
Therefore, regulation of gene expression at the transcriptional level is accepted as a key 
process in understanding the overall adaptive response to exercise. 
Furthering our understanding of both the transcriptome response to acute and chronic exercise 
and the molecular mechanisms underpinning these responses is important for establishing 
therapeutic strategies for disorders involving skeletal muscle. The aim of this thesis is to 
examine the modulation of gene expression in human skeletal muscle under varying 
physiological conditions, including divergent exercise intensities, untrained and trained muscle, 
and short-term endurance training, to further our understanding of the molecular biology of 
acute exercise and exercise training. 
1.5 Thesis overview: aims, objectives and hypotheses 
This thesis will examine the modulation of gene expression in human skeletal muscle under 
varying physiological conditions. Firstly, the effect of different exercise intensities on 
contraction-induced signalling cascades and gene expression of metabolic genes and 
transcriptional regulators in untrained men will be investigated. Secondly, the transcriptional 
response to a single bout of exercise in well-trained men will be examined in comparison to 
results from untrained men. Thirdly, the mRNA and protein abundance of a subset of metabolic 
genes and transcriptional regulators in response to short-term endurance training in previously 
untrained men will be examined. 
1.5.1 Experiment I 
Contraction-induced signalling and gene expression of metabolic genes and transcriptional 
regulators in human skeletal muscle: influence of exercise intensity 
Overview 
Eight healthy, sedentary males performed two isocaloric (400 kcal) cycle exercise trials, once 
each at either 40% or 80% VO2peak. Skeletal muscle biopsies from the m. vastus lateralis were 
taken at rest and at +0 h, +3 h and +19 h after exercise. 
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Specific aims 
(i) To investigate the effect of divergent exercise intensities on the expression of genes 
encoding transcriptional regulators and proteins involved in mitochondrial and substrate 
metabolism in untrained skeletal muscle in response to a single bout of exercise. 
(ii) To examine the potential for differential activation of contraction-induced signal transduction 
pathways in response to divergent exercise intensities 
Hypothesis 
(i) There will be greater activation of contraction-induced signalling kinases (AMPK, CaMKII) 
and transcript expression of selected gene targets (PGC-1α, FOXO1A, PDK4) after a single 
bout of high intensity compared to low intensity isocaloric exercise 
1.5.2 Experiment II 
The effect of glycogen-depleting exercise on contraction-induced signalling and gene 
expression of metabolic genes and transcriptional regulators in well-trained human skeletal 
muscle 
Overview 
Eight healthy well-trained males cycled for 90 min at 73% VO2peak. Skeletal muscle biopsies 
from the m. vastus lateralis were taken at rest and at +0 h and +1 h after exercise. 
Specific aims 
(i) To examine the effect of a single bout of glycogen-depleting exercise on the mRNA 
abundance of transcription factors and transcriptional coregulators in well-trained human 
skeletal muscle 
Hypothesis 
(i) The exercise-induced alterations in mRNA expression of selected gene targets will be 
qualitatively similar to those reported in untrained muscle  
1.5.3 Experiment III 
The effect of fourteen consecutive days of exercise training on the expression of metabolic and 
mitochondrial genes and their transcriptional regulators in skeletal muscle of previously 
untrained men 
Overview 
Eight healthy, sedentary males performed 60 min of exercise at 80% VO2peak, once per day for 
fourteen consecutive days. Skeletal muscle biopsies from the m. vastus lateralis were taken 
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prior to the start of training, and on the morning after the 1st, 3rd, 7th, 10th and 14th training 
session. 
Specific aims 
(i) To examine whether proposed accumulation of mRNA underlying muscular adaptation after 
repeated bouts of exercise training is evident after fourteen days of training. 
(ii) To examine the continuity between alterations in mRNA and translational changes in protein 
content during training. 
(iii) To examine the time course of adaptation at both the transcriptional and translational level 
during fourteen consecutive days of training. 
Hypotheses 
(i) There will be an increase in steady-state mRNA content of selected genes will be consistent 
with those that are reported to be transiently elevated after a single bout of exercise 
(ii) The steady-state increases in the expression of gene transcripts will be paralleled by 
increases at the translational level manifested as increased protein content of the encoded 
protein 
(iii) Sampling skeletal muscle at multiple time points during fourteen days of training will reveal a 
sequential accumulation of mRNA and protein abundance of selected exercise-responsive gene 
targets 
 8 
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2.1 Transcriptional regulation of metabolism in skeletal muscle 
The flow of information in biological systems is generally such that for a gene of interest, DNA is 
copied into mRNA by transcription and proteins are synthesised by translation using mRNA as 
the template. Unlike DNA and protein, mRNA is synthesised rapidly and on-demand, and 
changes in mRNA concentration generally reflect a change in the rate of transcription (under the 
control of the opposing effects of activation and repression) or the stability of mRNA (Koulmann 
& Bigard, 2006). The human genome contains approximately 20-25,000 genes and encodes 
approximately 85,000 different mRNAs, due to alternative mRNA splicing and variable 
polyadenylation (International Human Genome Sequencing Consortium, 2004). Transcriptional 
regulation of metabolism is critical to maintenance of homeostasis in living organisms in 
response to physiological cues (Desvergne et al., 2006;Feige & Auwerx, 2007). Furthermore, 
this process has been identified as the major molecular strategy of muscle governing the 
induction of structural and functional adaptations to exercise training (Booth & Baldwin, 
1996;Williams & Neufer, 1996;Hood, 2001;Fluck & Hoppeler, 2003). Therefore, regulation of 
gene expression at the transcriptional level is accepted as a key process in understanding the 
overall adaptive response to exercise. 
Transcriptional regulation may be thought of as the key step in integrating signals from dietary, 
metabolic and endocrine pathways to control target gene expression (Desvergne et al., 2006). 
The activation of gene transcription results in the transient synthesis of mRNA, which may 
undergo modification to generate the mature transcript. The mature transcript exits the nucleus 
via the nuclear pores and, when coupled to the translational machinery of the ribosome, is 
translated into the encoded peptide. However, gene activation is a multistep process involving a 
very large number of proteins functioning in discrete complexes (Spiegelman & Heinrich, 2004). 
Therefore, understanding transcriptional control in a biological system requires information on (i) 
events upstream of transcriptional activity, which define the signals involved and their route to 
the nucleus; (ii) the molecular mechanisms by which transcription factors operate; and (iii) 
events downstream of transcriptional activity, which depend on the groups of genes that are 
targeted and how further signals are generated to reach the dynamic equilibrium of homeostasis 
(Desvergne et al., 2006). Exercise-induced phenotypic alterations involve the sensation and 
transduction of contraction-induced stimuli through intracellular signal transduction pathways 
including protein kinases, phosphatases and deacetylases, their integration into physiological 
processes by downstream targets including transcription factors and transcriptional coregulators 
(Fluck, 2004;Hood et al., 2006;Freyssenet, 2007). The consequent alterations in mRNA 
abundance and protein accretion result in functional and structural adaptations localised to the 
exercised muscle. This review of literature will focus on the regulation and effectors of each of 
these nodes of control in skeletal muscle metabolism at rest and in response to acute exercise 
and exercise training. 
Transcriptional control requires specific signals to be transduced to the cell nucleus where 
defined sets of genes are targeted. The factors controlling the activation of these target genes 
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under the influence of these signals encompass a modest subset of well-defined transcription 
factors, nuclear receptors, and transcriptional coregulators (Scarpulla, 2008). These factors 
coordinate metabolic processes by adapting tissue responses to various challenges through the 
integration of endogenous and exogenous signals (Feige & Auwerx, 2007). To this end, the 
terminal point of many complex signal transduction cascades is the activation of transcriptional 
regulator proteins that bind to promoter and enhancer regions of target genes, which in turn 
activates transcription of that gene. The regulatory sequences of most genes contain binding 
sites for multiple transcription factors, allowing each gene to respond to multiple signalling 
pathways and facilitating the fine-tuning of transcript levels (McKenna & O'Malley, 
2002;Orphanides & Reinberg, 2002). 
2.1.1 Activation and repression of transcription 
In order for a transcription factor to be relevant to a particular gene encoding for a particular 
protein, there must be a binding site for that factor on the promoter region of that gene (Hood, 
2001). Transcription factors bind directly to DNA in a sequence-specific manner and essentially 
mark a gene for activation or repression through the recruitment of coactivator or corepressor 
proteins (Spiegelman & Heinrich, 2004). These coregulators are characterised by their ability to 
increase or decrease transcription without direct binding to DNA. Transcription factors bound to 
their specific site in the promoter region of the target gene recruit transcriptional coregulators in 
response to a cellular signal. Once recruited, these coregulators alter the transcriptional 
machinery mainly through the modification of local histones and recruitment of transcriptional 
enzymes. Coactivators are generally associated with histone acetyltransferase (HAT) activity 
resulting in histone acetylation and alteration in chromatin structure, which allows greater 
access to DNA for the activated transcription factor. Corepressors generally have the opposite 
effect on chromatin structure associated with histone deacetylase (HDAC) activity reducing the 
effect of transcription factors on the target gene. The unique local chromatin structure and 
histone acetylation state at enhancer/silencer and promoter regions provide critical regulatory 
input that allows the cell to greatly increase the range of transcriptional responses (Naar et al., 
2001). The global impact of coregulators on metabolism depends on their capacity to modulate 
metabolic balance by promoting or inhibiting anabolic and catabolic functions (Feige & Auwerx, 
2007).  
The regulation of gene activity at the transcriptional level has generally been thought to occur 
via changes in the abundance or activities (function) of transcription factors. This means that 
genes encoding transcription factors may themselves be transcriptionally induced or repressed 
or the existing transcription factor protein may be activated or deactivated. Similarly, coactivator 
and corepressor proteins may participate in gene regulation, not merely by being necessary 
gears in the transcriptional machinery but by being primary targets of physiological signals 
(Spiegelman & Heinrich, 2004). Protein phosphorylation and acetylation are prevalent 
posttranslational modifications by which the functions of transcription factors and coregulators 
are regulated in response to cellular stimuli (Orphanides & Reinberg, 2002), and are discussed 
in the context of skeletal muscle later. 
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2.1.2 Changes in mRNA abundance 
Increments in mRNA abundance are often referred to as increases in gene expression. This is 
technically incorrect, because increased gene expression and its associated 
phenotypic/functional manifestations do not take place until there is an increase in the 
concentration of the protein encoded by the gene (Baar et al., 2002). Gene expression in its 
broadest sense therefore refers to a process encompassing the activation of transcriptional 
regulators to the synthesis of a functional protein (Orphanides & Reinberg, 2002). Gene 
expression can be controlled at various points beyond transcription, so the extent to which a 
protein will increase in response to an adaptive stimulus cannot always be predicted from the 
increase in mRNA. In skeletal muscle, expression of mRNA does not always accurately reflect 
the abundance of proteins and can give no information regarding their posttranslational 
modifications (Hojlund et al., 2008). In addition, it is established in yeast (Gygi et al., 1999) that 
the correlation between mRNA and protein levels was insufficient to predict protein expression 
levels from quantitative mRNA data. Indeed, for some genes, while the mRNA levels were of 
the same value the protein levels varied by more than 20-fold. Conversely, invariant steady-
state levels of certain proteins were observed with respective mRNA transcript levels that varied 
by as much as 30-fold. Therefore, when considering alterations in transcriptional regulation or 
mRNA content in terms of muscle metabolism, although mRNA abundance is a strong 
determinant of protein synthesis, this relationship is neither simple nor linear. 
In summary, homeostatic perturbations, such as those induced by exercise in skeletal muscle, 
are integrated via intracellular signalling cascades into alterations in gene transcription. The 
diffusible gene copies produced then provide the message for the instruction of muscle tissue 
remodelling via translation and assembly of the encoded proteins. Based upon this relationship, 
it is hypothesized that the systematic exploration of differences in transcript levels relative to 
phenotypic adjustments arising from the impact of exercise will reveal the strategy underlying 
muscle plasticity (Fluck, 2006). 
2.2 PGC-1α and its associated transcriptional regulators in the regulation 
skeletal muscle metabolism 
In skeletal muscle and other metabolic tissues, an increasingly well defined network of 
transcription factors and coregulator proteins provide a critical level of control in a wide range of 
metabolic processes. This is illustrated by their ability to target and alter the expression of key 
metabolic enzymes and mitochondrial proteins and coordinate the process of mitochondrial 
biogenesis. The most well-characterised of these proteins that can be thought of as metabolic 
regulators in skeletal muscle include, but is not limited to, PGC-1α, PPARs, NRF-1, NRF-2, 
ERRα, FOXO1A, MEF2 and RIP140 and their subsequent coordination of alterations the 
expression of genes involved in carbohydrate metabolism (HKII, PDK4, GLUT4), lipid 
metabolism (CPT1, MCAD, LPL), oxidative phosphorylation (cytochrome c, COXIV) and 
mitochondrial biogenesis (Tfam).  
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2.2.1 Discovery and expression of PGC-1α 
PGC-1α is a transcriptional coactivator that is critical in controlling many aspects of cellular 
metabolism in a variety of tissues (Finck & Kelly, 2006;Handschin & Spiegelman, 2006). In 
muscle cells, altering the transcriptional activity of PGC-1α affects physiological responses that 
equip the cell to meet the energy demands of a changing environment including augmentation 
of mitochondrial biogenesis, cellular respiration rates and energy substrate uptake and 
utilisation (Wu et al., 1999;Michael et al., 2001;Lin et al., 2002;St-Pierre et al., 2003;Wende et 
al., 2005;Rohas et al., 2007;Wende et al., 2007). PGC-1α was first identified in brown fat as a 
cofactor for PPARγ that is required for adaptive thermogenesis in response to cold exposure 
(Puigserver et al., 1998). PGC-1α protein expression is highly expressed in mitochondria-
enriched tissues including skeletal muscle and its rapid and pronounced response to cold 
exposure indicated that it responded to physiological cues. This prompted investigations on the 
regulation of its activity by cellular signals in response to physiological stimuli. In human skeletal 
muscle, PGC-1α protein content is highest in type IIa, lower in type I and lowest in type IIx fibres 
(type IIa 2.2-fold > type I and 6-fold > type IIx; type I 2.5-fold > type IIx)(Russell et al., 2003). In 
terms of mRNA, whereas large differences in PGC-1α mRNA levels are seen between muscle 
types in rodents (up to five times higher in type I fibres) (Lin et al., 2002), there is no difference 
in PGC-1α mRNA levels between different human skeletal muscles (Plomgaard et al., 
2006;Mortensen et al., 2007). PGC-1α mRNA (Pilegaard et al., 2003), protein expression (Baar 
et al., 2002) and activation (Wright et al., 2007b) are stimulated by a single bout of exercise in 
skeletal muscle. Similar effects can be induced by fasting in liver (Rhee et al., 2003;Rodgers et 
al., 2005) but this chapter will be limited to skeletal muscle metabolism where possible. 
2.2.2 Interaction with transcription factors 
No intrinsic chromatin-modifying capabilities have been identified in PGC-1α but it can 
associate with many proteins that either alter chromatin structure or recruit other essential 
transcriptional components. After docking with a transcription factor on the promoter of a target 
gene, PGC-1α recruits several powerful HATs including CBP/p300 and SRC-1, leading histone 
acetylation, chromatin remodelling and access for additional factors for gene activation. 
Additionally, a mediator known as the TRAP/DRIP complex is recruited to PGC-1α and 
enhances the transcription process by recruiting RNA polymerase II. These two features are 
though to be the main mechanisms by which PGC-1α alters the transcriptional control of target 
genes (Lin et al., 2005). 
MEF2 is a transcription factor with response elements on a variety of genes involved in muscle 
remodelling (Potthoff & Olson, 2007). MEF2 relies on the recruitment of other transcriptional 
regulators to mediate its effects. Coactivation of MEF2 by PGC-1α provides a positive feed-
forward signal that rapidly induces PGC-1α expression in an autoregulatory loop (Handschin et 
al., 2003). This provides a mechanism to sustain PGC-1α levels in response to physiological 
stimuli (Finck & Kelly, 2006). MEF2 binds to PGC-1α on at least two binding sites and 
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modulates its expression through MEF2 interaction with HDAC5 (Czubryt et al., 2003). The 
importance of MEF2-PGC-1α interaction is underscored by the observation that MEF2 and CRE 
sites in the PGC-1α promoter previously described (Handschin et al., 2003;Czubryt et al., 2003) 
are indispensable in the activation of the PGC-1α promoter in response to contractile activity 
(Akimoto et al., 2004b). This suggests that contractile activity-induced PGC-1α gene 
transcription must be mediated through signals that are transduced through MEF2 and/or CRE 
binding proteins or certainly regulatory factors that interact with MEF2 and CRE sequence 
elements on the PGC-1α promoter. 
Ectopic expression of PGC-1α in muscle cells induces an increase in mitochondrial DNA and 
mitochondrial biogenesis and promotes the expression of a large number of nuclear- and 
mitochondrial-encoded mitochondrial genes. Since this phenomenon was first observed (Wu et 
al., 1999), the mechanisms underlying this response have delineated a specific pathway 
involving PGC-1α, NRF-1, NRF-2, ERRα and Tfam (Wu et al., 1999;Schreiber et al., 2004;Huss 
et al., 2004;Mootha et al., 2004). NRF-1 and NRF-2 are nuclear-encoded transcription factors 
linked to the transcriptional control of many mitochondrial genes by virtue of the presence of 
NRF binding sites within their promoters (Kelly & Scarpulla, 2004). ERRα is an orphan nuclear 
receptor expressed in high levels in oxidative tissues including cardiac and skeletal muscle. 
Mechanistically, PGC-1α induces expression of mitochondrial genes by increasing the levels of 
NRF-1, NRF-2 and ERRα (Wu et al., 1999;Schreiber et al., 2004;Mootha et al., 2004). When 
coactivated by PGC-1α, NRF-2 and ERRα promote their own, as well as each others’ 
expression, in a PGC-1α-dependent manner and subsequently elevate the levels of NRF-1 
(Schreiber et al., 2004). Subsequently, PGC-1α coactivates NRF-1 and NRF-2 binding to 
regulatory regions of the Tfam promoter (Wu et al., 1999). Tfam is a nuclear-encoded 
transcription factor essential for the replication, maintenance, and transcription of mitochondrial 
DNA (Finck & Kelly, 2006), and possesses the ability to bend and unwind DNA during 
stimulation of transcription after its binding to target DNA (Scarpulla, 2008). Tfam is required 
and responsible for normal expression of mitochondrial DNA and function (Larsson et al., 
1998;Ekstrand et al., 2004). Contractile activity-induced mitochondrial biogenesis is thought to 
occur through the stimulation of this pathway in skeletal muscle (Baar, 2004;Hood et al., 2006). 
Multiple roles for these factors and several other PGC-1α partners have been identified in the 
regulation of skeletal muscle metabolism (Fig. 2.1) and are considered below. Our current 
understanding of the physiological role of PGC-1α in skeletal muscle metabolism has largely 
been established based on the results of overexpression/gain-of-function and knockout/loss-of-
function experiments. 
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Figure 2.1 Regulation of PGC-1α expression in skeletal muscle and mechanisms by which PGC-1α 
stimulates mitochondrial gene expression. Coactivation of MEF2 by PGC-1α provides a positive feed-
forward signal to rapidly induce PGC-1α expression following muscle contraction. PGC-1α induces the 
expression of ERRα, which activates the expression of NRF-1, NRF-2, and ERRα itself. These molecular 
events lead to the stimulation of nuclear-encoded mitochondrial genes, (reproduced from Lin et al., 2005). 
2.2.3 Regulation of glucose disposal 
The insulin-responsive GLUT4 transporter is highly expressed in skeletal muscle and its 
activation and translocation the cell membrane accounts for the majority of insulin- and 
contraction-mediated skeletal muscle glucose uptake (Dohm, 2002). Muscle-specific GLUT4 
knockout markedly attenuates insulin-mediated glucose disposal (Kim et al., 2001), whereas 
skeletal muscle GLUT4 overexpression improves whole body insulin sensitivity (Ren et al., 
1995). In addition, a single bout of exercise in known to increase the transcription and 
expression of GLUT4 mRNA and protein content (Neufer & Dohm, 1993;Kraniou et al., 2006). 
Expression of the GLUT4 gene requires two distinct binding regions on the GLUT4 promoter for 
the MEF2 (Thai et al., 1998) and GEF transcription factors (Oshel et al., 2000). The molecular 
regulation of the GLUT4 gene and its response to exercise is thought to be associated with 
PGC-1α (McGee & Hargreaves, 2006). Adenoviral-induced expression of PGC-1α induces 
expression of GLUT4 and increases glucose transport in C2C12 cells (Michael et al., 2001) 
whereas conditional overexpression of PGC-1α in murine muscle increases muscle glycogen 
storage via several mechanisms including stimulation of glucose import, suppression of 
glycolytic flux, and by downregulation of the expression of glycogen phosphorylase (Wende et 
al., 2007). This effect is potentially mediated by a MEF2-HDAC-PGC-1α regulatory mechanism. 
Association with class II HDACs in the basal state represses MEF2 transcriptional activity. 
Removal of HDAC repression on MEF2 via HDAC phosphorylation allows MEF2 to act on its 
binding site in the promoter region of the GLUT4 gene and recruit PGC-1α to enhance the 
transcription process. A single bout of exercise reduces HDAC5 association with MEF2 (McGee 
& Hargreaves, 2004), possibly through phosphorylation of HDAC5 by exercise-induced kinases 
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such as AMPK and CaMKII (McGee & Hargreaves, 2006). Similarly, HDAC4-associated 
repression of MEF2 transcriptional activity is decreased coincident with HDAC4 nuclear efflux in 
electrically stimulated muscle fibres (Liu et al., 2005). In addition, acute exercise increases 
physical MEF2/PGC-1α association (McGee & Hargreaves, 2004), which taken together would 
result in exercise-induced enhancement in MEF2 transcriptional function, thereby potentially 
leading to increased PGC-1α and GLUT4 expression by the mechanisms described. 
2.2.4 Regulation of substrate utilisation 
In addition to regulating glucose transport at the level of transcription, forced expression of 
PGC-1α in C2C12 cells regulates the balance between carbohydrate and lipid metabolism by 
inducing PDK4 mRNA and protein expression leading to a reduction in glucose oxidation 
(Wende et al., 2005). The induction of GLUT4 expression is critical to the uptake of glucose 
under stimulated conditions. However, the ability of the muscle to switch effectively between 
fuel sources for oxidation and storage when challenged with fasting and feeding is an essential 
feature of metabolic flexibility (Storlien et al., 2004). This is also true in the post-exercise period 
wherein rapid glycogen repletion following a bout of intense exercise is an important adaptive 
response, preparing the muscle for subsequent bouts of activity. Thus the post-exercise period 
is characterised by a reduction in glucose oxidation, increase in glycogen synthesis and 
increase mitochondrial fatty acid oxidation (Kimber et al., 2003). This acute metabolic response 
is thought to be PGC-1α-mediated through the coordinated induction of genes encoding 
proteins involved in these processes. The pyruvate dehydrogenase complex (PDC) is the key 
step regulating the complete oxidation of glucose proceeding from glycolysis to the Kreb cycle. 
Inactivation of this complex via phosphorylation by PDK4 shuts down the conversion of pyruvate 
to acetyl CoA, resulting in allosteric inhibition of glycolysis and suppression of glucose oxidation 
leading to the diversion of imported glycogen precursors to storage (Sugden & Holness, 2006). 
PGC-1α-associated induction of PDK4 expression is mediated by the activity of ERRα and 
FOXO1A (Furuyama et al., 2003;Wende et al., 2005;Araki & Motojima, 2006). FOXO1A is a 
forkhead transcription factor, regulated by posttranslational modifications including acetylation 
and phosphorylation and known to regulate genes involved in energy metabolism (Accili & 
Arden, 2004;Gross et al., 2008). Induction of ERRα and subsequent binding to the PDK4 gene 
promoter in a complex with PGC-1α is induced by PGC-1α and results in increased PDK4 
expression, a pathway in which ERRα is indispensable (Wende et al., 2005).  
In transgenic mice overexpressing muscle-specific FOXO1A, PGC-1α mRNA levels are 
increased at rest suggesting that FOXO1A promotes PGC-1α gene expression in muscle 
(Kamei et al., 2004). In skeletal muscle, FOXO1A is known to positively regulate fat metabolism 
and glucose sparing through the induction of LPL and PDK4 gene transcription (Kamei et al., 
2003;Furuyama et al., 2003) and fat transport by enhancing FAT/CD36 expression in the 
plasma membrane (Bastie et al., 2005). FOXO1A binds directly to the PDK4 promoter (Kwon et 
al., 2004) and overexpression of inducible FOXO1A in C2C12 cells increases PDK4 expression, 
leading to decreased pyruvate dehydrogenase activity and glycolytic flux (Bastie et al., 2005). 
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2.2.5 Regulation of lipid metabolism 
In addition to the role of ERRα in the induction of PDK4 expression and reduction of glucose 
oxidation, ERRα is capable of regulating the lipid metabolism by inducing the expression of 
MCAD, an enzyme catalysing the first step of the β-oxidation pathway (Sladek et al., 1997). The 
results of ERRα overexpression and cotransfection studies demonstrate that MCAD is an 
endogenous target for ERRα and but that only in the presence of PGC-1α does ERRα 
transactivate the MCAD promoter (Huss et al., 2002;Huss et al., 2004).  
PGC-1α was identified as a regulator of lipid metabolism by virtue of its ability to increase 
mitochondrial fatty acid oxidative enzyme gene expression and cellular oxidation rates in 
concert with PPARα in preadipocytes (Vega et al., 2000). Similar findings have been reported in 
L6 muscle cells where PGC-1α overexpression upregulates PPAR-target genes involved in fatty 
acid catabolism and β-oxidation (Koves et al., 2005). These results have been recapitulated in 
vivo with the additional observation that fatty acid transporters and the rate of mitochondrial fatty 
acid oxidation were increased after PGC-1α transfection (Benton et al., 2008). The resultant 
modest overexpression of PGC-1α protein in rodent muscle upregulates expression of proteins 
involved in lipid metabolism at the level of membrane (FABPpm, FAT/CD36) and mitochondrial 
transport (CPT1). 
These results suggest that induction of PGC-1α controls muscle fuel selection by increasing 
glucose uptake but reducing glucose oxidation, thereby increasing glucose storage, while at the 
same time reciprocally upregulating mitochondrial fatty acid oxidation. Therefore, PGC-1α has a 
critical role in fuel selection in resting skeletal muscle and in response to physiological stimuli. 
2.2.6 Overview of mitochondrial biogenesis 
2.2.6.1 Fundamentals of mitochondrial biogenesis 
The process of mitochondrial biogenesis refers to increase in muscle mitochondrial volume and 
alterations in organelle composition, a well-established consequence of endurance training 
(Holloszy, 1967;Hoppeler et al., 1973). This is a complex and highly regulated process requiring 
the coordination and coexpression of both the nuclear and mitochondrial genomes for the 
assembly and expansion of the reticulum (Hood, 2001;Goffart & Wiesner, 2003). These 
processes include the transcription of nuclear genes, translation of the newly formed mRNAs 
and import of proteins into mitochondria, replication of mtDNA, transcription and translation of 
mitochondrial genes, biosynthesis of mitochondrial membrane phospholipids, and assembly of 
the enzyme complexes (Freyssenet et al., 1996). The expression of genes promoting 
mitochondrial biogenesis is predominantly controlled by the global principles of gene expression 
(Goffart & Wiesner, 2003) described in section 2.1. In the context of skeletal, mitochondrial 
biogenesis is regulated by signals intrinsic to the contracting muscle (Hood, 2001) described 
later in section 2.6. These signals are known to activate protein kinases and phosphatases that 
modify the activity of transcription factors acting in the nucleus, as well as mRNA stability factors 
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acting within the cytosol, resulting in an increase in the mRNA expression of nuclear-encoded 
mitochondrial proteins (Fig. 2.2). The translated proteins are then appropriately chaperoned to 
the mitochondria and imported into the different organelle compartments, such as the matrix 
space, the inner or outer membranes. A small subgroup of nuclear-encoded mitochondrial 
proteins comprises transcription factors that act directly on mitochondrial DNA (mtDNA) to 
increase the mRNA expression of mitochondrial gene products, as well as mtDNA copy number 
(Scarpulla, 2008). One such factor, Tfam, regulates the expression of the thirteen mtDNA gene 
products, including proteins such as COX. Nuclear-encoded mitochondrial proteins and mtDNA-
encoded proteins are assembled to form multi-subunit enzyme complexes required for oxygen 
consumption and ATP synthesis. This coordination between nuclear and mitochondrial 
genomes is necessary for organelle biogenesis.  
Exercise-induced modulation of these processes either directly or indirectly by targeting other 
regulatory factors (e.g. ERRα, MEF2), and therefore has the ability to modulate the 
mitochondrial phenotype. Although the modulation of mitochondrial phenotype is important to 
the function of skeletal muscle during exercise, dysfunctional mitochondria have been 
implicated in the age-related loss of muscle mass i.e. sarcopenia (Bua et al., 2002) and insulin 
resistance (Lowell & Shulman, 2005). Thus, mitochondrial biogenesis induced by chronic 
exercise is now recognized to have implications for a broader range of health issues than just 
the enhancement of endurance performance. 
 
Figure 2.2 Mitochondrial biogenesis is a component of contractile activity-induced muscle plasticity 
(reproduced from Hood et al., 2006) 
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2.2.6.2 PGC-1α in the regulation of mitochondrial biogenesis 
PGC-1α overexpression both in vivo and in vitro is associated with an increase in the induction 
of mitochondrial gene expression program including increased respiratory chain subunit 
expression, mitochondrial density and mitochondrial enzyme activity (Wende et al., 
2007;Benton et al., 2008). Skeletal muscle-specific PGC-1α overexpression driven by the 
muscle creatine kinase promoter results in the transition from type II fibres to an increased 
proportion of type I muscle fibres coincident with increased oxidative phenotype, expression of 
mitochondrial markers and resistance to electrically stimulated fatigue (Lin et al., 2002). The 
regulation of this phenomenon through PGC-1α, NRFs and ERRα was described in section 
2.2.2. In addition to the stimulatory effect of NRFs on Tfam expression, these transcription 
factors also bind to target sequences on nuclear- and mitochondrial-encoded mitochondrial 
genes, including cytochrome c and COXIV (Scarpulla, 2008). Similarly, ERRα has recently been 
associated with PGC-1α-induced mitochondrial biogenesis (Schreiber et al., 2004;Mootha et al., 
2004) in association with NRF-2. ERRα was shown to be essential for PGC-1α-mediated 
mitochondrial biogenesis and function upstream of the previously mentioned NRF-1 action in 
the program of oxidative phosphorylation gene expression (Mootha et al., 2004). To this end, 
ERRα binding sites are present in the promoters of genes such as cytochrome c and β-ATP 
synthase (Scarpulla, 2008). 
2.2.6.3 Functional consequences of mitochondrial biogenesis 
The major functional adaptation that occurs within skeletal muscle fibre types as a result of 
endurance training is an improvement in fatigue resistance, which is strongly correlated with an 
increased mitochondrial enzyme activity (Holloszy, 1967;Baldwin et al., 1972;Walsh et al., 
2001). This is evidenced by an increased capacity to oxidize respiratory substrates in whole 
homogenates (Baldwin et al., 1972), isolated mitochondria (Holloszy, 1967;Bizeau et al., 
1998;Tonkonogi et al., 2000) and permeabilised muscle fibres (Walsh et al., 2001). Studies of 
mitochondria isolated from endurance-trained muscle have revealed a reduced sensitivity to 
ADP-stimulated respiration (Walsh et al., 2001), but an enhanced creatine-stimulated response 
(Tonkonogi & Sahlin, 2002). The combination of a greater response to creatine, along with the 
higher overall mitochondrial content of trained muscle, leads to a greater sensitivity of whole 
muscle mitochondrial respiration to ADP (Dudley et al., 1987). The greater mitochondrial 
content means that a lower ADP is required to achieve the same level of oxygen consumption 
per gram of muscle (Dudley et al., 1987). This reduces the consumption of phosphorylcreatine, 
attenuates the rate of glycolysis and lactic acid production, reduces the formation of AMP and 
ammonia, improves the fraction of energy obtained aerobically, and decreases the activation of 
AMPK. It also means that each mitochondrial electron transport chain operates at a lower 
fraction of its maximal rate to produce the same oxygen consumption as before the adaptation 
took place (Hood, 2001). 
These are the molecular mechanisms underpinning the functional consequences of endurance 
training i.e. a reduction on the reliance of carbohydrate as a fuel and an increase in the 
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contribution from lipid sources when exercise is performed at the same relative exercise 
intensity after a period of training (Holloszy & Coyle, 1984). These adaptations are considered 
specifically in section 2.5.1. From a disease perspective, a current hypothesis is that inefficiency 
to couple “complete” β-oxidation of fatty acids to mitochondrial respiration in skeletal muscle is a 
possible cause of insulin resistance and type 2 diabetes (Koves et al., 2008). Exercise training-
induced and PGC-1α-associated mitochondrial remodelling is proposed to favourably alter the 
efficiency of mitochondrial fatty acid oxidation resulting in a reduction in the accumulation of 
intramuscular acylcarnitines, metabolic by-products of incomplete fatty acid oxidation, thus 
ameliorating lipid-induced glucose intolerance (Koves et al., 2005). 
2.2.7 Metabolic consequences of PGC-1α knockout 
PGC-1α overexpression/gain-of-function studies demonstrate the capability of PGC-1α 
induction to alter skeletal muscle metabolism, but the necessity of PGC-1α in regulating 
metabolic processes is better established in knockout/loss-of-function studies. Whole body 
PGC-1α knockout mice display multiple pathologies indicative of altered energy metabolism 
including an inability to evoke a thermogenic response upon exposure to cold, and reduced 
mitochondrial content and oxidative capacity in type I muscle fibres leading to a reduction in 
exercise tolerance (Lin et al., 2004a;Leone et al., 2005). Muscle-specific PGC-1α knockout mice 
(Handschin et al., 2007b) have been generated to examine the isolated effects on skeletal 
muscle in the absence of the influence of whole body phenotypical changes such as 
hyperactivity exhibited by whole body knockouts (Lin et al., 2004a). These muscle-specific 
knockout mice have a higher percentage of the glycolytic type IIx and IIb fibres at the apparent 
expense of a loss of oxidative type I and IIa fibres, reduced voluntary physical activity and 
impaired exercise endurance and strength performance (Handschin et al., 2007a). The 
metabolic phenotype of these mice is one of impaired glucose tolerance but not peripheral 
insulin resistance despite impaired mitochondrial function (Handschin et al., 2007b). The 
transcriptional mechanisms underlying these alterations in muscle metabolism may be the 
coordinated downregulation of mRNAs for transcription factors regulating mitochondrial 
biogenesis (ERRα, NRF-2), mRNAs encoding proteins of oxidative phosphorylation 
(cytochrome c, COXVb, β-ATP synthase) and mRNA of the glucose transporter GLUT4. 
Mitochondrial enzymatic activity was also reduced in these knockouts coupling the decrease in 
mitochondrial gene expression with defects in mitochondrial function (Handschin et al., 2007b). 
The effect of muscle-specific PGC-1α knockout on the regulation of metabolic and mitochondrial 
gene expression at rest and in response to exercise is considered in section 2.6.8. 
2.2.8 Summary 
Collectively this section demonstrates that PGC-1α has a critical role in the control of skeletal 
muscle metabolism at rest and in the induction of appropriate cellular responses to physiological 
stimuli. In addition, this level of control resides in its ability to coordinate the expression of 
mitochondrial and metabolic genes. Although the data do not fully demonstrate causation, PGC-
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1α is necessary for the normal expression of nuclear- and mitochondrial-encoded mitochondrial 
gene expression. A critical aspect to this control is its versatility in its ability to respond to 
cellular signals by interacting with a variety of transcription factors and other regulators to 
induce the expression of well-defined gene subsets depending on the physiological response 
required. The functional interactions of PGC-1α with its transcriptional partners in effecting the 
responses described above are in turn regulated by the functional activity of existing PGC-1α 
protein as described below. 
2.3 Regulation of PGC-1α-associated transcriptional activity 
As would be predicted by its inducibility, the activity of PGC-1α is linked to variety of upstream 
signal transduction pathways that modulate PGC-1α function and protein stability through 
posttranslational modifications. These modifications are one means of modulating metabolic 
function through the activation or inactivation of enzymes, or by affecting protein stability. In the 
context of transcriptional regulation, posttranslational modifications are a means of altering 
transcriptional regulators either by affecting transcription factor/coregulator nuclear translocation 
or exclusion, or by affecting activation status of the factor within the nucleus (Desvergne et al., 
2006). This is of major importance to muscle metabolism as it links intracellular signalling to 
transcriptional regulation (Feige & Auwerx, 2007). Phosphorylation-dependent regulation of 
PGC-1α stability and activity, and the regulation of acetylation-mediated metabolic regulation 
through the Sirt1 deacetylase have been established (Fig. 2.3)(Rodgers et al., 2008). 
2.3.1 Regulation by phosphorylation 
The half-life of PGC-1α protein is relatively short (2.3 h) (Handschin & Spiegelman, 2006). 
Therefore, upon cessation of stimulatory pathways on PGC-1α expression, PGC-1α protein is 
rapidly degraded and induction of many PGC-1α downstream target genes returns to basal 
levels. Phosphorylation of PGC-1α by p38 MAPK (section 2.6.4), leads to a tripling of protein 
half-life, and thus higher PGC-1α protein levels are observed (Puigserver et al., 2001). 
Conversely, in liver cells, PGC-1α protein stability is reduced by phosphorylation by Akt (Li et 
al., 2007). As well as affecting PGC-1α protein stability, phosphorylation by p38 MAPK 
enhances the transcriptional activity of PGC-1α (Puigserver et al., 2001). Phosphorylation at 
these p38 MAPK sites removes the repressive effect of inhibitory factor known as p160 myb 
binding protein on PGC-1α activity (Fan et al., 2004). In skeletal muscle, AMPK (section 2.6.2) 
is known to directly phosphorylate PGC-1α at two sites that are indispensable to the effect of 
AMPK on PGC-1α mRNA induction and protein function, and the expression of metabolic and 
mitochondrial genes (Jager et al., 2007). Phosphorylation by AMPK enhances the functional 
activity of PGC-1α on its own promoter. Similarly, although untested, AMPK-mediated 
phosphorylation could modulate the ability of PGC-1α to dock on certain transcription factors or 
affect the binding or function of other cofactors in the PGC-1α coactivator complex. This might 
provide a simple explanation by which this kinase could activate certain PGC-1α functions in 
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muscle (Zong et al., 2002). The activation of calcium signalling cascades in skeletal muscle has 
also been implicated in the induction of PGC-1α activity, although the precise mechanism is not 
well defined (Wu et al., 2002;Wright et al., 2007a). That acute exercise results in the activation 
of each of these signal transduction kinases (section 2.6) strongly implicates rapid alterations in 
PGC-1α protein as a key regulatory mechanism in the exercise-induced modulation of skeletal 
muscle metabolism (Atherton et al., 2005;Akimoto et al., 2005;Wright et al., 2007b). 
2.3.2 Regulation by acetylation 
The acetylation status of PGC-1α protein is the most prominent modification in terms of control 
of its activity and physiological output (Feige & Auwerx, 2007;Rodgers et al., 2008). Functional 
activity of PGC-1α is inhibited by acetylation and the PGC-1α acetylation status is directly 
balanced by the action of the GCN5 acetyltransferase and the NAD+-dependent Sirt1 
deacetylase in liver (Rodgers et al., 2005;Lerin et al., 2006) and skeletal muscle cells . GCN5 
directly acetylates PGC-1α, negatively regulating its transcriptional activity in part through 
nuclear sublocalisation, at least in liver cells (Lerin et al., 2006;Gerhart-Hines et al., 2007). Sirt1 
is capable of direct physical interaction with PGC-1α, deacetylating the PGC-1α protein and 
increasing its transcriptional activity (Nemoto et al., 2005). Sirt1 is a member of the sirtuin family 
of NAD+-dependent class III HDACs, which are capable of coupling the cleavage of NAD+ to 
nuclear gene expression (Gerhart-Hines et al., 2007;Dali-Youcef et al., 2007). In this model of 
metabolic regulation, increases in NAD+ levels are sensed by Sirt1, which is in turn activated. 
Sirt1 then targets and deacetylates PGC-1α at promoter regions of target genes to induce gene 
expression of mitochondrial and fatty acid oxidation to maintain the bioenergetic state of the cell 
(Rodgers et al., 2008). This model provides a molecular mechanism by which fluctuations in 
energy status of the cell induce cellular adaptation. During muscle contraction, the NAD+/NADH 
ratio is subject to dynamic fluctuations imposed by the rate of NAD+ reduction to NADH and rate 
of NADH oxidisation to NAD+ (Robergs et al., 2004). However, our understanding of Sirt1 
regulation in skeletal muscle is limited. 
2.3.3 Sirt1-mediated metabolic regulation 
The regulation of Sirt1 at a translational level is currently unknown. However, Sirt1 enzymatic 
activity is directly affected by fluctuations in NAD+ as well as the ratio of NAD+/NADH. NAD+ is 
an obligate cosubstrate (Imai et al., 2000), whereas NADH (Lin et al., 2004b) and nicotinamide 
(Bitterman et al., 2002) are inhibitors of Sirt1. Thus, the redox state of the cell controlled by the 
activation of different metabolic pathways that change these variables will affect Sirt1 activity 
(Rodgers et al., 2008). The potential role of Sirt1 was first shown in the liver, where Sirt1 in a 
complex including HNF-4 deacetylates and activates PGC-1α, promoting gluconeogenesis and 
expression of fatty acid oxidation genes following fasting (Rodgers et al., 2005). Fasting 
increases in the levels of pyruvate and NAD+ in the liver which resulted in elevated Sirt1 protein 
and enzymatic activity.  
 






































Figure 2.3 Regulation of the physiological output of PGC-1α by (A) acetylation, and (B) phosphorylation. 
See text for detailed discussion. 
 
A compound known as resveratrol significantly increase Sirt1 activity through an allosteric 
interaction, resulting in the increase of Sirt1 affinity for both NAD+ and the acetylated substrate 
(Howitz et al., 2003). In skeletal muscle, Sirt1-mediated effects on PGC-1α regulation and target 
gene expression in vivo have recently been established (Lagouge et al., 2006). Myofibres from 
resveratrol-treated mice were enriched in mitochondria, exhibited enhanced oxidative capacity, 
and displayed a greater resistance to fatigue because of the concerted activation of a genetic 
program geared for aerobic metabolism (Lagouge et al., 2006). The effects of resveratrol on 
PGC-1α target gene expression were dependent on the presence of the wild-type PGC-1α 
protein. In addition, these effects were lost in cases where the acetylation sites in PGC-1α that 
are targeted by Sirt1 were mutated or when Sirt1 expression was disrupted. Gene-expression 
analysis supported an increase in fatty-acid oxidation since MCAD expression was increased 
and glucose utilization reduced as PDK4 levels were increased. Gerhart-Hines et al. (2007) 
have since shown that Sirt1 was bound to promoters of PGC-1α targets such as cytochrome c, 
PDK4 and PGC-1α and ectopic expression of PGC-1α induced a 7-10-fold recruitment of Sirt1 
to these promoters. In addition, this ectopic PGC-1α expression increased ERRα expression 
and increased mitochondrial gene expression, including respiratory chain (cytochrome c, 
COXV) and fatty acid utilization (MCAD, CPT1 and PDK4) genes, an effect that was largely 
prevented by knocking down Sirt1 (Gerhart-Hines et al., 2007). 
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However, it cannot be concluded that PGC-1α is the sole target of Sirt1, as Sirt1 interacts with 
and deacetylates other substrates (Dali-Youcef et al., 2007), including potential regulators of 
metabolism and mitochondrial function such as FOXO1A (Brunet et al., 2004;Motta et al., 
2004). The role of acetylation of FOXO1A is less clear; acetylation impairs FOXO1A factor 
activity on reporter constructs but has also been reported to enhance FOXO1A activity (van der 
Heide & Smidt, 2005). It is possible that acetylation either enhances or represses FOXO factors 
in a target-gene-specific context or tissue-specific context. In general, acetylation of FOXO1A 
reduces its DNA binding activity and makes its more sensitive to phosphorylation, resulting in 
nuclear exclusion and cytosolic proteasomal degradation (Matsuzaki et al., 2005). However, 
p300-mediated FOXO1A acetylation results in transcriptional activation (Perrot & Rechler, 
2005). Deacetylation of FOXO1A renders the protein resistant to phosphorylation and results in 
nuclear accumulation of the protein (Frescas et al., 2005). Reports demonstrating Sirt1-
mediated effects on FOXO1A transcriptional activity are conflicting, with activity repressed in 
prostate cancer cells (Yang et al., 2005b) but activated in liver cells (Nakae et al., 2006). The 
role of FOXO1A acetylation in skeletal muscle metabolism or an exercise context is not 
established. In rodents, FOXO proteins act as switch from carbohydrate to predominantly lipid 
utilisation as a fuel substrate in skeletal muscle during periods of starvation (Furuyama et al., 
2003). However, in humans fasted for 48 h, FOXO1A mRNA, total protein expression and Ser256 
phosphorylation were unaltered despite marked changes in whole body metabolism and the 
expression of the FOXO1A target, PDK4 (Tsintzas et al., 2006). 
2.4 The role of corepression in metabolic regulation 
Whereas the importance of activating gene transcription in the regulation of skeletal muscle 
metabolism is well established, the contribution of transcriptional inhibition is less well defined 
(Christian et al., 2006). Recently it has been shown that a transcriptional corepressor known as 
RIP140 exerts critical physiologic roles by actively repressing gene transcription (Powelka et al., 
2006;Seth et al., 2007;White et al., 2008). RIP140 is a ligand-dependent corepressor for most, if 
not all, nuclear receptors by binding to nuclear receptors through their LXXLL motifs. Because 
several nuclear receptor coactivators also possess and utilize these motifs, RIP140 may 
compete with the coactivators of the same binding sites on the ligand-bound receptors 
(Christian et al., 2006). RIP140 acts as scaffold protein in a similar manner to PGC-1α but has 
the opposite effects, recruiting chromatin remodelling enzymes leading to chromatin 
condensation and transcriptional repression (White et al., 2008). The repressive function of 
RIP140 is mediated by the presence of four repression domains which recruit HDACs leading to 
increased repression (Wei et al., 2000). The recruitment of HDACs is mediated by the binding of 
the carboxyl-terminal binding protein (CtBP). CtBP is a functional dehydrogenase that binds 
both NAD+ and NADH (Zhang et al., 2002) and is associated with repression of transcription by 
RIP140 by facilitating HDAC recruitment (White et al., 2008). Therefore changes in cellular 
redox potential may affect RIP140 repressive activity mediated by CtBP acting as a sensor of 
redox state (White et al., 2008). This may have functional consequences for control of gene 
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expression in skeletal muscle after exercise as acute exercise is known to alter redox state (see 
section 2.6.5). 
Like PGC-1α, the control of RIP140 repressive activity is largely under the control of 
posttranslational modifications including phosphorylation and acetylation (White et al., 2008). 
Phosphorylation of RIP140 results in greater HDAC recruitment and enhanced repression 
(Gupta et al., 2005), whereas acetylation of RIP140 prevents CtBP recruitment and relieves 
transcriptional repression (Vo et al., 2001). Therefore it is likely that cellular signal transduction 
cascades regulate its activity but acute exercise-induced effects are entirely unexplored at this 
time. The expression pattern in skeletal muscle is opposite to PGC-1α expression; expression 
in lowest in muscles with high oxidative capacity and highest in muscles with higher glycolytic 
activity (Seth et al., 2007). 
RIP140 plays a crucial role in lipid metabolism demonstrated by the fact that RIP140-null mice 
are lean and resistant to obesity (Leonardsson et al., 2004), an effect mediated by the 
upregulation of a number of metabolic genes (Powelka et al., 2006). The increased expression 
of GLUT4 and the mitochondrial proteins COXVb and SDH in cultured RIP140-null adipocytes is 
ERRα-dependent (Powelka et al., 2006). In skeletal muscle, RIP140 depletion markedly 
upregulates genes encoding metabolic enzymes and proteins that catalyze mitochondrial 
respiration, a phenomenon that may also be ERRα-dependent. The phenotype of RIP140-null 
mice is remarkably similar to PGC-1α overexpression experiments, with RIP140-depletion of 
muscle previously high in RIP140 expression exhibiting a more oxidative fibre type coincident 
with increased mitochondrial number and an upregulation of genes involved in oxidative 
metabolism, most notably fatty acid oxidation (Seth et al., 2007). Conversely, a reduction in 
mitochondrial gene expression is seen in transgenic mice overexpressing RIP140. Therefore 
the effects of RIP140 on transcriptional repression may be dependent on the relative expression 
of RIP140 evidenced by the differences and the intermediate phenotypes observed in 
heterozygous animals (White et al., 2008). Finally, overexpression of RIP140 in transgenic mice 
does not impair muscle fibre remodelling in response to six weeks of voluntary exercise training 
compared to wild-type mice (Seth et al., 2007), suggesting that RIP140 does not alter the 
exercise training response but does determine the relative oxidative capacity. 
The mechanism by which these effects are controlled is not fully understood. In the context of 
skeletal muscle fat oxidation, RIP140 has been shown to bind directly to MCAD and MCAD 
expression is increased in the RIP140-null muscle, coincident with an increase in ERRα (Seth 
et al., 2007). As described earlier, ERRα induction of MCAD is PGC-1α-dependent. In general, 
there is a remarkable similarity between RIP140 and PGC-1α target genes, with RIP140 
primarily repressing and PGC-1α activating, suggesting a functional interplay between the 
coregulators could be an integral part of the regulation of metabolic processes (White et al., 
2008). 
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2.5 Skeletal muscle plasticity in response to contractile activity 
The phenomenon of skeletal muscle plasticity is illustrated by the remodelling of the muscle’s 
structure and functional make-up, as seen in muscular force, endurance and contractile velocity 
of mammalian skeletal muscle, as a result of alterations in functional demand (Booth & Baldwin, 
1996;Fluck, 2006). The adaptation to endurance exercise is characterised by functional 
adaptations in proteins involved in mitochondrial ATP production (Holloszy, 1967), mobilisation, 
transport and oxidation of fatty acids (Bonen et al., 1999), glucose transport and glycogen 
synthesis (Houmard et al., 1993), and oxygen delivery to and extraction from skeletal muscle 
(Hickson, 1981). These adaptations collectively contribute towards maximising substrate 
delivery, respiratory capacity and contractile parameters during submaximal exercise. The net 
effect is an enhanced resistance to fatigue, or what is thought of as a more robust defence of 
homeostasis in the face of metabolic perturbation (Mahoney & Tarnopolsky, 2005). 
Although each individual bout of exercise is necessary as a stimulus for adaptation, it alone is 
not sufficient to alter muscle phenotype. A change in muscle phenotype is the result of repeated 
bouts of exercise. The adaptation is mediated at transcriptional level, where pulses of elevated 
mRNA abundance after acute bouts of exercise may accumulate to new steady-state level, 
which after translation leads to a change in protein abundance and associated physiological 
adaptation (Fig. 2.4)(Booth & Baldwin, 1996;Williams & Neufer, 1996;Hood et al., 2006;Fluck, 
2006). In support of this hypothesis, endurance-trained athletes with approximately two-fold 
higher VO2peak and muscle mitochondrial volume compared to sedentary individuals have 
elevated mRNA concentrations for genes encoding six enzymes involved in oxidative 
phosphorylation (Puntschart et al., 1995). These elevations were in direct proportion to the 
higher mitochondrial content of the muscle. Enhanced levels of gene transcripts therefore 
support the synthesis of protein components and provoke structural remodelling and functional 
adjustments in the long term (Fluck, 2006). 
 
Figure 2.4. Microadaptations of transcript expression relate to the training effect. Model of the increase in 
RNA and endurance performance with repetition of exercise. Each bout of exercise leads to an overshoot 
of transcript levels in the recovery phase from fatiguing exercise, which leads via translation to a 
microadaptation of the encoded protein and related structure. This relays to the gradual accumulation (∆) 
of mitochondrial volume density and the improved oxidative capacity with repetition of endurance exercise. 
A match of transcriptional, structural and functional parameters is observed in recruited muscle groups 
between untrained and endurance-trained steady-states, (reproduced from Fluck, 2006). 
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2.5.1 Adaptations to exercise training 
2.5.1.1 Mitochondrial and biochemical adaptations 
Regular endurance training improves performance during tasks that rely mainly on aerobic 
energy metabolism, in large part by increasing the body’s ability to transport and use oxygen 
and altering substrate metabolism by working skeletal muscle. The adaptive increase in skeletal 
muscle oxidative capacity after exercise training was first established over forty years ago 
(Holloszy, 1967). Twelve weeks of training (5 d/wk) resulted in an approximately two-fold 
increase in mitochondrial enzymes (SDH, NADH dehydrogenase, COX activities per gram of 
muscle) and in the capacity of skeletal muscle to oxidize pyruvate. This provided evidence of 
mitochondrial biogenesis in skeletal muscle in response to exercise training, a fact that was 
confirmed in human muscle when it was demonstrated that an increase in mitochondrial size 
and number was evident after several years of endurance training (Hoppeler et al., 1973). 
Protein concentration of cytochrome c in skeletal muscle was also increased two-fold and the 
protein fraction of mitochondria in total muscle was increased by approximately 60% (Holloszy, 
1967). This was reflective of an increase in mitochondrial number. Endurance capacity was 
improved by approximately six-fold in these animals. In humans, an increase in total 
mitochondrial volume density by 40% in m. vastus lateralis and increase in maximal oxygen 
uptake capacity increase by 14% has been reported when sedentary subjects were trained for 
six weeks (5 d/wk for 30 min) and are typical of results observed (Hoppeler et al., 1985). These 
changes were accompanied by an increase of the volume density of mitochondria in all three 
fibre types, the difference being somewhat larger in type IIa than in type I and type IIx fibres 
(Howald et al., 1985). 
2.5.1.2 Effects on glycolytic metabolism 
Endurance training generally has little effect on or reduces the enzymatic activity of glycolytic 
enzymes with the exception of hexokinase, which increases after a period of exercise training 
(Baldwin et al., 1973;Green et al., 1983;Phillips et al., 1996b). Intense endurance training leads 
to a reduction in the enzymatic activity of glycogen phosphorylase, GAPDH, pyruvate kinase 
and LDH in rodent skeletal muscle (Green et al., 1983). However, in human skeletal muscle, no 
change is observed in the enzymatic activity of LDH, PFK, PK, GAPDH, HK or glycogen 
phosphorylase after ten to twelve days of training (Green et al., 1991). Comparison of skeletal 
muscle from elite distance runners and untrained men shows no difference in glycogen 
phosphorylase activity but a reduction in LDH activity in the trained muscle (Fink et al., 1977) 
consistent with data from rodent muscle. Similarly, no difference existed in PFK activity when 
comparing trained and untrained muscle (Gollnick et al., 1972), although these authors 
subsequently reported that PFK activity was increased in response to five months of endurance 
training (Gollnick et al., 1973). Although many enzymes of the glycolytic pathway may not be 
upregulated by endurance exercise training, the concentration of the muscle glucose transport 
protein GLUT4 is consistently increased with acute exercise (Kraniou et al., 2004), short- (Gulve 
& Spina, 1995), and long-term (Houmard et al., 1993) training. Therefore, it is likely that the 
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training effect on glucose metabolism enhances the ability to store muscle glycogen but has 
little effect on the catabolism of glucose at the level of the glycolytic pathway. 
2.5.1.3 Effects on lipid metabolism 
In addition to increased enzymatic activity of mitochondrial β-oxidation enzymes observed after 
endurance training (e.g. β-HAD) (Spina et al., 1996), exercise training alters several regulatory 
proteins of the fatty acid oxidation pathway. A 70% higher muscle LPL activity in the vastus 
lateralis muscle was demonstrated after eight weeks of regular, dynamic knee-extensor 
exercise training compared with the untrained muscle in the same individuals (Kiens & Lithell, 
1989). Similarly, individuals who engage in regular physical exercise training for several years 
have significantly higher muscle LPL activity than sedentary-matched males and females (Kiens 
et al., 2004). In the same study, FAT/CD36 protein content was not different between groups, 
but short-term training for nine days (Tunstall et al., 2002) as well as a single exercise bout 
(Roepstorff et al., 2004) increased FAT/CD36 protein content slightly (20–25%) in muscle. This 
suggests that increased FAT/CD36 expression is an early adaptation to increased muscle 
activity. Higher FABPpm protein expression in homogenates from the vastus lateralis muscle 
was also demonstrated with exercise training (Kiens et al., 1997). Regulation of fatty acyl-CoA 
entry into the mitochondria by CPT1 has been identified as a rate-limiting step in the oxidation 
of fatty acids (McGarry & Brown, 1997). The activity of CPT1 is higher in muscle from trained 
compared to untrained humans (Berthon et al., 1998;Jong-Yeon et al., 2002), and this was 
strongly correlated with citrate synthase activity and VO2peak (Berthon et al., 1998). In addition, a 
period of training in previously sedentary individuals results in an increase in CPT1 activity 
(Bruce et al., 2006) and FAT/CD36 associated CPT1 protein complexes (Schenk & Horowitz, 
2006). Thus, the net effect exercise training on lipid metabolism is to increase the mitochondrial 
capacity to oxidise fatty acids but also increase the capacity for lipid mobilisation and transport 
across the plasma and mitochondrial membrane. 
2.5.1.4 Effects on fuel storage 
Longitudinal training studies have shown higher concentration of intramuscular triglyceride and 
glycogen in the vastus lateralis muscle in healthy subjects after endurance training (Phillips et 
al., 1996b;Gibala et al., 2006;Schrauwen-Hinderling et al., 2006;Tarnopolsky et al., 2007). 
Cross-sectional data confirm these observations: muscle glycogen and intramuscular 
triglyceride concentrations are higher in endurance-trained athletes compared to sedentary 
individuals (Gollnick et al., 1972;van Loon et al., 2004). 
2.5.2 Metabolic and physiological consequences of endurance training 
When previously sedentary individuals adapt to endurance training, maximal oxygen uptake 
increases and endurance at submaximal intensities increases (Holloszy & Coyle, 1984). The 
increase is maximal oxygen uptake is largely due to an increased ability of the vascular system 
to deliver oxygenated blood and the increase in the muscle’s ability to extract and utilise the 
supplied oxygen (Holloszy & Coyle, 1984). The increased endurance at submaximal exercise 
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intensity is attributed to enhanced fatigue resistance to exercise by virtue of reduced muscle 
glycogen depletion and smaller disturbances to homeostasis with a consequent reduction in 
metabolic by-products (Coggan & Williams, 1995). Well-trained athletes deplete their muscle 
glycogen stores less rapidly during submaximal standardized exercise compared with untrained 
individuals (Hermansen et al., 1967). Endurance training reduces the production, uptake and 
oxidation of plasma glucose during both moderate and intense exercise (Coggan et al., 
1990;Coggan et al., 1995). The decreased carbohydrate utilization during submaximal exercise 
in the trained state is compensated for by a proportional increase in fat oxidation rates at the 
same absolute and relative intensity (Coggan & Williams, 1995). 
2.5.3 Adaptation in skeletal muscle after short-term training (14 days or less) 
The time course of adaptation to endurance exercise is not well described. Although an 
increase in mitochondrial content of approximately 50-100% is generally observed after six 
weeks of training (Hood, 2001), measurable changes in skeletal muscle metabolism such as 
enzymatic activity and altered substrate metabolism during exercise are observed after as little 
as three (Green et al., 1989), five (Green et al., 1992), seven (Spina et al., 1996), ten 
(Mendenhall et al., 1994), fourteen (Gibala et al., 2006) and thirty-one (Phillips et al., 1996b) 
days of training. In addition, adaptations in this time frame are observed at mitochondrial (Spina 
et al., 1996), metabolic (Green et al., 1991), intracellular signalling (McConell et al., 2005) and 
transcriptional (Pilegaard et al., 2003) levels. 
Short-term training has been shown to induce similar metabolic effects to longer term 
endurance training, namely an increase in maximal oxygen uptake, and when exercise was 
performed at the same absolute intensity after training, smaller decreases in high-energy 
phosphates, smaller increases in inorganic phosphate and creatine, a reduction in exercising 
RER, muscle glycogen utilisation and blood lactate accumulation and concomitant increase in 
lipid utilisation was observed (Green et al., 1991;Green et al., 1992;Phillips et al., 1995;Phillips 
et al., 1996a). In these studies, seven to fourteen days of training for 2 h/d at 60-70% VO2peak 
did not result in an increase in mitochondrial enzymes but the training regimen resulted in a 
delayed increase in skeletal muscle mitochondria that did not occur until sometime between the 
second and fourth weeks of training (Green et al., 1995). 
These findings led to the suggestion that metabolic adaptations, such as changes in the 
concentration of allosteric modulators of glycolysis, are largely responsible for the initial 
metabolic consequences of exercise training and occur in the absence of mitochondrial 
adaptation (Green et al., 1992;Phillips et al., 1995). The adaptation in mitochondrial phenotype 
is apparent however after thirty-one days of the same training program (Phillips et al., 1996b). 
However, Spina et al. (1996) have since shown that seven to ten days of the same training 
regimen is sufficient to induce mitochondrial adaptation, as measured by citrate synthase and β-
HAD enzymatic activity, coincident with an increase in maximal oxygen consumption. These 
findings were confirmed by Starritt et al. (1999) who demonstrated increases in citrate synthase 
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activity and mitochondrial ATP production rate in isolated mitochondria after both five and seven 
days of training (Starritt et al., 1999). 
An absence of mitochondrial adaptation would be in some ways contradictory to what intuitively 
would be expected based on our current knowledge of molecular adaptation. The adaptive 
increase in proteins with a short half-life, such as GLUT-4 or δ-ALAS, can occur within two days 
(Holloszy & Winder, 1979;Ren et al., 1994) in response to exercise. In the case of enzymes with 
a longer half-life, such as the mitochondrial enzymes cytochrome c, COX, and citrate synthase 
that have a half-life of seven days, one-half of the adaptive increase in response to a constant 
stimulus occurs within the first week, 75% in the second week, and so on, in skeletal muscle of 
rats (Booth, 1977;Holloszy & Winder, 1979;Town & Essig, 1993). In fact, significant increases in 
mitochondrial respiratory enzymes were observed within two to three days in skeletal muscle of 
rats (Booth, 1977;Holloszy & Winder, 1979). 
Other proteins involved in skeletal muscle metabolism have been shown to be upregulated at 
the protein content or activity level after short-term exercise training. In terms of glucose 
metabolism, resting muscle glycogen (Chesley et al., 1996), hexokinase activity (Spina et al., 
1996) and GLUT4 protein content (Gulve & Spina, 1995) are increased after one week of 
training whereas PFK activity is decreased (Green et al., 1992). The regulation of lipid 
metabolism in response to short-term training is not well defined despite increased fatty acid 
oxidation rates and decreased RER observed during exercise after training (McConell et al., 
2005;Talanian et al., 2007). Increased activity of β-HAD after short-term training (Spina et al., 
1996) indicates a greater capacity for β-oxidation of fatty acids, whereas an increase in 
FAT/CD36 (Tunstall et al., 2002) and FABPpm (Talanian et al., 2007) protein content indicates 
adaptation at the level of lipid transport into the muscle cell. 
Muscle glycogenolysis is regulated by glycogen phosphorylase, which itself is regulated by 
activation by epinephrine via the cAMP second messenger system and the release of calcium 
during contractions (Connett & Sahlin, 1996). The activity of phosphorylase in the active “a” 
form is also stimulated via the contraction-induced accumulation of allosteric regulators, free 
ADP and AMP. Accumulations of free ADP and AMP and consequent activation of 
glycogenolysis are reduced after short-term training (McConell et al., 2005;Talanian et al., 
2007). This suggests there is less homeostatic perturbation associated with exercise after 
training, a fact that is emphasised by the reduction in AMPK activation after short-term training 
(McConell et al., 2005). Little is known about the regulation of other signalling cascades after 
short-term training (section 2.6.7). 
2.5.3.1 Alterations in mRNA abundance in response to short-term training 
What remains unclear is the role of transient induction or incremental accumulation of mRNA 
and the function of transcriptional regulators during the adaptive response to short-term training. 
Coupling increments in mRNA to changes in enzymatic activity has not been demonstrated. For 
instance, HKII mRNA was unchanged after two weeks of exercise training that would be 
expected to increase its enzymatic activity (Schrauwen-Hinderling et al., 2006) whereas Kraniou 
et al. (2004) demonstrated an increase in GLUT4 protein content in the absence of any change 
                                                                                                         Chapter II Review of literature 
30 
in mRNA after seven days of training. In contrast, Tunstall et al. (2002) demonstrated coincident 
increases in both FAT/CD36 mRNA and protein content after nine days of training. These 
results may simply reflect the transient nature of mRNA and protein expression, where the 
sampling points for muscle biopsies may conflict with measurable and functional changes in 
mRNA and protein due to variations in respective half-lives or stability. Thus, although the 
metabolic effects of short-term training are reasonably well-established, the molecular 
mechanisms at the level of mRNA or regulation by transcription factor networks are not 
described despite this fact being widely accepted (Cameron-Smith, 2002;Hood et al., 
2006;Fluck, 2006). However, it does appear that a training-induced accretion of mRNA (1.5-2.2-
fold) is evident after short-term training for metabolic enzymes including HKII, citrate synthase 
and β-HAD, and apparent, but non-significant, increases in steady-state mRNA for factors such 
as NRF-2 and Tfam (Pilegaard et al., 2003). In addition, PGC-1α protein content is increased 
after two weeks of exercise training sessions that would be expected to repeatedly transiently 
upregulate its mRNA expression (Burgomaster et al., 2008). However, to date no data exists on 
the time course of incremental increases in mRNA or their possible role in the adaptive process. 
Similarly, the effect of short-term exercise training on the expression of transcription factors and 
transcriptional coregulators purported to modulate skeletal muscle metabolism is not described. 
2.6 Molecular mechanisms regulating skeletal muscle plasticity and 
exercise-induced phenotypes 
2.6.1 Contraction-induced signal transduction pathways 
Signal transduction refers to the transfer of signals and stresses from the outside or inside of a 
cell, usually by kinase or phosphatase cascades or other signalling processes, to cytosolic or 
nuclear targets (Wackerhage & Woods, 2002). In the context of exercising skeletal muscle, the 
effect on these targets can be either to affect an acute process such as substrate metabolism or 
a delayed process such as alterations in gene expression. For instance, a decline in cellular 
energy status through ATP depletion can activate the AMPK pathway which increases fuel 
metabolism in the short term but alters metabolic gene expression in the longer term (next 
section). In this regard, the benefits of acute or regular exercise can be manifested either 
through improvements in glucose and lipid homeostasis or through functional remodelling of the 
skeletal muscle tissue (Sakamoto & Goodyear, 2002). How these signals are deciphered and 
integrated into functional alterations in gene expression is not fully understood at present. In 
addition, the contribution or redundancy of different signal transduction cascades in response to 
various metabolic perturbations and which subsets of transcriptional regulators are responsive 
to each signal are poorly described in vivo. Acute muscle contraction alters calcium flux, ATP 
turnover, cellular stress, redox potential, oxygen tension and reactive oxygen species 
production, each of which have been implicated in the activation of signal transduction 
cascades regulating skeletal muscle plasticity (Fig. 2.5)(Fluck, 2004;Hood et al., 
2006;Freyssenet, 2007;Coffey & Hawley, 2007). 
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Figure 2.5 Scheme visualizing the integration of the complex stimulus of exercise in recruited skeletal 
muscle. Different homeostatic perturbations, such as those related to metabolic flux, loading, hormonal 
and neuronal alterations, are converted by specific sensory molecules into the activation of signalling 
cascades. These ultimately control muscle fate via the regulation of gene expression. Consequently, gene 
expression represents an important layer of control for the processing of physiological information towards 
a biological outcome, (reproduced from Fluck, 2006). 
2.6.2 Cellular energy status and AMP-activated protein kinase 
One of the most fundamental parameters that any healthy cell must maintain is a high ratio of 
ATP to ADP (of the order of 10:1). Almost all energy-requiring processes in the cell are driven, 
either directly or indirectly, by hydrolysis of one or other of the acid anhydride bonds in ATP, 
yielding ADP or AMP. Eukaryotic cells have a very active adenylate kinase that interconverts 
ATP, ADP and AMP, and maintains this reaction close to equilibrium. If it is at equilibrium, the 
AMP/ATP ratio will vary as the square of the ADP/ATP ratio (Hardie & Hawley, 2001). If a 
cellular stress causes the rate of ATPases to exceed that of the ATP synthases, the ADP:ATP 
ratio will rise, and the adenylate kinase reaction will increase AMP generation (Hardie & 
Hawley, 2001). If the ADP/ATP ratio rises by 5-fold, the AMP:ATP ratio will rise 25-fold and 
thus, the cellular concentrations of AMP change much more dramatically than do those of ATP 
or ADP (Hardie & Hawley, 2001). It therefore makes sense for any system that monitors cellular 
energy status to respond to AMP (or the AMP/ATP ratio) rather than ADP (or the ADP/ATP 
ratio). As it name suggests, AMPK is allosterically activated by 5’-AMP, an effect that is 
antagonised by high concentrations of ATP (Hardie & Hawley, 2001). Therefore, an important 
feature of AMPK as a signal transducer for skeletal muscle metabolic adaptations is its capacity 
to monitor and respond to the cellular energy status. 
AMPK exists as a heterotrimer, consisting of α, β and γ subunits. The α subunit, of which there 
are two known isoforms (α1 and α2), contains the catalytic domain that transfers a high-energy 
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phosphate from ATP to serine and threonine residues on a number of different target proteins. 
The α subunit also contains a specific threonine residue (Thr172) that functions as an activating 
phosphorylation site for one of several ‘upstream’ AMPK kinases. Multiple isoforms of β (β1, β2) 
and γ (γ1, γ2, γ3) regulatory subunits have also been identified that are essential for full enzymatic 
activity, and also seem to function in localising the AMPK molecule within cells (Kahn et al., 
2005). The binding of AMP to AMPK at the γ subunit brings about a conformational change 
which allows phosphorylation (and activation) by the major upstream AMPK kinase, LKB1 
(Hawley et al., 2003). Recently, CaMKKs have been identified as upstream AMPK kinases 
capable of inducing phosphorylation at Thr172 and thus activating AMPK (Hurley et al., 
2005;Hawley et al., 2005). In fact, AMPK activation occurs directly as a result of calcium 
signalling in myotubes (Freyssenet et al., 2004). AMPK activation is regulated allosterically by 
changes in energy status of the cell (i.e. ‘low’ energy status), reflected by increases in the 
AMP/ATP and creatine/phosphocreatine ratios. A wide range of cellular stresses that deplete 
ATP (such as metabolic poisons) or increase the cellular AMP/ATP ratio (such as glucose 
deprivation or oxidative stress) are known to activate AMPK (Kahn et al., 2005). Given the 
increase in ATP turnover and increase in production of AMP associated with muscle contraction 
(Spriet, 1995), it is not surprising that acute exercise has consistently been shown to increase 
phosphorylation of AMPK and its enzymatic activity (Rasmussen & Winder, 1997;Wojtaszewski 
et al., 2000;Fujii et al., 2000;Wojtaszewski et al., 2002;Chen et al., 2003), as has electrical 
stimulation (Atherton et al., 2005). 
2.6.2.1 Effect of exercise on AMPK activity 
Available evidence suggests that activation of AMPK during exercise occurs in an intensity-
dependent and isoform-specific manner (Aschenbach et al., 2004), with activation reported at 
intensities greater than ~60% VO2peak and during exercise lasting between five minutes and 3.5  
hours. Initial studies investigating the effect of various exercise intensities on AMPK activity in 
skeletal muscle were conducted on rats (Rasmussen & Winder, 1997;Rasmussen et al., 1998). 
Six-fold increases in AMPK activity were induced by only five minutes of exercise at greater 
than 20 m•min-1. The increase in kinase activity was relatively transient and returned to baseline 
within 90 min after the cessation of exercise. 
Based on the results of subsequent human experiments, the AMPK response to exercise may 
be summarised as follows (Wojtaszewski et al., 2000;Fujii et al., 2000;Wojtaszewski et al., 
2002;Chen et al., 2003;Sriwijitkamol et al., 2007) 
(i) activation of AMPK during exercise occurs in an intensity-dependent and isoform-
specific manner 
(ii) AMPK is not activated at intensities less than 50-60% VO2peak unless exercise 
prolonged for more than 2 h but can be activated during exercise as short as five 
minutes when intensity is greater than 70% VO2peak (almost exclusively α2 AMPK in 
each instance) 
                                                                                                         Chapter II Review of literature 
33 
(iii) α2 AMPK is more readily activated in skeletal muscle to facilitate metabolism during 
‘prolonged’ exercise; α1 AMPK is less readily activated and may serve as an additional 
ATP regeneration boost during low energy status in the cell like during maximal and 
supramaximal exercise 
(iv) the fact that α1 AMPK is less sensitive to AMP than α2 AMPK, and thus would require 
greater metabolic changes to become active, supports this view 
(v) AMPK activation during exercise in vivo is likely better explained by the recruitment of 
muscle fibres according to the ramp theory of threshold activation and not fibre type per 
se (Aschenbach et al., 2004). 
(vi) the respective roles of blood-borne and intramuscular substrates in the activation of 
AMPK are not clear currently. 
There appears to be a threshold of activation for AMPK at approximately 60% VO2peak 
(Wojtaszewski et al., 2000;Sriwijitkamol et al., 2007). This intensity-dependence of AMPK 
activation is to be expected since the intracellular changes in the AMP/ATP ratio do not change 
appreciably at intensities similar to 50% VO2peak (Howlett et al., 1998). However, activation of α2 
AMPK (2.5-fold increase) at exhaustion (2:39-4:00 h) after cycling at 45% VO2peak has been 
demonstrated (Wojtaszewski et al., 2002). This increase in activity was tightly associated with 
the degree of Thr172 phosphorylation. As with previous studies there was no activation of the α1 
isoform, and α2 AMPK activity had returned to basal levels at 1 h after exercise. At this intensity, 
it is likely that decreases in blood glucose and muscle glycogen exert primary influence on 
AMPK activity given the fact that the AMP/ATP ratio was unchanged throughout exercise and 
that AMPK activity increased as fuel stores decreased, reaching a peak and nadir, respectively, 
at the same time points. Muscle glycogen is thought to partly regulate the activity of AMPK 
during exercise. The AMPK β subunit possesses a glycogen binding domain and glycogen 
loading of muscle suppresses AMPK signalling in response to both exercise/contraction and 
pharmacological activation (Derave et al., 2000;Wojtaszewski et al., 2003). However, when 
preexercise glycogen levels are similar, the rate of muscle glycogen utilisation does not directly 
regulate the extent of AMPK activation during exercise in humans (Wadley et al., 2006). 
2.6.2.2 Putative role in skeletal muscle metabolism 
The generalised effects of AMPK activation on skeletal muscle metabolism are thought to occur 
in such a manner as to conserve ATP by inhibiting biosynthetic pathways and anabolic 
pathways, while stimulating catabolic pathways that generate ATP in a control mechanism that 
acts to restore cellular energy (ATP) stores (Hardie et al., 2006). In the context of skeletal 
muscle, this is observed acutely as a suppressive effect of AMPK on glycogen synthesis and 
protein synthesis and a permissive effect on glucose transport and fatty acid oxidation, whereas 
chronic effects of AMPK activation lead to alterations in metabolic gene expression and 
mitochondrial biogenesis.  
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Briefly, AMPK is thought to inhibit protein synthesis by inhibition of the mTOR pathway (Bolster 
et al., 2002), thereby preventing the initiation of mRNA translation to a synthesised protein 
(Bolster et al., 2004). AMPK phosphorylates glycogen synthase, reducing its enzymatic activity 
(Carling & Hardie, 1989;Jorgensen et al., 2004), and thereby attenuating glycogen synthesis, 
which is consistent with a role for AMPK in defending cellular energy homeostasis by limiting 
anabolic processes. Pharmacological activation of AMPK using AICAR increases glucose 
uptake and AMPK activity in perfused rat muscle (Merrill et al., 1997) and in general, it is 
thought that AMPK activity regulates glucose uptake in resting muscle and is at least partly 
responsible for contraction-mediated glucose uptake (Jorgensen et al., 2004). AMPK-stimulated 
increases in glucose transport are mediated via the translocation of existing GLUT4 to the 
plasma membrane (Koistinen et al., 2003), possibly in an AS160-dependent manner (Bruss et 
al., 2005). Lastly, activation of AMPK is associated with increase fatty acid uptake to the cell via 
FAT/CD36 translocation to the plasma membrane (Raney et al., 2005) and increases the rate of 
fatty acid oxidation by relieving inhibition of fatty acid entry into the mitochondria (Osler & 
Zierath, 2008). The concentration of malonyl CoA is a potent inhibitor of CPT1, which is the rate 
limiting enzyme in mitochondrial fatty acid uptake. AMPK phosphorylates the muscle isoform of 
acetyl CoA carboxylase, ACCβ, making it more sensitive to inhibition which in turn decreases 
the formation of malonyl CoA. In addition, AMPK can lower malonyl CoA content by 
phosphorylating and activating malonyl CoA decarboxylase, the enzyme responsible for 
decarboxylating malonyl CoA to acetyl CoA. These combined effects lower malonyl CoA 
content upon AMPK activation and relieve CPT1 inhibition, thereby increasing mitochondrial 
fatty acid oxidation (Hardie & Hawley, 2001).  
Given the critical role for the AMPK in regulating intracellular energy metabolism in response to 
acute energy crises, it is perhaps not surprising that AMPK has also been identified as a major 
regulator of mitochondrial biogenesis in response to chronic energy depletion (Kahn et al., 
2005). Feeding rats β-guanadinopropionic acid (β-GPA), a chronic pharmacological activator of 
AMPK that works by chronically depleting muscle phosphocreatine stores, for eight weeks 
resulted in chronic AMPK activation in skeletal muscle and increases in NRF-1 binding activity, 
δ-ALAS mRNA expression, cytochrome c protein expression, and mitochondrial content, thus 
clearly demonstrating that AMPK activation promotes mitochondrial biogenesis through PGC-1α 
and the NRFs (Bergeron et al., 2001). Other pharmacological studies have also established a 
link between chronic AMPK activation and the upregulation of key mitochondrial enzymes in 
skeletal muscle. AICAR administration to rats for four weeks increased protein expression of 
cytochrome c and δ-ALAS and increased activities of citrate synthase, MDH and SDH in skeletal 
muscle (Winder et al., 2000). 
To determine if AMPK is required for mitochondrial biogenesis, transgenic mice expressing a 
dominant-negative mutant form of AMPK in skeletal muscle and wild-type mice were fed β-GPA 
for eight weeks. While AMPK was activated in the skeletal muscle of the wild-type mice in 
response to β-GPA feeding, the transgenic mice fed β-GPA showed no similar increase in 
AMPK activation. Moreover, PGC-1α mRNA expression, cytochrome c protein expression 
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levels, mitochondrial DNA content and mitochondrial density were all increased in the wild-type 
mice, and none of these parameters were increased in the β-GPA transgenic mice lacking a 
functional form of AMPK (Zong et al., 2002). Clearly, these data demonstrate that AMPK is 
necessary for mitochondrial biogenesis in response to chronic energy deprivation, and it 
appears likely that pharmacologically activated AMPK conveys its signal to induce mitochondrial 
biogenesis via the PGC-1α–NRF pathway. In terms of metabolic gene expression, 
pharmacological activation of AMPK enhances the expression of FOXO1A, CPT1, GLUT4 and 
HKII (Holmes et al., 1999;Jorgensen et al., 2005), a program of gene expression that would 
increase substrate transport to, and utilisation by, the muscle cell. This indicates a role for 
AMPK in defending cellular energy status by initiating an adaptive response that favours 
enhancement of ATP producing pathways. 
Exercise studies demonstrate that AMPK activation is followed by increased PGC-1α 
expression, suggesting AMPK signalling may work through PGC-1α to promote mitochondrial 
biogenesis. Six hours of low intensity swimming resulted in increases in AMPK activation and 
PGC-1α mRNA expression (Terada et al., 2002). Electrical stimulation designed to mimic 
endurance exercise also activated AMPK and increased PGC-1α protein expression (Atherton 
et al., 2005). However, Coffey et al. (2006a) have shown that PGC-1α mRNA expression is 
induced in the muscle of both endurance- and resistance-trained athletes in response to a 
single bout of endurance- but not resistance-type exercise. This finding is notable because 
despite the fact that AMPK activation was not activated in endurance-trained muscle, PGC-1α 
mRNA was elevated in the same condition. AMPK activation was increased by resistance 
exercise in endurance-trained muscle but no increase in PGC-1α mRNA was observed. 
Furthermore, exercise has been shown to increase PGC-1α mRNA expression in the absence 
of a functional copy of α2 AMPK (Jorgensen et al., 2005), which suggests that AMPK is 
dispensable in the adaptive response to exercise. Similarly, in response to exercise training, α2 
AMPK knockout and α2 AMPK kinase dead mice show no defect in mitochondrial increases 
(Jorgensen et al., 2007;Rockl et al., 2008). Thus, despite its apparent capacity to increase 
mitochondrial biogenesis, AMPK is not required for the exercise-induced training responses. 
Whereas these α2 AMPK knockout mice have a similar exercise-induced increase in PGC-1α, 
FOXO1A and PDK4 mRNA to wild-type littermates, this response is suppressed in the knockout 
animals following AICAR stimulation. This highlights two critical points when interpreting studies 
delineating the role of AMPK in skeletal muscle metabolism: (i) pharmacological activation using 
AICAR or other means may not accurately represent the metabolic milieu of contracting muscle, 
and (ii) results obtained in transgenic animals may be affected by compensatory alterations in 
AMPK isoform activity or alternative signalling pathways (Jorgensen et al., 2006). Therefore, the 
precise role for AMPK in contraction-mediated regulation of metabolic gene expression remains 
to be fully elucidated. Exploring further how exercise affects AMPK and PGC-1α and whether 
this leads to an increase in mitochondrial biogenesis are important issues that need to be 
addressed. 
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2.6.2.3 Downstream targets of AMPK 
If AMPK activation is causally linked to the reported effects on gene expression and 
mitochondrial adaptation, AMPK activity must be capable of directly or indirectly altering 
mechanisms of transcriptional regulation. This is consistent with the function of the AMPK yeast 
homologue Snf1, which is known to regulate a range of metabolic genes (Lo et al., 2001). Snf1 
regulates gene transcription by directly phosphorylating nuclear transcription factors (Lo et al., 
2001). Similarly, AMPK complexes containing the α2 subunit are preferentially localized to the 
nucleus (Salt et al., 1998). This suggests that AMPK translocates to the nucleus where it could 
then interact with transcriptional regulators or DNA directly to control gene expression. Exercise 
has been shown to increase AMPK nuclear abundance (McGee et al., 2003) and it has been 
proposed that AMPK directly links cellular metabolism to gene regulation by phosphorylation of 
nuclear proteins (Leff, 2003). Recently, it has been shown that AMPK directly phosphorylates 
PGC-1α (Jager et al., 2007). Many effects of activated AMPK on gene expression in skeletal 
muscle, including the inductions of the PGC-1α, GLUT4, and mitochondrial genes, required the 
presence of the PGC-1α protein. PDK4 induction by AMPK activation did not require the 
presence of PGC-1α protein, indicating the existence of PGC-1α-independent but AMPK-
dependent pathways regulating gene expression in muscle cells (Jager et al., 2007). AMPK is 
also thought to phosphorylate and activate CREB, which would theoretically enhance the 
transcription of genes with CRE binding sites in their promoter region, such as HKII (Thomson 
et al., 2008) 
AMPK activation alters transcriptional regulation by modulating the DNA binding activities of 
transcription factors including NRF-1 and MEF2 (Bergeron et al., 2001;Zheng et al., 2001), a 
mechanism that would explain alterations in mitochondrial and GLUT4 gene expression 
mediated by AMPK. Finally, AMPK can directly phosphorylate HDAC5 leading to its nuclear 
exclusion and relieving its repression of MEF2-mediated GLUT4 transcription (McGee et al., 
2008). This is a very similar mechanism described previously for CaMK/HDAC4/MEF2 in 
response to stimulated contractions (Liu et al., 2005). Although much more work is required to 
fully characterise the pathway of contraction-induced AMPK activation and modulation of gene 
expression, the available data suggest that this pathway is important in the acute and adaptive 
response of skeletal muscle gene expression to exercise. 
2.6.3 Calcium flux and calcium/calmodulin-dependent protein kinases 
Calcium is essential for facilitating the interaction between myosin and actin during myofibrillar 
contraction. Neural activation of skeletal muscle results in the release of acetylcholine from the 
neuromuscular junction and depolarisation of the plasma membrane, which activates force 
production. A transient increase in cytosolic calcium concentration is triggered by each wave of 
sarcolemmal depolarization during muscle contraction and mounting evidence links these 
calcium transients and associated activation of calcium-dependent protein kinases and 
phosphatases with adaptive response to exercise (Chin, 2004;Ojuka, 2004). The frequency, 
intensity and duration of stimulation determine the amplitude and duration of the calcium 
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transients and as a result the level of force output by the muscle (Westerblad & Allen, 1991). 
Intracellular calcium concentrations can be elevated by up to five- and fifty-fold in slow and fast 
twitch muscle fibres, respectively, during muscle contraction (Westerblad & Allen, 1991). 
Experiments using agents to elevate intracellular calcium levels in vitro (Ojuka et al., 
2003;Freyssenet et al., 2004;Kusuhara et al., 2007) or with transgenic mice with altered calcium 
homeostasis (Chen et al., 2001;Wu et al., 2002;Chin et al., 2003) provide unequivocal evidence 
linking calcium flux to alterations in metabolic and mitochondrial gene expression and muscle 
plasticity. The expression of many genes encoding mitochondrial proteins are increased in 
response to elevations in intracellular calcium (Ojuka et al., 2003). However, transcript 
expression of certain genes is not induced by elevated calcium, whereas others follow a distinct 
time-course of induction (Ojuka et al., 2003;Freyssenet et al., 2004;Wright et al., 2007a). 
Elevations in calcium may only partially mediate the contractile-activity induced changes in 
mitochondrial biogenesis and may act in concert with other signalling pathways (Ojuka et al., 
2002;Hood et al., 2006). 
Elevations in intracellular calcium are initially decoded by an intermediate binding protein, 
calmodulin (CaM). CaM is a multifunctional signal transducer that undergoes conformational 
changes before activating other CaM binding proteins, primarily downstream kinases and 
phosphatases (Chin, 2005). The mechanism by which the nature of the calcium oscillations is 
decoded by CaM includes changes in CaM conformation and CaM subcellular localisation upon 
binding of the calcium ion (Chin, 2005). Calcium/calmodulin-dependent protein kinases (CaMK) 
are multifunctional serine/threonine protein kinases that are activated in a calmodulin-
dependent manner and that translate calcium oscillations into discrete levels of kinase activity. 
In human skeletal muscle, CaMKII has been shown to the dominant isoform expressed, and this 
isoform and the CaMKIV isoform have been implicated in the regulation of skeletal muscle 
plasticity (Fluck et al., 2000;Wu et al., 2002). Initial activation of CaMKII is facilitated by calcium-
dependent calmodulin binding, resulting in autophosphorylation on Thr287 and activation of a 
calcium/calmodulin independent form of CaMKII (Chin, 2005). 
Phosphorylation of CaMKII has been previously shown to increase in an intensity-dependent 
manner in response to exercise in human skeletal muscle (Rose & Hargreaves, 2003;Rose et 
al., 2006), with evidently no further increases with an increase in exercise duration. The greater 
increase in CaMKII activity may be related to the greater proportion of muscle fibres activated, 
the different types of fibre recruited, or the higher calcium concentrations expected at higher 
force outputs. Phosphorylation of CaMKII at Thr287 is highly correlated with autonomous 
enzymatic activity (Rose et al., 2006;Rose et al., 2007a), although these authors suggest that it 
is obligatory for autonomous CaMKII activity rather than necessarily reflecting in vivo kinase 
activity. Phosphorylation of CaMKII makes the kinase partially independent of calcium/CaM and 
thus, when a calcium transient is over, the kinase retains heightened activity above basal 
(Hudmon & Schulman, 2002). Another important feature conserved in skeletal muscle CaMKII is 
that the activation of CaMKII is sensitive to the frequency of calcium oscillations (De Koninck & 
Schulman, 1998). The functional consequence of autophosphorylation is believed to be 
maintenance of enzymatic activity between calcium transients, thereby allowing persistent 
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phosphorylation of downstream substrates during repeated stimulation (Hudmon & Schulman, 
2002). The intensity-dependent increase in CaMKII activation is consistent with CaMKII being a 
stimulation-frequency decoder in skeletal muscle (Chin, 2005).  
2.6.3.1 Putative role in skeletal muscle metabolism 
Conclusive mechanistic data from human skeletal muscle linking the effect of CaMK activation 
to skeletal muscle adaptation is currently lacking but there are several lines of evidence based 
on in vitro and animal models. However, the limited data from exercising human skeletal muscle 
indicates that as well as being rapidly activated by contraction, it phosphorylates downstream 
targets including the transcription factor, SRF (serum response factor) (Rose et al., 2006). 
Several putative CaMK targets and mechanisms have been implicated in the regulation of 
skeletal muscle gene transcription including CREB and MEF2, two transcription factors critical in 
the regulation of PGC-1α expression (Handschin et al., 2003;Akimoto et al., 2004b). In addition, 
endurance exercise training leads to an increase in CaMKII expression and autonomous activity 
at rest, an effect which may increase the sensitivity of CaMKII to calcium transients (Rose et al., 
2007b). Similar results were reported in wheel running rats after two weeks of training (Fluck et 
al., 2000). These findings have been taken to suggest that an increase in resting autonomous 
CaMKII activity is sustained beyond the cessation of contractile activity and may be mediating a 
calcium-related change in muscle plasticity. This data would at least suggest that there is some 
potential role for CaMKII in acute exercise metabolism and adaptation to exercise training. 
When considered in concert with several other lines of evidence, the role is more convincing. 
Overexpression of a constitutively active form of CaMKIV in skeletal muscle resulted in 
increased mitochondrial volume, increased expression of both nuclear- and mitochondrial-
encoded mitochondrial enzymes involved in fatty acid metabolism and electron transport, and 
enhanced recovery from fatigue (Wu et al., 2002). These changes were associated with 
increased expression of PGC-1α, and it is thought that the CaMKIV signal was transduced 
directly or indirectly through PGC-1α. However, CaMKIV protein expression is not detectable in 
human skeletal muscle (Rose & Hargreaves, 2003;Rose et al., 2006), which precludes this 
pathway in human muscle. In addition, CaMKIV null mice exhibit similar increases in PGC-1α 
and COXIV protein content as do wild-type mice in response to voluntary wheel running 
(Akimoto et al., 2004a). The generalised influence of the calcium ion on skeletal muscle 
plasticity is demonstrated in mice with alterations in calcium handling via modulation of 
parvalbumin, a calcium buffering protein. Parvalbumin-deficient mice exhibit increased 
mitochondrial volume and COX activity coincident with elevations in intracellular calcium 
concentrations (Chen et al., 2001). Conversely, mice overexpressing parvalbumin (and 
consequently reduced calcium levels) have increased mitochondrial enzyme activity of SDH 
(Chin et al., 2003). 
In studies using a combination of calcium releasing agents and CaMK inhibitors, the role of 
CaMK in skeletal muscle metabolism has been elegantly described (Ojuka et al., 2002;Ojuka et 
al., 2003;Wright et al., 2004;Freyssenet et al., 2004;Kusuhara et al., 2007;Wright et al., 2007a). 
In terms of glucose metabolism, elevating calcium c
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increases in glucose uptake (Wright et al., 2004). This effect may be mediated by chronic 
increases in the mRNA and protein abundance of GLUT4 and its regulatory transcription factor 
MEF2 (Ojuka et al., 2003), and HKII expression (Kusuhara et al., 2007). These stimulatory 
effects of elevated calcium on glucose metabolism are diminished by incubation with either an 
inhibitor of calcium release (e.g. dantrolene) or CaMK activity (e.g. KN62). Similar effects are 
reported when markers of mitochondrial biogenesis are examined. Caffeine-treatment of 
myotubes increased the mRNA and protein expression of PGC-1α and Tfam and increased 
NRF-1 and NRF-2 DNA binding (Ojuka et al., 2003), whereas similar results were reported for 
PGC-1α, COXI and δ-ALAS (Wright et al., 2007a). Again, these effects are reversed when 
incubation with dantrolene or KN93 (Ojuka et al., 2003). Finally, a recent report has shown that 
the elevation observed in PGC-1α mRNA after 40 min of electrical stimulation is reduced when 
KN62 is added to the incubation medium, providing evidence that the contraction-induced 
increase in PGC-1α mRNA is in part mediated by a CaMK-dependent mechanism (Kusuhara et 
al., 2007). 
The exact mechanism by which CaMKs regulate skeletal muscle gene expression is not 
defined. Direct modulation of transcription factor function by protein phosphorylation is one 
possible mechanism. Transcription factors such as CREB and SRF are known CaMK targets 
(Shaywitz & Greenberg, 1999;Rose et al., 2006). The presence of CRE motifs in the promoter 
region of a large number of functionally diverse genes involved in cellular metabolism is 
evidence for an essential role for CREB as an activator of stimulus-induced gene transcription 
(Mayr & Montminy, 2001). For instance, PDK4 and PGC-1α both contain consensus sites for 
CREB binding, although expression of PDK4 doesn’t appear to be under the control of calcium-
dependent regulation (Kusuhara et al., 2007). Activation of CREB via phosphorylation at Ser133 
appears to be an important step in a cascade of events that results in the integration of several 
signaling pathways leading to the execution of PGC-1α-mediated actions in various tissues 
(Akimoto et al., 2005;Hood et al., 2006;Wu et al., 2006). Phosphorylation at this residue is 
necessary, but not always sufficient, for stimulus-induced activation of CREB and consequent 
gene transcription (Mayr & Montminy, 2001). Another potential mechanism of CaMKII function is 
by modulating HDAC activity. One report has demonstrated a causal link between the activation 
of CaMKII by electrical stimulation of cultured muscle cells, its phosphorylation and subsequent 
nuclear exclusion of HDAC4, thereby relieving repression of MEF2 transcriptional activity (Liu et 
al., 2005). This model would thus couple contraction-induced calcium signaling to an increase in 
the rate of transcription of MEF2 target genes such as PGC-1α and GLUT4. 
In summary, there is strong circumstantial evidence that exercise-induced intracellular calcium 
flux mediates so-called ‘excitation-transcription coupling (Chin, 2005)’ in skeletal muscle. 
However, the majority of our understanding is based on in vitro and animal experiments and so 
remains to be established in in vivo exercising human experiments. 
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2.6.4 Cellular stress and the mitogen-activated protein kinases 
Because of the wide variety of biochemical and biophysical processes activated by muscle 
contraction, it is unsurprising that the MAPK family of signalling kinases are activated by acute 
exercise. Growth factors, cytokines, and cellular stress lead to changes in activity of various 
members of the MAPK family (Long et al., 2004), and these signal transduction cascades are 
well established in physiological processes such as cell proliferation, differentiation, 
hypertrophy, inflammation, gene expression and apoptosis (Kyriakis & Avruch, 2001). Three 
main subfamilies of MAPK have been implicated in altering skeletal muscle metabolism: (i) the 
extracellular-regulated kinase (ERK1/2), (ii) c-jun N-terminal kinase (JNK), and (iii) p38 MAPK 
(Koulmann & Bigard, 2006). MAPKs phosphorylate diverse substrates, including transcription 
factors and coactivators localized in the cytoplasm or nucleus, thereby forming a basis for the 
regulation of transcriptional events (Long et al., 2004). Exercise leads to the activation of at 
least three MAPK signalling pathways, i.e. ERK1/2, p38 MAPK and JNK, in skeletal muscle 
(Zierath, 2002). Regulation of PGC-1α-dependent gene transcription in skeletal muscle is 
mediated through p38 MAPK (Yan et al., 2007), and therefore discussion will be limited to this 
kinase.  
2.6.4.1 Activation by contraction 
In human subjects p38 MAPK is phosphorylated in skeletal muscle in response to cycle 
exercise (Widegren et al., 1998;Chan et al., 2004) and marathon running (Boppart et al., 
2000;Yu et al., 2001). In contrast to marked but transient ERK1/2 activation, one-leg cycling 
exercise leads to a smaller increase but more persistent p38 MAPK activation. p38 MAPK 
phosphorylation is also increased in the resting leg, indicating the potential influence of a 
systemic factor or perhaps the stress of muscle sampling (Widegren et al., 1998). In addition, in 
well-trained skeletal muscle, p38 MAPK is activated when muscle performs unaccustomed 
exercise i.e. endurance-trained athletes perform resistance exercise or resistance-trained 
athletes perform endurance exercise (Coffey et al., 2006b). Therefore, the level of activation is 
somewhat dependent on the nature of exercise. In isolated rat skeletal muscle concentric 
contractions increase ERK1/2 phosphorylation with no effect on p38 MAPK, whereas eccentric 
contractions increase phosphorylation along both kinase cascades (Wretman et al., 2001). In 
human subjects, one session of eccentric contractions during leg press resistance exercise is 
associated with an increase in ERK1/2 phosphorylation, with no effect on p38 MAPK 
phosphorylation (Williamson et al., 2003). 
2.6.4.2 Role in skeletal muscle metabolism 
Although MAPK pathways are candidate systems that may convert mechanical/biochemical 
stimuli into modulations of muscle gene expression, the transcription factors activated by these 
intracellular cascades and their integration into other signalling pathways involved in the 
changes of muscle gene expression remain to be elucidated (Koulmann & Bigard, 2006). The 
phosphorylation of transcription factors by MAPK signalling pathways can regulate their 
activities in several ways including intracellular localisation, transcription factor protein levels, 
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binding to DNA, and their interactions with regulatory proteins (Yang et al., 2003). In terms of 
skeletal muscle metabolism, the most pertinent interaction is the effect of p38 MAPK on PGC-
1α function as described earlier. Phosphorylation by p38 MAPK increases PGC-1α protein 
stability and removes the repressive effect of inhibitory factors such as p160 myb binding 
protein (Puigserver et al., 2001;Fan et al., 2004). p38 MAPK can directly stimulate upstream 
transcription factors of the PGC-1α gene, such as ATF2 and MEF2 (Akimoto et al., 2005). ATF2 
is nuclear CRE-element binding transcription factor that is activated by p38 MAPK and binds to 
the CRE binding site on the PGC-1α promoter, enhancing PGC-1α transcription (Cao et al., 
2004). This pathway has recently been shown to be critical to the exercise-induced increase in 
PGC-1α mRNA. Contractile activity was associated with p38 MAPK and ATF2 phosphorylation, 
coincident with an increase in PGC-1α mRNA (Akimoto et al., 2005;Wright et al., 2007b). 
Constitutive activation of p38 MAPK induced increases in PGC-1α and COXIV protein content, 
whereas the acute increase in PGC-1α mRNA induced by p38 activation was ATF2-dependent 
(Akimoto et al., 2005). 
MAPKs are known to phosphorylate CREB at Ser133 (Deak et al., 1998), which could potentially 
increase the transcription of CREB target genes. Yet, exercise is not associated with increased 
CREB phosphorylation in the working skeletal muscle; CREB phosphorylation in skeletal 
muscle after exercise is either unchanged (Widegren et al., 2000) or repressed (Widegren et al., 
1998), despite increases in MAPK phosphorylation described above. Thus, the role of CREB 
phosphorylation under control of MAPKs or other kinases in skeletal muscle after exercise is not 
clear. 
2.6.5 Cellular redox state: NAD+/NADH ratio 
The degradation of glucose and fatty acids produces acetyl CoA, which is rapidly shuttled 
through the TCA cycle to generate ATP and the reduced equivalents NADH and FADH2, which 
in turn yield more ATP through oxidative phosphorylation and the electron transport chain. 
During muscle contractions, the cytosolic NAD+/NADH ratio is subject to dynamic fluctuations 
imposed by the rate of NAD+ reduction to NADH, which is mediated by glyceraldehyde 3-
phosphate dehydrogenase, and the rate of NADH oxidization to NAD+, which is collectively 
governed by lactate dehydrogenase, the glycerol phosphate shuttle, and the malate aspartate 
shuttle (Robergs et al., 2004). The mitochondrial monocarboxylate transporter, which mediates 
the uptake of pyruvate into mitochondria, also indirectly contributes to the regulation of the 
NAD+/NADH ratio. Acute exercise of moderate to high intensity induces a redox response by 
increasing NADH concentration (Sahlin et al., 1987;Odland et al., 2000) or decreasing NAD+ 
concentration (Graham et al., 1978). In addition, the lactate/pyruvate ratio increases as exercise 
intensity increases, shifting the lactate dehydrogenase equilibrium and decreasing the 
NAD+/NADH ratio (Denis et al., 1991). Green et al. (1992) have shown a progressive decline in 
NAD+/NADH ratio during 60 min of exercise at 67-76% VO2peak. However, measurements of 
NAD+/NADH ratio during exercise are subject to controversy and a number of methodological 
considerations (Graham & Saltin, 1989). NAD+/NADH ratio has also been reported to increase 
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during submaximal and maximal exercise (Graham & Saltin, 1989). Fluctuations in NAD+/NADH 
and the production of lactate are potential intracellular signals affecting skeletal muscle gene 
regulation (Fig. 2.6) (Hawley & Zierath, 2004). 
The function of several dehydrogenases is NAD+/NADH-dependent including Sirt1 and CtBP 
(sections 2.3.3 & 2.4). A decrease in the NAD+/NADH ratio increases CtBP-dependent 
repression (Zhang et al., 2002), which in theory would mean that acute exercise would increase 
the repressive function of RIP140, contrary to what intuitively would be expected to occur in 
response to exercise. Sirt1-PGC-1α regulation (section 2.3.3) provides a means of linking 
energy status of the cell, sensed by Sirt1 through the NAD+/NADH ratio, to a transcriptional 
output on metabolic networks regulated by PGC-1α. However, an exercise-induced decrease in 
the NAD+/NADH ratio would potentially lead to a decrease in Sirt1 activity. In terms of effects on 
gene expression, this again is contrary to what intuitively would be expected to occur in 
response to exercise. Thus far there is no experimental data examining the function or 
expression of CtBP, RIP140 or Sirt1 in response to acute exercise. The relationships between 
NAD+/NADH ratio and these transcriptional regulators may be tissue- or stimulus-specific 
(Freyssenet, 2007), or it may be that the NAD+/NADH concentrations in the particular cellular 
compartments (i.e. cytosolic vs. mitochondrial redox) are more important in their regulation than 
those that have been routinely measured during exercise.  
















Figure 2.6 Putative regulation of transcriptional pathways by alterations in cellular redox state. See text for 
detailed discussion. 
 
Finally, it is well established that acute exercise stimulates lactate production in human skeletal 
muscle and with increasing exercise intensity, lactate production increases proportionately and 
is manifested as a curvilinear increase blood lactate concentration (Robergs et al., 2004). 
Recently, lactate has been identified as a potent activator of gene transcription of a subset of 
genes in myotubes (Hashimoto et al., 2007). Incubation with physiological relevant 
concentrations of lactate, resulted in increased mRNA expression of the mitochondrial 
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monocarboxylate transporter MCT1, PGC-1α and COXIV, and increased the DNA binding of 
NRF-2 and CREB, both of which have binding sites in the MCT1 promoter. This program of 
expression is consistent with the induction of a mitochondrial lactate oxidation complex, in direct 
response to an increase in intracellular lactate and succinctly demonstrates the specificity of 
adaptation in response to a physiological stimulus. Coordination of MCT1 expression and 
mitochondrial biogenesis by NRF-2 and CREB is likely physiologically relevant for increasing 
oxidative lactate clearance capacity in skeletal muscle. In addition, lactate may serve as a 
second messenger in the initiation of a program of mitochondrial biogenesis in an exercise 
context such that elevated lactate flux and concentration signals not only lead to adaptation of 
pathways of lactate removal, but also signals many of the adaptations in muscle found in 
response to endurance training (Hashimoto et al., 2007). 
In summary, preliminary evidence suggests that metabolites under redox control including 
NAD+, NADH and lactate are potential sensory molecules mediating contraction-induced 
modulation of skeletal muscle gene expression. However, the precise mechanisms of regulation 
and subsequent signal transduction pathways remain to be established in exercising human 
skeletal muscle.  
2.6.6 Integrating signalling cascades/cross talk 
Although the review thus far has defined discrete signalling pathways in response to contractile 
activity, it is unlikely that these pathways act in isolation. These cascades are likely to be highly 
regulated at multiple levels, with substantial crosstalk between pathways producing a highly 
sensitive, complex transduction network (Fig. 2.7)(Coffey & Hawley, 2007). Signalling to muscle 
adaptation is likely to involve more than one signal transduction pathway depending on the 
nature of the exercise stimulus and gene targets. Similarly, signal transduction pathways may 
be redundant in certain instances or only regulate part of the adaptation response. Much of the 
data on this aspect of signalling comes from in vitro pharmacological and transgenic animal 
models and is not established in exercising human skeletal muscle. 
Regarding CaMKII and AMPK, it is tempting to consider these as distinct signalling cascades 
that can be preferentially activated by stimuli such as exercise or pharmacological agents 
(Ojuka, 2004). However, recent evidence suggests that each has common characteristics and 
overlapping effects on cellular metabolism. AMPK and CaMKII are closely related enzymes that 
belong to the same protein kinase subfamily and recognize the same amino acid consensus 
sequence (Hawley et al., 1995). The tumor suppressor kinase LKB1 has been identified as the 
predominant AMPK kinase in skeletal muscle but CaMK kinases show significant homology to 
LKB1 (Hurley et al., 2005). CaMKK has been shown to phosphorylate AMPK in vitro (Hawley et 
al., 1995). Furthermore, several lines of evidence in cell and rodent models suggest that 
CaMKK is both an upstream AMPKK and regulates its functional activity (Hurley et al., 
2005;Witczak et al., 2007;Jensen et al., 2007). Alternatively, a CaMKII-TAK1/MAP3K7 pathway 
has been proposed to regulate AMPK phosphorylation directly or through LKB1 (Jensen et al., 
2007). Taken together, current evidence suggests that the AMPK and calcium-dependent 
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signalling pathways are not entirely independent. However, whether a time- or intensity-
dependent switch occurs in the relative importance of each pathway (Jensen et al., 2007) 
especially with regard to functional effects during exercise in vivo remains to be determined. 
Recently, acute elevations in intracellular calcium leading to alterations in gene expression have 
been shown to act through p38 MAPK, secondary to the activation of CaMKII (Wright et al., 
2007a). Inhibition of CaMKII prevented p38 MAPK phosphorylation whereas inhibition of p38 
MAPK prevented the calcium-induced increases in mitochondrial gene expression. AMPK 
activation was also shown in response to acute elevations in intracellular calcium through both 
CaMKII-dependent and -independent mechanisms that in turn increase fatty acid oxidation 
(Raney & Turcotte, 2008). In addition, these data indicate that the calcium-independent 
regulation of fatty acid uptake in skeletal muscle is mediated through an ERK1/2 mechanism.  
The activation of multiple signal transduction cascades in response to muscle contraction has 
been well established in exercising human skeletal muscle. Cell culture and animal studies have 
in turn demonstrated that these pathways are critical to skeletal muscle metabolism and target 
various nodes critical to transcriptional regulation. However, the interplay between contraction-
induced signalling pathways and demonstrating continuity between pathway activation and 
functional consequences is perhaps too complex to be fully delineated in the milieu of 
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Figure 2.7 Current players in the integration of acute exercise-induced signals to alterations in skeletal 
muscle gene expression 
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2.6.6.1 Modulating the exercise-induced signal by altering exercise intensity 
The intensity of exercise is well established as a determinant of substrate utilisation during 
exercise (Romijn et al., 1993;van Loon et al., 2001) as well as a critical component in 
determining the nature and magnitude of training adaptation (Dudley et al., 1982). Given that 
skeletal muscle energy flux is intensity-dependent, it is unsurprising that signal transduction 
cascades are differentially regulated by the intensity of an acute exercise challenge 
(Wojtaszewski et al., 2000;Widegren et al., 2000;Rose et al., 2006). A simple working 
hypothesis is that increasing intensity of exercise leads to greater activation of signal 
transduction pathways, which, assuming the molecular regulation of transcription by these 
kinases described above is conserved in exercising human skeletal muscle, would result in 
differential changes in gene expression of target genes compared to lower intensity exercise. 
For instance, the activation of p38 MAPK, AMPK, and CaMKII increases as exercise intensity 
increases. The regulation of PGC-1α transcriptional activity is under direct and indirect control 
of p38 MAPK-, AMPK- and CaMKII-dependent mechanisms. Greater activation of these kinases 
will potentially lead to greater PGC-1α transcriptional activity, and hence, the expression of 
PGC-1α-dependent transcriptional programs. 
2.6.7 Alterations in signal transduction pathways after endurance exercise training 
Endurance exercise training modulates the magnitude of the contraction-induced signalling 
response by altering the flux of signal activators, the activity of the signalling kinases 
themselves and the expression of the signalling components. This is ultimately reflected as a 
reduction in the activation of contraction-induced signalling kinases after a period of exercise 
training (McConell et al., 2005) or when comparing trained to untrained muscle (Yu et al., 2003). 
A period of exercise training in rats attenuates, but does not abolish, the activation of skeletal 
muscle AMPK during treadmill exercise (Durante et al., 2002). In addition, during 20 min of 
exercise at 80%VO2peak in endurance-trained athletes compared with untrained individuals, 
there is an attenuation of the exercise-induced increases in AMPK Thr172 phosphorylation and 
ACCβ phosphorylation in the endurance-trained participants, although α2 AMPK activity 
increases similarly in both groups (Nielsen et al., 2003). The same pattern has been observed 
for AMPK phosphorylation in another study but this was coincident with a reduction in α2 AMPK 
activity in the trained individuals, even though the trained group completed twice the amount of 
exercise (Yu et al., 2003). McConell et al. (2005) found that the approximately 10-fold increase 
in α2 AMPK activity observed during prolonged exercise before training was abolished during 
exercise at the same absolute workload following short-term exercise training in previously 
sedentary individuals. Increased expression of AMPK isoforms and elevated basal AMPK 
activity are also observed after training (Frosig et al., 2004) and may explain the reduced 
increase in exercise-induced AMPK activation. In this context, these results illustrate the 
important point that AMPK activity is not a marker of total energy flux during exercise, but rather 
a result of the perturbations in the energy charge induced by exercise (Nielsen et al., 2003). 
After a period of exercise training, the same cellular rate of mitochondrial oxidative 
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phosphorylation is attained with a lower rate of oxidative phosphorylation per mitochondrion for 
any absolute workload in muscle fibres with elevated mitochondrial content (Dudley et al., 
1987). ATP and creatine phosphate concentrations decrease to a smaller degree, and the free 
ADP concentration increases to a lesser extent in cells with elevated mitochondrial contents at 
the same absolute work rate (Dudley et al., 1987;Green et al., 1991). Better preservation of free 
ADP lowers the rate of AMP formation, ultimately decreasing the activation of AMPK and its 
upstream activators.  
A considerably lower increase in lactate concentration is observed after endurance training 
when exercise is performed at the same submaximal workload, coincident with a greater 
contribution of fat to overall substrate utilisation at the expense of glycolytic metabolism 
(Holloszy & Coyle, 1984). This would possibly alter the NAD+/NADH-dependent regulation of 
Sirt1 activity, which is yet to be established in exercise-mediated skeletal muscle metabolism. 
Muscle glycogen stores are higher at rest and are depleted less rapidly during standardized 
exercise in the trained state. Muscle glycogen is established as a potent regulator of muscle 
metabolism (Hargreaves, 2004) and alterations in muscle glycogen content can modulate both 
exercise-induced gene expression and contraction-responsive kinase activation (Pilegaard et 
al., 2002;Chan et al., 2004). 
Exercise-induced signalling responses for p38 MAPK have been shown to be greater in 
untrained men, even at the same relative cycling exercise intensity, even though the trained and 
untrained subjects exercised at approximately the same relative intensity (approximately 85–
90% of VO2peak)(Yu et al., 2003). Thus, skeletal muscle from previously-highly trained individuals 
appears to require a greater stimulus to activate signal transduction via p38 MAPK, indicating 
an extent of training-induced adaptation along MAPK pathways. Little data is available on the 
adaptation of calcium signalling to exercise training. Repeated bouts of exercise have been 
shown to induce an adaptive response, resulting in less perturbation in calcium release and 
uptake, and subsequently improved calcium cycling and resistance to fatigue (Holloway et al., 
2006). Exercise training results in increased CaMKII mRNA expression (Timmons et al., 2005b), 
basal CaMKII protein expression and maximal and autonomous CaMKII(Rose et al., 2007b) but 
the CaMKII response to acute exercise after training is not established. 
Taken together, these results can be interpreted in several ways. The muscle from highly 
trained athletes with a prolonged history of endurance training requires a greater stimulus to 
activate signal transduction through MAPK and AMPK pathways. The fact that signals induced 
by acute exercise are less pronounced after training may simply indicate that these kinases are 
not the sole mediators of the adaptive response or that there are finite limits to the adaptive 
response with repeated exercise bouts. Alternatively, the elevations in basal kinase activity and 
isoform expression may result in downstream targets of these pathways being more sensitive to 
activation by exercise, with consequent reduction in the requirement for activation. Similarly, 
enhanced AMPK and CaMKII expression/activity in the rest periods between training bouts may 
also affect muscle gene expression in a sustained rather than acute manner. 
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2.6.8 PGC-1α expression in response to acute exercise and exercise training 
Given the remarkable similarity between the phenotype of endurance-exercise trained humans 
(Holloszy & Coyle, 1984) and transgenic mice overexpressing PGC-1α (Calvo et al., 2008), and 
between the phenotype of long-term inactivity in humans (Booth & Lees, 2007) and muscle-
specific PGC-1α knockout mice (Handschin et al., 2007a), it is not surprising that investigations 
on the modulation of PGC-1α expression and function by exercise have been numerous. If 
exercise is indeed a panacea for metabolic dysfunction by inducing mitochondrial biogenesis, 
improvements in oxidative phosphorylation, and favourable changes in metabolic gene 
expression, then it will presumably do so through the system of transcriptional regulation 
described thus far. The transcriptome response to acute exercise and exercise training will be 
considered in more detail in section 2.6.9, but firstly consideration will be given to the effect of 
exercise on PGC-1α and the possible role in mediating exercise-induced alterations in skeletal 
muscle metabolism. 
Goto et al. (2000) first demonstrated an exercise effect on PGC-1α mRNA abundance in rodent 
skeletal muscle. An increase in PGC-1 mRNA by ~50% and two-fold above control after three 
and seven days, respectively, of 2 h/day swim training was observed in the epitrochlearis 
muscle (Goto et al., 2000). The same investigators later demonstrated a 7-fold increase in PGC-
1α mRNA above control immediately after exercise in response to 6 h of low intensity swimming 
(Terada et al., 2002). This finding was also observed by another research group who showed a 
two-fold increase in PGC-1α protein content 18 h after the cessation of exercise (Baar et al., 
2002). However, the first study on human skeletal muscle showed no affect of either acute 
exercise (60 min at 63% VO2peak) or nine days of exercise training on PGC-1 mRNA, despite 
measurable changes in mRNA abundance of lipid metabolism genes such as CPT1 (Tunstall et 
al., 2002). 
In human skeletal muscle, Pilegaard et al. (2003) were the first to demonstrate a rapid increase 
in PGC-1α mRNA in response to a single bout exercise. Using a nuclear run-on technique to 
measure the rate of transcription, exercise (3 h of knee extensor exercise) was shown to 
transiently increase the rate of PGC-1α gene transcription which was manifested as an 
elevation in mRNA content at 2 and 6 h after exercise. Interestingly, four weeks of training 
resulted in a dramatic increase in the rate of PGC-1α gene transcription at rest and after 
exercise and a larger increase in PGC-1α mRNA during recovery when compared to the 
untrained response. This suggested that the factors regulating PGC-1α expression become 
more ‘sensitive’ with training (Pilegaard et al., 2003), a finding that has recently been confirmed 
(Mortensen et al., 2007). 
Numerous studies since have shown an increase in PGC-1α mRNA expression in response to 
acute exercise, peaking at 0-3 h after exercise, and returning to baseline later than 6 h after 
exercise (Norrbom et al., 2004;Watt et al., 2004;Vissing et al., 2005;Russell et al., 2005;Cartoni 
et al., 2005;Cluberton et al., 2005;Mathai et al., 2008). In short, when exercise is performed at a 
sufficient intensity, the magnitude of the increase above baseline or control has been reported 
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between 50% up to 12-fold. This induction is entirely as a result of contractile activity. In the 
absence of exercise, PGC-1α mRNA abundance did not change in response to repeated biopsy 
or dietary intervention (Vissing et al., 2005). The continuity between an elevation in mRNA 
abundance and subsequent increase in PGC-1α protein content after a single bout of exercise 
is equivocal. In rodent experiments, a 50% up to two-fold increase in PGC-1α protein content is 
seen at various time points up to 18 h after exercise (Baar et al., 2002;Terada & Tabata, 
2004;Terada et al., 2005;Akimoto et al., 2005;Wright et al., 2007b). In human studies, PGC-1α 
protein content has generally gone unreported although one report showed a tendency for an 
increase (70%) immediately after exercise (Watt et al., 2004). Recently, Mathai et al. (2008) 
have reported elevated PGC-1α protein content (~23%) during the first two hours of recovery 
from ~120 min of exhaustive exercise at 65% VO2peak. After 24 h of recovery, PGC-1α protein 
remained elevated by 16% above baseline values. These changes in protein content were 
preceded by 2- to 6-fold increases in mRNA abundance in the first two hours of recovery but 
returned to pre-exercise values after 24 h (Mathai et al., 2008). 
The rapid upregulation of PGC-1α mRNA and protein during recovery from exercise is 
consistent with a role for the coactivator in the regulation of exercise-induced gene expression 
as part of the adaptive response to exercise. However, the necessity for an increase in PGC-1α 
protein content to mediate alterations in gene expression in response to an acute bout of 
exercise and exercise training is debated (Wright et al., 2007b;Leick et al., 2008). If 
accumulation of increments in mRNA abundance and alterations in protein content are indeed 
the molecular basis of training adaptation, a measurable increase in PGC-1α expression is 
expected after a period of endurance training. This, in fact, has been observed in human 
skeletal muscle in several experiments both in terms of mRNA and protein content (Russell et 
al., 2003;Short et al., 2003;Kuhl et al., 2006;Burgomaster et al., 2008), where two- to three-fold 
changes in PGC-1α protein content have been observed. In these studies, this has been 
coincident with increases in mitochondrial enzyme activity and mitochondrial gene expression 
(Russell et al., 2003;Burgomaster et al., 2008). Similar findings in terms of the acute (Atherton 
et al., 2005) and chronic (Irrcher et al., 2003) responses to contraction have been demonstrated 
in electrical stimulation models. A strong correlation (r = 0.74) was established between COX 
activity and PGC-1α protein expression, indicating that over 50% of the variance in 
mitochondrial content, as reflected by COX activity, can be attributed to variations in PGC-1α 
protein level (Irrcher et al., 2003). However, causation by PGC-1α in the adaptation to training 
has not been conclusively established.  
A link between PGC-1α and exercise training adaptations is illustrated in mice with muscle-
specific overexpression of PGC-1α who demonstrate marked improvements in exercise 
performance both during submaximal exercise intensities and during graded exercise to 
exhaustion (Calvo et al., 2008). The mice exhibited lower RER values during submaximal 
exercise reflecting that the molecular modifications induced by high PGC-1α levels increase fat 
oxidation and thus likely provide a carbohydrate-sparing effect relative to wild-type mice. This is 
coincident with an increase in mRNA data for genes encoding enzymes in oxidative 
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phosphorylation and fat metabolism, and citrate synthase activity, indicating an increased 
muscle oxidative capacity. Together these findings show that PGC-1α-induced changes in 
metabolic protein expression profile can indeed change performance and metabolism during 
exercise in mice. 
Muscle-specific PGC-1α knockout mice have reduced resting protein content of mitochondrial 
proteins such as cytochrome c and COXI and reduced exercise tolerance phenotype (Leick et 
al., 2008). Despite this, no difference was observed in the magnitude of change in cytochrome c 
or COXI mRNA and protein content in the adaptive response to five weeks of endurance 
training. PGC-1α is therefore not likely to be mandatory for exercise-training induced 
adaptations in skeletal muscle mitochondrial proteins (Leick et al., 2008), despite the fact that 
PGC-1α is necessary to maintain normal resting levels of the same mRNA and proteins (Lin et 
al., 2002;Leick et al., 2008). However, the induction of cytochrome c mRNA after a single 
exercise bout is attenuated in skeletal muscle of PGC-1α knockout mice compared to wild-type 
mice (Leick et al., 2008), and suggests that PGC-1α protein does modulate the transcriptional 
response to acute exercise. Consistent with the role for PGC-1α in muscle refuelling (Wende et 
al., 2007), reduced muscle glycogen content at rest and impaired glycogen resynthesis during 
recovery was reported in the knockout mice, although the molecular mechanism responsible 
was not established (Leick et al., 2008). 
Therefore, PGC-1α is a key factor in regulating resting levels of mitochondrial gene expression, 
adaptive responses to acute endurance exercise leading to enhanced oxidative capacity of 
skeletal muscle and, thus, increased capacity for both fat and carbohydrate utilization, but is not 
the sole mediator of the adaptive response to exercise training. Other, as of yet unknown, 
compensatory factors or mechanisms may take over when PGC-1α is absent (Leick et al., 
2008). Conversely, the activation or stabilisation of existing PGC-1α protein may mediate the 
effects of acute exercise in modulating skeletal muscle gene expression (Wright et al., 2007b) in 
concert with an increase in transcription factor functional activity such as DNA binding (Baar et 
al., 2002;Wright et al., 2007b). Critical to delineating the molecular mechanisms in the 
transcriptome response is resolving the key exercise-induced signal transduction pathways that 
lead to these effects on transcriptional regulation. 
2.6.9 Exercise-induced alterations in skeletal muscle gene expression 
In addition to mitochondrial biogenesis, increased gene expression of metabolic proteins 
following endurance exercise contributes to promoting the enhanced endurance phenotype 
(Coffey & Hawley, 2007). An important characteristic of many metabolic genes is that they are 
transcribed at a basal level, yet can be readily activated or repressed in relation to the nutritional 
or physiological state (White et al., 2008). Contraction generates transient increases in the 
abundance of mRNA for a multitude of genes that typically peaks 3-12 h after cessation of 
exercise and returns to basal levels within 24 hours (Pilegaard et al., 2000;Mahoney et al., 
2005;Yang et al., 2005a;Schmutz et al., 2006). Increments in mRNA are associated with the 
same directional change in their encoded protein to what is considered a new steady-state level 
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(Booth & Baldwin, 1996). Training-induced muscle adjustments are by definition the 
consequence of repetition of single exercise stimuli (Fluck, 2006). Thus, as stated earlier, long 
term adaptation to training is due to the cumulative effects of each acute exercise bout leading 
to a new steady-state of mRNA and protein expression and a new functional threshold.  
The adaptation to increased contractile activity is thought to be confined to the recovery phase 
from each fatiguing bout of exercise. This allows an overshoot of cellular adaptations that 
support the accumulation of incremental remodelling responses after each session, and with the 
repetition of the single exercise stimuli, this would support the enhanced endurance 
performance (Fig. 2.4)(Fluck, 2006). The molecular phenomenon underlying exercise-induced 
increase in mRNA abundance is an increased rate of gene transcription for the target gene 
(Pilegaard et al., 2000;Hildebrandt et al., 2003), consistent with a mechanism in which 
contraction-induced signals activate pathways leading enhanced transcriptional activation 
through a subset of activated transcriptional regulators. 
2.6.9.1 Gene transcripts elevated during recovery from a single bout of endurance exercise 
Gene-specific transcriptional activation during and after a bout of exercise is involved, on some 
level, in reestablishing homeostasis in skeletal muscle during recovery, as well as contributing 
to the skeletal muscle adaptations that occur in response to exercise training (Mahoney & 
Tarnopolsky, 2005). In human skeletal muscle, a single bout of endurance exercise has been 
shown to increase mRNA abundance of a growing number of genes, including immediate early 
genes (c-fos, c-jun), myogenic genes (myogenin, MRF4, myoD), antioxidant factors 
(metallothionein II), calcium signalling (MCIP1), carbohydrate metabolism (HKII, PDK4, GLUT4, 
glycogenin), lipid mobilisation, transport and oxidation (LPL, CPT1, β-HAD), mitochondrial 
metabolism (UCP3, COXIV), mitochondrial biogenesis (PGC-1α, NRF-1, NRF-2, Mfn2, ERRα) 
and transcriptional regulators (PPARα, PPARδ, MEF2, GEF, FOXO1A) (Puntschart et al., 
1998;Pilegaard et al., 2000;Keller et al., 2001;Pilegaard et al., 2002;Pilegaard et al., 
2003;Norrbom et al., 2004;Watt et al., 2004;Vissing et al., 2005;Russell et al., 2005;Cartoni et 
al., 2005;Cluberton et al., 2005;Civitarese et al., 2005;Pilegaard et al., 2005;Mahoney et al., 
2005;Penkowa et al., 2005;Yang et al., 2005a;Kraniou et al., 2006;Schmutz et al., 2006;Coffey 
et al., 2006a;Tunstall et al., 2007). The induction of mRNA expression is generally several-fold 
above resting values for each target gene, but the magnitude of this increase is specific to the 
gene and the exercise challenge. In addition, the temporal pattern of induction is specific to the 
gene of interest with some genes (e.g. PGC-1α) consistently shown to be elevated in the first 6 
h of recovery from exercise, whereas others (e.g. COXIV) are elevated much later in recovery 
(Pilegaard et al., 2003;Cartoni et al., 2005).  
In response to acute exercise stress, the recovery period in skeletal muscle after the exercise 
bout is now thought to be characterized by two major phases: the first is homeostatic recovery, 
and the second is the cellular contributions to adaptation (Mahoney & Tarnopolsky, 2005). 
Homeostatic recovery is the process whereby skeletal muscle recovers from the stress imposed 
by the exercise bout and reestablishes homeostasis in the immediate hours after exercise. The 
metabolic consequences are characterized by glucose sparing, elevated fat oxidation, glycogen 
                                                                                                         Chapter II Review of literature 
51 
resynthesis (Kiens & Richter, 1998;Kimber et al., 2003). The molecular adaptation that 
underpins endurance training described above leads to an enhanced ability to maintain muscle 
homeostasis during exercise, enhancing the resistance to fatigue. The temporal pattern of 
induction of genes involved in substrate metabolism in the immediate recovery period after 
exercise, followed latterly by genes involved in mitochondrial metabolism supports this 
contention. The induction of mRNA of broad range of transcriptional regulators during recovery 
is consistent with their transcriptional activation by exercise-mediated processes and their 
subsequent role in the induction of expression of target genes involved in cellular metabolism. 
However, continuity between the induction of mRNA and the expression of the encoded protein 
has not always been demonstrated. 
Expression of muscle mRNA may not accurately reflect the protein abundance and can give no 
information regarding their posttranslational modifications (Hojlund et al., 2008). This indicates a 
need to correlate the results from global gene expression experiments and measurements of 
protein abundance. The half-lives of many mRNAs are relatively short compared with their 
target proteins, with transcription gene activation sometimes occurring before sustained and 
measurable increases in protein (Hargrove et al., 1991). Although the extent to which a protein 
might be modified in response to an adaptive stimulus cannot be predicted from an increase in 
mRNA, it has been reported that increased abundance of genes encoding for substrate 
metabolism is accompanied by a concomitant increase in the cellular content of the transcribed 
protein (Peters et al., 2001;Cameron-Smith et al., 2003;Tsintzas et al., 2006). Discrepancies in 
the magnitude or temporal pattern of mRNA induction from different experiments is attributed to 
specifics of the research design including nature of exercise protocol, timing of muscle 
sampling, training status of the muscle, probe and primer design, kinetics of the specific gene 
target, and nutritional control.  
2.6.9.2 Modulation of exercise-induced gene expression by nutritional intervention and altering 
metabolic stress 
The specific but malleable nature of the transcriptome response to acute exercise is illustrated 
by experiments where muscle glycogen content (Pilegaard et al., 2002;Pilegaard et al., 2005), 
blood glucose availability (Russell et al., 2005;Cluberton et al., 2005) and circulating FFA 
concentration (Watt et al., 2004;Tunstall et al., 2007) have been manipulated. Presumably the 
modulation of the transcriptional response reflects an alteration in the nature of the metabolic 
stress of exercise and thus affecting either the contraction-induced signal or the activity of 
transcription factors in some manner. 
The mechanisms linking alterations in muscle glycogen content and modulation of gene 
expression are not established. However, low muscle glycogen content has been associated 
with the potentiation of exercise-induced gene expression. Exercise with lowered muscle 
glycogen concentration increases the magnitude of exercise-induced elevations in mRNA 
abundance for HKII, PDK4, UCP3 and IL-6 (Keller et al., 2001;Pilegaard et al., 2002). In a 
similar fashion, low carbohydrate feeding during recovery elicits a prolonged and/or secondary 
activation of select exercise-responsive metabolic genes (PDK4, UCP3, LPL, CPT1, FAT/CD36, 
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FOXO1A), whereas high carbohydrate feeding elicits a reversal of the exercise-induced 
activation of these genes (Pilegaard et al., 2005). PGC-1α mRNA expression increased to a 
similar extent in both trials up to 5 h of recovery but after 8 h expression returned to baseline 
with high carbohydrate feeding but remained elevated in the low carbohydrate diet. Therefore, 
replenishment of muscle glycogen reserves may be linked to the regulation of metabolic gene 
expression during recovery from exercise. Alternatively, signalling mechanisms affected by 
differences in circulating substrate availability (i.e. glucose and/or FFA, insulin, 
counterregulatory hormones) may be primary factors contributing to the transcriptional 
regulation of metabolic genes during recovery from exercise (Pilegaard et al., 2005). Evidence 
for this hypothesis is equivocal. Feeding carbohydrate during exercise has been shown to have 
no measurable effect on exercise-induced gene expression of transcription factors or 
coregulators (Russell et al., 2005). Conversely, carbohydrate feeding blunts GLUT4 and PDK4 
mRNA induction and downregulates UCP3 and CPT1 mRNA expression compared to fasted, 
placebo-fed exercise (Civitarese et al., 2005). Similarly, carbohydrate feeding in the recovery 
period after exercise suppresses exercise-induced increases in PDK4 and UCP3 mRNA but 
does not alter the pattern of PGC-1α mRNA induction (Cluberton et al., 2005). 
Carbohydrate feeding is associated with suppression of lipolysis and a reduction in circulating 
FFA concentration. To test whether alterations in FFA concentrations are responsible for the 
observed effects of carbohydrate feeding, lipolysis and circulating FFA levels have been 
suppressed by pharmacological means prior to exercise (Watt et al., 2004;Tunstall et al., 2007). 
This did not affect the exercise-induced response in mRNA induction, although elevated PGC-
1α mRNA at rest in the suppressed FFA trial is associated with elevated epinephrine (Watt et 
al., 2004). This effect may be mediated through β-adrenergic receptor activation, which, in part, 
is responsible for the induction of PGC-1α (Puigserver et al., 1998;Miura et al., 2007). Finally, 
Vissing et al. (2005) have demonstrated that certain genes such as PDK4 are more responsive 
to feeding and fasting than exercise, whereas PGC-1α is indeed responsive to exercise. 
The studies outlined above raise two important considerations. Firstly, in experiments 
examining exercise-induced modulation of gene expression, dietary intake preceding and during 
recovery from exercise must be standardised for all participants. In addition, results must be 
considered in light of any potential influence of the dietary intake pattern i.e. meal timing, fasting 
duration. Secondly, the exercise-induced modulation of selected genes is highly malleable in 
response to alterations in whole body metabolism, as evidenced by altering nutritional state. 
The molecular mechanism is thought to involve alterations in signal transduction, possibly 
through AMPK (Hargreaves, 2004), which is consistent with the idea that the transcriptome 
response is proportional to the metabolic stress imposed (Hoppeler et al., 2007). This raises the 
interesting possibility that by modifying the metabolic stressor (i.e. the nature of the imposed 
exercise demand), alterations in signal transduction may be reflected by concomitant alterations 
in gene expression. For example, comparing the response to hypoxic versus normoxic exercise 
has shown that key transcripts of carbohydrate metabolism and mitochondrial biogenesis are 
upregulated to a greater extent when exercise is carried out under hypoxic stress (Zoll et al., 
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2006). This is potentially mediated by elevated AMPK signalling observed during hypoxic 
exercise (Wadley et al., 2006). Similarly, during exercise at identical power outputs, the 
induction of PGC-1α mRNA is higher when ischemic stress is applied compared to unrestricted 
blood flow (Norrbom et al., 2004). Thus, by modulating the metabolic stress of exercise, it may 
be possible to alter activation of signalling pathways and consequent transcriptional activation to 
explore in vivo integration of kinase activation and gene activation. 
An attractive variable to utilise here would be the intensity of exercise, which is well established 
as an important regulator of substrate utilisation (Romijn et al., 1993), adaptation to exercise 
(Dudley et al., 1982) and signal transduction (Wojtaszewski et al., 2002;Rose et al., 2006). 
Surprisingly, the effect of intensity of exercise on skeletal muscle gene expression is poorly 
described. In human skeletal muscle, GLUT4 mRNA induction by exercise is similar whether 
400 kcal of exercise was performed at either 40% or 80% VO2peak (Kraniou et al., 2006). 
However, Sriwijitkamol et al. (2007) have shown a tendency for higher PGC-1α and NRF-1 
mRNA after 40 min at 70% VO2peak compared to 50% VO2peak. These results could be potentially 
confounded by the differences in total work completed. In addition, data from animal studies 
(Hildebrandt et al., 2003;Terada et al., 2005) has shown a tendency for an intensity-dependent 
effect on mRNA and protein expression. Both the intensity and duration of exercise influence 
the magnitude of the increase in HKII, PDK4, UCP3 and LPL transcription during recovery 
(Hildebrandt et al., 2003). In terms of PGC-1α protein content, Terada et al. (2005) compared 
responses to high (14x20 s with 14% body mass attached) and low (2x3 h with 45 min rest) 
intensity swimming exercise in rats. Although actual energy expenditure during exercise was not 
controlled for or quantified, at 18 h after exercise PGC-1α protein content was increased by 
67% in LO, whereas in the HI trial, it increased by 126%. However, this trend did not result in a 
statistically significant difference between the trials, so it was concluded that the intensity of 
exercise does not affect the subsequent protein content of PGC-1α. Clearly the effect of 
modulating metabolic stress through exercise intensity and the molecular mechanisms 
underlying altered gene expression requires further investigation. 
2.6.9.3 Effect of exercise mode and exercise training on the acute transcriptional response 
Like the induction of intracellular signal transduction pathways, the transcriptome response to a 
single exercise bout is specific to the stimulus and can be modulated by the training status of 
the muscle. Using microarray analysis of global mRNA, Mahoney et al. have shown that the 
induction of gene transcripts in response to endurance exercise is very much distinct to gene 
transcripts induced by acute eccentric exercise (Mahoney et al., 2005;Mahoney et al., 2008). 
Endurance exercise is associated with elevations in mRNA encoding proteins involved in 
substrate metabolism and mitochondrial biogenesis, the oxidant stress response and electrolyte 
transport across membranes, whereas eccentric contractions induce elevations in mRNA 
encoding proteins involved in cholesterol and lipid synthesis and/or modification, skeletal 
muscle growth, remodelling, and stress management. The divergent transcriptome response is 
thought to reflect both the different homeostatic perturbation and the nature of the adaptive 
response to endurance versus eccentric resistance exercise (Mahoney & Tarnopolsky, 2005). In 
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addition, direct comparison of the two gene sets revealed thirty-six genes that responded in a 
similar time course and magnitude to the two distinct exercise challenges. These genes may 
belong to a class of ‘‘exercise-responsive’’ genes, which respond to common signals and 
stresses inherent in both exercise modes, as evidenced by the fact that many of the genes are 
immediate early genes or genes involved in the cell stress response (Mahoney & Tarnopolsky, 
2005). The number of common genes probably would decrease throughout a period of training, 
as the muscle fine tunes the transcriptional response to meet the needs of the specific stresses 
placed on it more accurately. Coffey et al. (2006a) have shown, using well-trained resistance 
and endurance-trained athletes, that a single endurance exercise bout produced comparatively 
similar transcriptional responses in metabolic genes whereas training history markedly altered 
the response of myogenic genes. A single bout of resistance exercise produced a markedly 
greater transcriptional response in endurance-trained subjects but few differences were evident 
in the overall response to resistance exercise between groups. This suggests that prior training 
history can modify the acute gene responses in skeletal muscle to subsequent exercise.  
That training may alter the transcriptional response to exercise is illustrated by the fact that IL-6 
mRNA induction after 3 h of acute exercise is reduced to approximately 25% of pre-training 
values after ten weeks of training (1 h/d, 5 d/wk), even though the amount of work done was 
44% higher in the post-training bout (Fischer et al., 2004). Similarly, short-term training has 
been shown to modulate the transcriptional response to a single bout of exercise of genes 
including PDK4, HKII, Tfam, PPARα, CPT1 (Tunstall et al., 2002;Pilegaard et al., 
2003;Nordsborg et al., 2003). Studies using gene-by-gene analysis are said to be inadequate in 
predicting long-term adaptations in skeletal muscle phenotype to endurance training (Keller et 
al., 2001). Thus, transcriptomics or genome-wide assessments of the transcriptional response 
to exercise have been employed as a more powerful tool (Mahoney et al., 2005;Timmons et al., 
2005b). Detailed studies on the modulation the transcriptome response to a single bout of 
exercise by a period of exercise training are few but indicate (i) exercise training results in an 
increase in steady-state mRNA, (ii) exercise training attenuates the transcriptome response to 
acute exercise, and (iii) the induction of certain genes prior to training may not necessarily be 
involved in the adaptive response to repeated exercise but merely reflect the nature of the 
stresses placed on the muscle (Choi et al., 2005;Timmons et al., 2005b;Schmutz et al., 
2006;Keller et al., 2007). This hypothesis is supported by a microarray study in mice, in which a 
single bout of endurance exercise elicited the expression of many genes involved in myocyte 
proliferation, a stress-related paradigm more commonly observed after resistance exercise, a 
response that was not observed after a period of endurance training (Choi et al., 2005). In 
humans, Schmutz et al. (2006) have used custom-designed arrays to examine the 
transcriptome response to acute exercise before and after six weeks of endurance training. An 
approximately two-fold enhancement of steady-state levels of mRNAs encoding proteins for 
fatty acid transport and mitochondrial respiratory function was observed after training, 
consistent with the theory that increments in mRNA underpin phenotypic adaptation. However, 
the vast majority of these transcripts were not measurably increased by a single bout of 
exercise before or after training. In addition, the transcriptional response, i.e. transient 
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upregulation of many genes, to a matched exercise bout before and after training was blunted. 
Functional and structural adaptations are attenuated with ongoing training with the same 
relative intensity, a phenomenon that may be explained in part by the attenuated transcriptional 
response in the trained state (Schmutz et al., 2006). Modulation of the transcriptome response 
may be due to increased steady-state mRNA abundance resulting in a more sensitive 
transcriptome in which large changes in mRNA are no longer required. Similarly, it may be that 
the response to exercise becomes fine-tuned and as such the induction of certain mRNA 
targets is no longer evident. Finally, it has been suggested that some acutely responsive genes 
are induced to programme the restoration of homeostasis, but if not involved in the molecular 
basis of adaptation are not responsive to exercise training (Mahoney et al., 2005). Clearly, 
further investigation of the effect of training on the transcriptional response to exercise and the 
time course of alterations in steady-state mRNA in response to training is warranted. 
In summary, an intense bout of exercise induces a rapid but transient transcriptome response in 
untrained muscle. This results in an increase in the rate of gene transcription and mRNA 
abundance during recovery from the exercise bout. These induced transcripts encode proteins 
involved in many aspects of skeletal muscle metabolism including substrate transport and 
utilisation, mitochondrial metabolism and mitochondrial biogenesis. However, continuity 
between the induced transcript and a change in protein function has not always been 
established. These transcriptional alterations are thought to be induced to affect a biphasic 
response to acute exercise resulting first in restoration of homeostasis and latterly cellular 
adaptation to exercise. Repeated exercise leads to increments in steady-state levels of mRNA 
abundance as a consequence of these transient pulses in mRNA. This is thought to be the 
molecular basis for exercise training-induced alteration of skeletal muscle phenotype. 
2.7 General summary 
The regulation of mitochondrial biogenesis and skeletal muscle metabolism is governed by a 
well-defined subset of transcription factors and transcriptional coregulators. Several signalling 
pathways involving cytoplasmic protein kinases, transcription factors and transcriptional 
coregulators are recognised as regulators by which activation transduces physiological stimuli 
into transcriptional adaptations (Fluck, 2004). Regulation of transcriptional activity occurs via 
change in the protein content or activity (e.g. posttranslational modifications) of transcriptional 
regulators (Spiegelman & Heinrich, 2004). Therefore, transcription factors, nuclear receptors 
and their transcriptional coregulators are key players in integrating signals from physiological 
stimuli into adaptive tissue responses to coordinate metabolic processes (Spiegelman & 
Heinrich, 2004;Desvergne et al., 2006;Feige & Auwerx, 2007). Skeletal muscle contraction is 
one such physiological stimulus and initiates a cascade that results in the activation and/or 
repression of specific signalling pathways regulating exercise-induced gene expression (Coffey 
& Hawley, 2007). 
PGC-1α overexpression, both in vivo and in vitro, is associated with an increase in the induction 
of mitochondrial gene expression program including increased respiratory chain subunit 
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expression, mitochondrial density and mitochondrial enzyme activity (Wende et al., 
2007;Benton et al., 2008). The synergistic effect of these phenotypical changes is responsible 
for the improvement in exercise capacity and decreased reliance on glucose metabolism during 
acute exercise seen in transgenic mice overexpressing PGC-1α (Calvo et al., 2008), mirroring 
the phenotype seen in endurance-trained humans (Holloszy & Coyle, 1984). Endurance-type 
exercise training induces an increase in mitochondrial enzymatic activity and mitochondrial 
volume density in the recruited muscle (Holloszy, 1967;Hoppeler et al., 1973), and is one of the 
more dramatic phenotypic alterations in response to contractile activity. 
The most accepted hypothesis is that adaptation is mediated at the level of transcription 
(Mahoney & Tarnopolsky, 2005). That the activation of intracellular signalling pathways and the 
expression and/or function of transcriptional regulators can be markedly and rapidly induced by 
acute exercise is critical to the molecular regulation of skeletal muscle plasticity in an exercise 
context. Based on data from microarray experiments, a single bout of exercise induces a robust, 
but transient, increase in transcript abundance of hundreds of genes encoding proteins involved 
in a variety of processes critical to cellular metabolism (Mahoney et al., 2005;Schmutz et al., 
2006). A single exercise stimulus carries a molecular signature that is typical both for the type of 
stimulus as well as the actual condition of the muscle tissue (Hoppeler et al., 2007). 
Transcriptional activation of certain genes is thought to play a role in immediate homeostatic 
recovery, whereas the transcriptional activation of others is thought to be linked to the 
adaptation to exercise training (Mahoney & Tarnopolsky, 2005). Therefore, the accumulation of 
specific gene transcripts in skeletal muscle due to repetitive action of an exercise training 
stimulus may contribute to functional improvements that are typical of the endurance-trained 
state (Hood et al., 2006;Fluck, 2006). The series of experiments reported herein have attempted 
to examine these contentions in in vivo human exercise models using exercise intensity, training 
status and short-term endurance training as investigative tools. 
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Detailed descriptions of the experimental design and procedures for each experiment are 
described in the respective Chapters IV, V and VI. This chapter outlines the design of each 
experiment and describes the measurements and protocols common to all three experiments. 
3.1 Experimental design overviews 
Experiment I: Contraction-induced signalling and gene expression of metabolic genes and 
transcriptional regulators in human skeletal muscle: influence of exercise intensity 
Eight healthy, sedentary males performed two isocaloric (400 kcal) cycle exercise trials, once 
each at either 40% or 80% VO2peak. Skeletal muscle biopsies from the m. vastus lateralis were 




Exercise at 40% or 80% VO2peak until 400 kcal expended
Ex. start - 4 h Ex. start + 0 h + 3 h + 19 h
O/N Fast O/N Fast
 
Figure 3.1 Schematic of experimental design for experiment I 
 
Experiment II: The effect of glycogen-depleting exercise on contraction-induced signalling and 
gene expression of metabolic genes and transcriptional regulators in well-trained human 
skeletal muscle 
Eight healthy well-trained males cycled for 90 min at 73% VO2peak. Skeletal muscle biopsies 
from the m. vastus lateralis were taken at rest and at +0 h and +1 h after exercise. 
 
Biopsies
-15 min 0 min 90 min 150 min
O/N Fast
Exercise at 73% VO2peak for 90 minPrep Bed rest
Pre + 0 h + 1 h
 
Figure 3.2 Schematic of experimental design for experiment II 
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Experiment III: The effect of fourteen consecutive days of exercise training on the expression of 
metabolic and mitochondrial genes and their transcriptional regulators in skeletal muscle of 
previously untrained men 
Eight healthy, sedentary males performed 60 min of exercise at 80% VO2peak, once per day for 
fourteen consecutive days. Skeletal muscle biopsies from the m. vastus lateralis were taken 
prior to the start of training, and on the morning after the 1st, 3rd, 7th, 10th and 14th training 
session. 
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Figure 3.3 Schematic of experimental design for experiment III 
 
3.2 Participant recruitment 
Participants for each experiment were recruited by email from the undergraduate, postgraduate 
and staff population at Dublin City University. A plain language statement was given to those 
expressing an interest in the study and written informed consent was provided by individuals 
wishing to participate. Each experiment was approved by the Dublin City University Research 
Ethics Committee and conformed to the Declaration of Helsinki. Finally, each participant 
completed a health history questionnaire underwent a medical screening examination and 
electrocardiogram to confirm their suitability for the experiment. 
3.3 Determination of maximal oxygen uptake 
All exercise tests took place under standard laboratory conditions (19-21°C, 40-55% relative 
humidity). In each experiment, prior to any experimental testing participants performed an 
incremental exercise test to volitional fatigue on an electronically braked cycle ergometer 
(Ergoline 900, SensorMedics, Yorba Linda, CA) to determine peak oxygen consumption 
(VO2peak). Briefly, in experiments one and two, participants began cycling at 100 W for five 
minutes warm-up and the power output was increased by 50 W every two minutes thereafter 
until volitional fatigue. In experiment III, participants began cycling at 80 W for five minutes 
warm-up and the power output was increased by 40 W every two minutes thereafter until 
volitional fatigue. Oxygen uptake was considered to have peaked if two of the following criteria 
were met: (i) a levelling off of VO2 with increasing power output (increase of less than 2 mL.kg-
1
.min-1), (ii) a HR within 10 beats of the age predicted HRmax (220 bpm – age in years), (iii) a 
RER greater than 1.10. Expired air was collected continuously throughout exercise and 
analysed using the Vmax 29C gas analysis system (SensorMedics, Yorba Linda, CA). Heart 
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rate was continuously monitored during exercise by telemetry (Polar Vantage NVTM; Polar, Port 
Washington, NY). 
3.4 Verification of submaximal exercise intensities 
The power output required to elicit a given percentage of VO2peak was interpolated based on the 
linear relationship between oxygen uptake (y-axis) and power output (x-axis). For a given 
percentage of VO2peak, the corresponding power output is estimated by solving for x using the 
linear function, y=mx+c, where y is VO2, x is power output, m is the slope of the relationship 
between VO2 and power output and c is the y-axis intercept.  Between four and seven days 
after maximal oxygen uptake test, each participant returned to the laboratory to perform a test to 
verify the power outputs required to elicit the requisite VO2peak for each experimental trial: 
experiment I, 40% and 80% VO2peak; experiment II, 75% VO2peak; experiment III, 80% VO2peak. 
Participants cycled for 10 min at each of three different power outputs: 15 W below the 
predicted power output, at the predicted power output and 15 W above the predicted power 
output. Pedal cadence was required to be kept between 75 and 80 rpm for all exercise tests and 
experimental trials 
3.5 Assessment of body composition 
Body density was calculated by the method of Jackson & Pollock (1978) based on the sum of 
seven skinfolds (tricep, subscapular, mid-axillary, pectoral, suprailiac, abdominal, thigh) 
measured with Harpendon skinfold callipers (Jackson & Pollock, 1978). Percentage body fat 
was calculated using the Siri equation (Siri, 1961). 
3.6 Muscle biopsy procedure 
Skeletal muscle specimens were taken by muscle biopsy from the m. vastus lateralis under 
local anaesthesia. An area of skin, subcutaneous tissue, and fascia was anaesthetized with 2% 
w/v Lidocaine HCl and a small (0.5 cm) incision made. The biopsy needle was inserted into the 
muscle and approximately 100 mg of tissue removed (200 mg in experiment III) using the 
percutaneous muscle biopsy technique with suction applied. A fresh incision was made for each 
biopsy, at least 2 cm from a previous biopsy site. Muscle samples were snap-frozen in liquid 
nitrogen and stored at –80°C until analysis. Specifics of timing, location and number of biopsies 
are described in the respective experiment chapters. 
3.7 Calculations of substrate utilisation 
Values for VO2, VCO2, RER, VE (STPD), and FEO2 were recorded from expired air using 60 s 
averages and used to calculate the rate of energy expenditure (Weir, 1949), rates of 
carbohydrate and fat oxidation (Zuntz, 1901), and the percentage contribution of each substrate 
to total energy production (Kuo et al., 2005). 
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3.8 Determination of muscle glycogen concentration 
Frozen muscle samples (~10 mg) were lyophilised, dissected free of connective tissue, weighed 
and hydrolysed with 1 M HCl by incubation at 100°C for 2 h and then neutralised with 0.67 M 
NaOH. Glycogen concentrations were determined by a standard enzymatic technique with 
fluorometric detection (Passonneau & Lauderdale, 1974). 
3.9 RNA extraction from biopsy samples 
Total RNA was isolated from ~20 mg crude muscle tissue based on the acid guanidinium 
thiocyanate-phenol-chloroform extraction method (Chomczynski & Sacchi, 1987) using TRI 
reagent (T9424; Sigma-Aldrich, UK) as per the manufacturer’s instructions. Muscle tissue was 
lysed using a motorised pestle in 1 ml of TRI reagent (4°C) per 50 mg of tissue, followed by 
drawing through a 25G needle with a 1 ml syringe. Total RNA concentration was determined 
spectrophotometrically at an absorbance of 260 nm (NanoDrop ND-1000 Spectrophotometer, 
ThermoFisher Scientific, Waltham, MA). The integrity of each RNA sample was verified by gel 
electrophoresis (RNA 6000 Nano Lab Chip & 2100 Bioanalyzer, Agilent Technologies, Palo 
Alto, CA) and by measuring the spectrophotometric A260/A280 (>1.8) and A260/A230 (>1.5) 
ratios. RNA (1 µg) was reverse transcribed to cDNA using the Reverse Transcription System 
(A3500; Promega, Madison, WI) primed with oligo-dT(15) as per the manufacturer’s instructions. 
The cDNA template was stored at -20°C until subsequent analysis. 
3.10 Quantitative real-time PCR 
qPCR was performed using the ABI Prism 7500 Sequence Detection System and software 
package (version 1.1; Applied Biosystems, Foster City, CA) using Assay-on-Demand pre-
designed gene-specific primer and probe sequences (P/N 4331182; Taqman® Gene 
Expression Assays, Applied Biosystems). The PCR reaction mix in each well consisted of 30 ng 
cDNA template (6 ng/µl), Taqman probe, forward and reverse primer set, Taqman Universal 
Master Mix (Applied Biosystems) and nuclease-free water in a 20 µl reaction. Gene targets for 
qPCR are reported in Table 3.1. The PCR profile for all genes consisted of one cycle at 50°C for 
2 min, followed by a denaturing cycle at 95°C for 10 min, followed by 40 cycles of denaturing at 
95°C for 15 sec and annealing and elongation at 60°C for 1 min. Each sample was run in 
duplicate. mRNA content was calculated from a corresponding standard curve (critical threshold 
cycle number vs. log dilution) run together with the samples. The standard curve was 
constructed using serial dilutions of an RNA sample pooled from the entire sample set and 
included in the qPCR reaction. The average critical threshold cycle (CT) value of the unknown 
samples was converted to relative expression data using the appropriate standard curve. mRNA 
data is expressed as the ratio between the gene of interest and a housekeeper gene, allowing 
normalisation of mRNA expression to a stable mRNA. 
According to Mahoney et al. (2004), the selection of housekeeping gene as an endogenous 
control requires several considerations: (i) expression of the gene must stay constant 
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throughout the given intervention; (ii) amplification efficiency of the gene should be similar to 
that of the gene of interest; (iii) abundance of housekeeping gene should be similar to that of 
genes of interest. In general, housekeeping genes should be constitutively expressed and 
minimally regulated (Mahoney et al., 2004). We explored the suitability of several proposed 
housekeeping genes for each experimental design. These included GAPDH (4333764F, 
Applied Biosystems), cyclophilin A (4333763F, Applied Biosystems), β2-microglobulin 
(4333766F, Applied Biosystems) and 18S rRNA (4331182: Hs99999901_s1, Applied 
Biosystems). Our analysis showed that GAPDH was an appropriate housekeeping gene for 
experiments I and III, whereas 18S ribosomal RNA was appropriate for experiment II. 
Table 3.1. Gene targets for qPCR 
        
Target   Gene ID Assay ID 
    
COXIV   1327 Hs00266371_m1  
CPT1  1375 Hs00189258_m1  
CREB  1385 Hs00231713_m1  
ERRα 
 2101 Hs01067166_g1  
FOXO1A   2308 Hs00231106_m1  
GEF   56731 Hs00219920_m1  
GLUT4  6517 Hs00168966_m1  
MEF2A   4205 Hs00271535_m1  
MEF2D   4209 Hs00232237_m1  
NRF-1  4899 Hs00192316_m1  
NRF-2  2551 Hs00745591_s1  
PDK4  5166 Hs00176875_m1  
PGC1α 
 10891 Hs00173304_m1  
PPARδ 
 5467 Hs00602622_m1  
RIP140  8204 Hs00534035_s1  
Sirt1  23411 Hs01009006_m1  
UCP3  7352 Hs00243297_m1  
        
    
Assay ID corresponding to the TaqMan® Gene Expression Assay ID (P/N 4331182; Applied Biosystems). Probe and 
primer sequences are proprietary information. 
3.11 SDS-PAGE and immunoblot analysis 
Muscle specimens were homogenised in ice-cold homogenisation buffer (20 mM Tris [pH 7.8], 
137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1% Triton X-100, 10% [wt/vol] glycerol, 10 mM NaF, 1 
mM EDTA, 5 mM sodium pyrophosphate, 0.5 mM Na3VO4, 1 µg/ml leupeptin, 0.2 mM 
phenylmethyl sulfonyl fluoride, 1 µg/ml aprotinin, 1 mM dithiothreitol, 1 mM benzamidine, and 1 
µM microcystin) using a motorised pestle. Homogenates were rotated end over end for 60 min 
at 4°C. Samples were subjected to centrifugation (12,000 g for 15 min at 4°C), and protein 
concentration of the supernatant was determined using a commercially available detergent-
compatible colorimetric assay based on the Lowry method (Lowry et al., 1951) (Bio-Rad 
Laboratories, Hercules, CA; 500-0116). In experiment I, crude muscle samples were 
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homogenised in 1 ml of buffer per 25 mg wet weight of tissue. In experiments II and III, muscle 
samples were lyophilised and dissected free of connective tissue and homogenised in 1 ml of 
buffer per 5 mg dry weight of tissue. 
An aliquot of muscle homogenate (50 µg protein) was mixed with Laemmli buffer containing 
20% v/v β-mercaptoethanol (protein concentration, 2 µg/µl) and subjected to SDS-PAGE. 
Samples for each subject from the respective exercise trials were compared in parallel, and 
representative blots of one such subject are shown in each “Results” section. Proteins were 
separated by SDS-PAGE (6, 8 or 10% resolving gel), transferred to PVDF membranes 
(Immobilon P-IPVH00010; Millipore, Billerica, MA) and blocked with Tris-buffered saline (pH 7.6) 
with 0.02% Tween 20 (TBS-t) containing 5% non-fat dried milk protein for 2 h at room 
temperature. Membranes were incubated overnight at 4°C with primary antibodies for 
respective protein targets detailed in Table 3.2. Membranes were washed in TBS-t and 
incubated with appropriate secondary horseradish peroxidase-conjugated antibodies (1:20000; 
Bio-Rad Laboratories, Hercules, CA). Immunoreactive proteins were visualized by enhanced 
chemiluminescence (ECL; Amersham Biosciences, Arlington Heights, IL) and quantified by 
densitometry. 
Table 3.2. Antibodies directed against target proteins for immunoblot analysis 
          
Target   Supplier 
Product 
code Concentration 
     
COXIV  Cell Signaling Technology 4844 1:1000 
CPT1  Santa Cruz Biotechnology sc-20670 1:500 
ERRα 
 Santa Cruz Biotechnology sc-32972 1:500 
FOXO1A  Cell Signaling Technology 9454 1:1000 
GAPDH  Santa Cruz Biotechnology sc-25778 1:500 
HKII  Cell Signaling Technology 2106 1:1000 
PDK4  Abgent AP7041b 1:500 
PGC-1α 
 Santa Cruz Biotechnology sc-13067 1:500 
phospho-Ser133-CREB  Cell Signaling Technology 9191 1:1000 
phospho-Ser79-ACC   Cell Signaling Technology 3661 1:500 
phospho-Thr172-AMPK   Cell Signaling Technology 2531 1:1000 
phospho-Thr286-CaMKII   Cell Signaling Technology 3361 1:1000 
          
     
3.12 Data analysis 
Experimental data are presented as mean ± SE. Data were evaluated using the SPSS for 
Windows v14.0 software package (SPSS, Inc., Chicago, IL). 
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4.1 Introduction 
Skeletal muscle shows a remarkable malleability to remodel its phenotype and to adapt 
functionally in response to contractile stimuli (Hood et al., 2006;Fluck, 2006). Exercise-induced 
phenotypes are accepted to involve the sensation and transduction of contraction-induced 
stimuli through intracellular signal transduction pathways, their integration by downstream 
targets including transcription factors and transcriptional regulators (Fluck, 2004;Hood et al., 
2006;Freyssenet, 2007). The consequent alterations in mRNA abundance and protein accretion 
result in functional and structural adaptations localised to the exercised muscle. 
In human skeletal muscle, ATP turnover, calcium flux and mechanical stress are thought to be 
the prominent contraction-induced signals resulting in altered metabolic gene expression in 
response to exercise (Ojuka, 2004;Long et al., 2004;Chin, 2005;Jorgensen et al., 2006). 
Transduction of these signals through the activation of AMPK, CaMKII and p38 MAPK pathways 
modulates PGC-1α-dependent transcriptional regulation of skeletal muscle metabolism 
(Akimoto et al., 2005;Jager et al., 2007;Wright et al., 2007a). Pharmacological activation of 
AMPK (Jorgensen et al., 2005), calcium flux (Ojuka et al., 2003) and p38 MAPK (Akimoto et al., 
2005) induces PGC-1α mRNA expression and the induction of several transcription factors and 
exercise-responsive genes. Given that skeletal muscle energy flux during contraction is 
intensity-dependent, it is unsurprising that signal transduction cascades are differentially 
regulated by the intensity of an acute exercise challenge (Wojtaszewski et al., 2000;Widegren et 
al., 2000;Rose et al., 2006). The intensity of exercise is well established as a determinant of 
substrate utilisation during exercise (Romijn et al., 1993;van Loon et al., 2001) as well as a 
critical component in determining the nature and magnitude of training adaptation (Dudley et al., 
1982;Gibala et al., 2006). However, it is less well understood how the intensity or duration of a 
single bout of exercise regulates skeletal muscle gene expression. Whether differential 
activation of these signalling cascades could lead to intensity-dependent regulation of PGC-1α 
expression is unknown. 
Sustained contraction generates transient increases in mRNA abundance of a multitude of 
genes, which typically peaks 3-12 h after cessation of exercise and returns to basal levels within 
24 hours (Pilegaard et al., 2000;Mahoney et al., 2005;Yang et al., 2005a;Schmutz et al., 2006). 
In human skeletal muscle, PGC-1α mRNA is transiently increased following a single bout of 
exercise (Pilegaard et al., 2003;Norrbom et al., 2004;Russell et al., 2005;Cartoni et al., 2005). 
PGC-1α coactivation of the orphan nuclear receptor ERRα is required for PGC-1α-mediated 
mitochondrial biogenesis (Schreiber et al., 2004). In addition, regulators of substrate utilization 
such as FOXO1A and PDK4 are also transiently increased following a single bout of exercise 
(Pilegaard et al., 2003;Mahoney et al., 2005). However, ERRα expression is also regulated by 
RIP140, a transcription factor corepressor that serves mutually antagonistic functions to PGC-
1α in the regulation of mitochondrial activity and fibre type composition (Seth et al., 2007). The 
regulation of metabolic gene networks may be determined by the relative levels or activation of 
PGC-1α and RIP140 (Christian et al., 2006;Seth et al., 2007). RIP140 is relatively highly 
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expressed in skeletal muscle (Seth et al., 2007) and but to date, the effect of exercise on 
RIP140 expression is unknown. 
The purpose of this experiment was to determine the impact of exercise intensity on 
contraction-mediated signalling cascades that regulate PGC-1α expression and nuclear-
encoded mitochondrial genes in human skeletal muscle. We hypothesised that a single bout of 
high intensity exercise would result in greater activation of the AMPK and calcium signalling 
cascades, leading to a differential regulation of PGC-1α-mediated gene expression, when 
compared to a single bout of isocaloric low intensity exercise. 
4.2 Materials and methods 
4.2.1 Experimental design 
Eight healthy, sedentary, males volunteered to participate in the study (Table 4.1). Each 
participant had a preliminary screening, an assessment of peak oxygen uptake and a 
verification of the power output required to elicit the desired exercise intensities as described in 
Chapter III. The first experimental trial took place at least seven days after the verification test. 
The experimental design (Fig. 4.1) required the participants to complete two main experimental 
trials consisting of cycle exercise on a stationary ergometer at either high (80% VO2peak, HI) or 
low (40% VO2peak, LO) intensity, in random order. Experimental trials were separated by exactly 
seven or fourteen days depending on facility and participant availability. The exercise bouts 
were isocaloric and required each participant to expend 400 kcal a priori. 
Experimental set up and protocol for the each trial was identical in every aspect except for the 
intensity, and consequently the duration, of the respective exercise challenge (Table 4.2). To 
preclude the influence of circadian variation on any experimental variable, each experimental 
trial began between 0730 and 0930. Participants reported the Metabolic Physiology Research 
Unit after an overnight (>8 h) fast and were requested to rest quietly in a supine position for 
approximately ten minutes. A resting muscle biopsy was taken (#1). Subjects then consumed a 
high CHO breakfast (see “Dietary control”) and remained in the laboratory with minimal 
ambulation until the commencement of the exercise bout. Exercise began 4 h after the 
consumption of the morning meal. Expired air was collected continuously throughout exercise 
and analysed using the Vmax 29C gas analysis system (SensorMedics, Yorba Linda, CA). 
Values for VO2 and VCO2 were used to monitor the exercise intensity, and calculate the rate of 
energy expenditure (Weir, 1949) and cumulative energy expenditure on a minute-by-minute 
basis. Participants were required to maintain the cycle cadence at between 75 and 80 rpm. A 
second muscle biopsy (#2) was taken immediately after the termination of exercise and another 
(#3) was taken 3 h after the termination of exercise. During this 3 h recovery, participants 
remained in the laboratory with minimal ambulation and were permitted to consume only water 
ad libitum. After the third biopsy, a standardised afternoon meal was consumed after which 
participants were free to leave the laboratory. In addition, a standardised evening meal and 
snack were provided and water was allowed ad libitum. The following morning participants 
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reported to the laboratory after an overnight fast equivalent to the previous night’s and were 
requested to rest quietly for approximately fifteen minutes. A fourth muscle biopsy (#4) was 
taken 19 h after the termination of exercise. 
 
Table 4.1. Physical characteristics of participants 
      
    n=8 
   
Age (yr)  24±1 
Height (m)  1.79±0.02 
Mass (kg)  80.3±2.2 
BMI (kg•m-2) 25.1±1.2 
Body fat (%) 16.0±3.3 
VO2peak (L•min-1) 3.23±0.18 
      




Exercise at 40% or 80% VO2peak until 400 kcal expended
Ex. start - 4 h Ex. start + 0 h + 3 h + 19 h
O/N Fast O/N Fast
 
 
Figure 4.1. Schematic of experimental design 
4.2.2 Muscle biopsies 
Biopsies #1 and #4 were taken from the right leg; biopsies #2 and #3 were taken from the left 
leg. A fresh incision was made for each biopsy and the site of each biopsy was at least 2 cm 
distal or proximal to any previous biopsy site. In the case of biopsy #2, local anaesthetic was 
administered immediately prior to exercise during HI. During LO, exercise was interrupted briefly 
at approximately fifteen minutes prior to the estimated exercise termination time and the 
anaesthetic was administered. Biopsies immediately after exercise were excised within 90 
seconds of the termination of exercise. 
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4.2.3 Dietary control 
Pre-exercise preparation was the same for each exercise test. Subjects were asked to abstain 
from caffeine and alcohol and refrain from physical activity of any nature for 24 h prior to testing. 
Subjects were asked to keep a one day food diary on the day prior to the first experimental trial 
and asked to repeat the content and pattern of intake on the day preceding the second 
experimental trial. 
Dietary intake during each trial was standardised in terms of total energy intake and 
macronutrient composition for each participant. Total energy intake was based on an estimate 
of daily energy expenditure using the Harris-Benedict equation 
BMR (kcal) = (13.75 * body mass in kg) + (5 * height in cm) - (6.76 * age in yr) + 66 
(Harris & Benedict, 1919) 
multiplied by an appropriate activity factor (1.4) (Durnin, 1996), plus 400 kcal added for calories 
expended during the exercise challenge; i.e. (1.4 * Harris-Benedict) + 400.  This caloric intake 
was provided in the form of three main meals and one snack. Each of the main meals provided 
30% of the total caloric intake with the remaining 10% provided by the evening snack. Total 
energy, CHO, fat and protein intake was 36 kcal•kg-1 BM, 6.0 g•kg-1 BM, 0.8 g•kg-1 BM, and 12 
g•kg-1 BM, respectively. Hence, the percentage contribution of each macronutrient was 67% 
CHO, 20% fat and 13% protein. No other food or beverage other than water was allowed. 
4.2.4 Statistical analysis 
Two-way (trial x time) repeated measures ANOVA with pair-wise comparisons was used to 
determine differences between the two intensities of exercise for variables with serial 
measurements. Where a main effect was found, Tukey’s post-hoc test was used to determine 
where the difference existed. Paired t-tests were used to determine differences between the 
trials for variables with single measurements. 
4.3 Results 
4.3.1 Energy expenditure and substrate utilization 
Total energy expenditure was similar between trials despite the difference in exercise intensity 
and total exercise time (p<0.05) (Table 4.2). The difference in the rate of energy expenditure 
(p<0.05) resulted in a greater reliance on the relative (p<0.05) and absolute (p<0.05) 
contribution of carbohydrate oxidation during the high intensity trial. As expected the 
contribution of fat oxidation to total energy expenditure was lower during the high intensity trial 
(p<0.05).  
Muscle glycogen content was similar at baseline (259±17 vs. 249±19 mmol•kg-1 dw for the LO 
and HI trials, respectively) and decreased following both exercise trials (176±22 vs. 128±34 
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mmol•kg-1 dw for the LO and HI trials, respectively; p<0.05), but returned to baseline the 
following morning. The net rate of glycogen utilization was higher during the high intensity trial 
(1.3±0.2 vs. 3.1±1.0 mmol•kg-1 dw•min-1, for the LO and HI trials respectively, p<0.05). Plasma 
lactate concentration was unchanged from baseline during LO, but increased to 7.23±1.07 mM 
at the end of HI (p<0.001 compared to both baseline and LO). 
 
Table 4.2. Energy expenditure and substrate utilization during isocaloric low and high intensity exercise 
trials. Values are mean±SE. ** significantly different compared to low intensity trial (p<0.05). 
   
  LO HI 
   
Total EE (kcal) 412±11 403±1 
Rate of EE (kcal·min-1) 6.0±0.3 11.5±0.7** 
Exercise intensity (%VO2peak) 38.8±0.4 79.4±1.5** 
Exercise time (min) 69.9±4.0 36.0±2.2** 
RER 0.90±0.01 0.98±0.01** 
CHO oxidation rate (g•min-1) 0.9±0.1 2.5±0.2** 
Total carbohydrate oxidized (g) 64±2 89±3** 
Rate of fat oxidation (g•min-1) 0.23±0.02 0.12±0.04** 
Total fat oxidized (g) 15±1 4±1** 
Rate of glycogen utilization (mmol•kg-1 dw•min-1) 1.3±0.2 3.1±1.0** 
Plasma lactate at termination (mM) 1.22±0.11 7.23±1.07** 
      
   
4.3.2 Contraction-activated signalling cascades 
AMPK phosphorylation (Fig. 4.2A) was similar at baseline, but increased 4.1-fold following 
exercise in the high (p<0.05), but not low intensity trial, resulting a difference between trials 
(p<0.05). ACCβ phosphorylation (Fig. 4.2B) increased 3.6- and 7.9-fold immediately following 
exercise for the low and high intensity trials, respectively (p<0.05), resulting in a difference 
between trials at this time point (p<0.05). 
Total CaMKII phosphorylation [summation of βM and γ/δ isoforms (Rose et al., 2006;Rose et al., 
2007a)] increased immediately following the high (42%, p<0.05), but not low intensity trial, with 
a difference between trials (Fig. 4.2C; p<0.05). Phosphorylation of CREB (Fig. 4.2D) was 
unaltered immediately or 3 h after exercise, but tended to increase after 19 h of recovery. 
Phosphorylation of the CaMKII substrates phospholamban and SRF was unaltered either 
immediately after exercise or in the recovery period (data not shown). 
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4.3.3 Gene expression 
PGC-1α mRNA expression increased in response to the exercise protocols in a manner 
analogous to the intracellular signalling cascades (Fig. 4.3A). PGC-1α mRNA was elevated by 
3.8- and 10.2-fold 3 h after LO and HI, respectively (p<0.05), with an effect of exercise intensity 
noted between trials (p<0.05). ERRα mRNA expression was unaltered at any time point (Fig. 
4.3E). Expression of FOXO1A mRNA (Fig. 4.3B) increased immediately and 3 h after both the 
LO and HI trials (p<0.05). FOXO1A mRNA was greater 3 h following the high intensity 
compared to the low intensity trial (p<0.05). Expression of PDK4 mRNA (Fig. 4.3C) was 
increased 3 h after exercise (p<0.05), with a similar effect observed between trials. 
Exercise did not change the expression of a broad range of transcription factors (NRF-1 and 
NRF-2), nuclear-encoded mitochondrial genes (COXIV, CPT1, UCP3) or genes related to 
glucose transporter expression (GLUT4, MEF2A, MEF2D, GEF; Table 4.3). However, an 
intensity-dependent difference in the expression of PPARδ mRNA was observed 3 h following 
exercise. Interestingly, exercise increased the expression of RIP140 mRNA, both immediately 
(p<0.05) and 3 h after exercise (p<0.05). There was no effect of exercise intensity on this 
pattern of expression (Fig. 4.3D). 
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Figure 4.2. Protein phosphorylation of (A) AMPK, (B) ACCβ, (C) CaMKII and (D) CREB, normalised to 
GAPDH protein content. Representative blots for each protein are included. Values are mean±SE. ** 
significantly different to Pre (p<0.05); † significant difference between trials (p<0.05). 





















































































































































































































































































































Figure 4.3. mRNA expression of selected transcriptional regulators and metabolic genes, (A) PGC-1α, (B) 
FOXO1A, (C) PDK4, (D) RIP140, (E) ERRα, and (F) PPARδ. Values are mean±SE, normalised to GAPDH 
mRNA. *** significantly different to Pre (p<0.001); ** significantly different to Pre (p<0.05); * significantly 
different to Pre (p<0.1); † significant difference between trials (p<0.05). 
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Table 4.3. mRNA expression of selected transcription factors, nuclear-encoded mitochondrial genes and 
metabolic genes unaltered by exercise. Values are mean±SE, normalised to the housekeeper gene 
GAPDH. 
                          
  Pre  + 0 h  + 3 h  + 19 h 
  LO HI  LO HI  LO HI  LO HI 
             
NRF-1  1.21±0.30 1.22±0.24  0.99±0.10 1.37±0.21  1.09±0.11 1.40±0.12  0.98±0.06 1.72±0.19 
NRF-2  0.97±0.07 1.12±0.05  0.90±0.08 1.29±0.17  0.90±0.04 1.32±0.18  1.23±0.19 1.17±0.12 
COXIV  1.17±0.19 1.26±0.15  1.16±0.14 1.03±0.20  1.08±0.12 1.10±0.22  1.20±0.18 1.18±0.20 
CPT1  1.23±0.26 1.21±0.13  1.14±0.16 0.98±0.15  0.99±0.16 0.93±0.20  1.11±0.20 1.16±0.24 
UCP3  1.01±0.20 0.98±0.21  0.61±0.09 0.57±0.13  1.12±0.14 1.34±0.29  1.19±0.16 1.23±0.15 
GLUT4  0.96±0.11 1.13±0.16  1.15±0.14 1.04±0.16  0.95±0.11 0.98±0.15  1.19±0.20 1.23±0.21 
MEF2A  0.89±0.14 1.12±0.14  1.01±0.16 1.30±0.29  1.08±0.19 1.18±0.20  1.26±0.17 0.84±0.13 
MEF2D  1.02±0.10 1.08±0.08  1.32±0.09 1.14±0.11  0.99±0.06 1.00±0.09  1.14±0.12 0.99±0.13 
GEF  1.23±0.14 1.06±0.13  1.20±0.10 1.05±0.19  0.92±0.06 0.89±0.14  0.86±0.10 1.08±0.10 
                          
             
4.4 Discussion 
We tested the hypothesis that altering the intensity of exercise can engage distinct signalling 
cascades in active skeletal muscle, which may in turn differentially regulate gene expression in 
response to an isocaloric exercise bout. We show that PGC-1α expression is increased in an 
intensity-dependent manner following acute exercise. This may be partly mediated by an 
exercise intensity-dependent differential activation of AMPK and calcium-dependent signalling 
cascades. The increase in FOXO1A and PDK4 mRNA during recovery from exercise is 
consistent with a previous report (Mahoney et al., 2005) and may be part of a transcriptional 
response initiated with the goal of reestablishing metabolic homeostasis through increased 
glucose sparing and promoting a shift toward lipid oxidation. We also report the novel finding 
that the mRNA expression of RIP140, a transcription factor corepressor that serves mutually 
antagonistic functions to PGC-1α in the regulation of mitochondrial activity and fibre type 
composition (Seth et al., 2007), is increased immediately after acute exercise. 
AMPK phosphorylation increased following exercise at 80% VO2peak, but not at 40% VO2peak 
(Fig. 4.2A). Low intensity exercise increases ATP turnover, but not necessarily the AMP/ATP 
ratio (Howlett et al., 1998), unlike high intensity exercise where the rates of energy expenditure 
and glycogen utilization were higher (Table 4.2) and the AMP/ATP ratio is expected to increase. 
However, low intensity exercise may transiently activate AMPK, as ACCβ phosphorylation was 
increased following both exercise trials (Fig 4.2B). ACCβ phosphorylation is considered a 
sensitive indicator of skeletal muscle AMPK activity in vivo (Park et al., 2002;Chen et al., 2003). 
An increase in ACC phosphorylation in the absence of an increase in AMPK phosphorylation, 
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as seen in the low intensity trial, has been previously reported (Chen et al., 2003;Sriwijitkamol et 
al., 2007). Despite the absence of an increase in AMPK phosphorylation in LO, ACC 
phosphorylation was increased 3.6-fold above resting values suggesting that there may have 
been transient activation of AMPK during LO that wasn’t measurable at the cessation of 
exercise. Consequently, the increase in ACCβ phosphorylation was intensity-dependent (Fig. 
4.2B). ACCβ phosphorylation suppresses malonyl CoA formation and promotes lipid oxidation 
(Hardie & Hawley, 2001), but the precise role for AMPK in contraction-mediated regulation of 
metabolic gene expression is incompletely understood. AMPKα2 knockout mice have a similar 
exercise-induced increase in PGC-1α, FOXO1A and PDK4 mRNA to wild-type littermates, but 
this effect is suppressed in the knockout mice following AICAR stimulation (Jorgensen et al., 
2005), suggesting AMPK is not the sole mediator of exercise-induced gene transcription.  
Calcium flux is rapid and transient during muscle contraction, leading to signal transduction via 
activation of a calcium-dependent cascade believed to act through CaMKII in human skeletal 
muscle (Rose & Hargreaves, 2003;Chin, 2005). CaMKII activation during exercise is rapid and 
sustained (Rose & Hargreaves, 2003); it increases in an intensity-dependent manner and 
correlates with autonomous activity (Rose & Hargreaves, 2003;Rose et al., 2006;Rose et al., 
2007a). Our results demonstrate a similar intensity-dependent effect on CaMKII phosphorylation 
(Fig. 4.2C). However, the rapid and transient calcium oscillations during repeated contraction 
limit the delineation of this signalling cascade in exercising human skeletal muscle despite its 
putative role in metabolism (Wright et al., 2004) and gene transcription (Ojuka, 2004;Chin, 
2005). However, the pattern of CaMKII phosphorylation, autonomous activity, and 
phosphorylation of downstream substrates, is not always consistent (Rose et al., 2006;Rose et 
al., 2007b). Additionally, we did not observe an increase in phosphorylation of the putative 
CaMKII targets CREB (Fig. 4.2D), phospholamban and SRF (data not shown), which have been 
reported to increase during exercise (Rose et al., 2006). 
PGC-1α expression increased in an intensity-dependent manner following isocaloric exercise 
(Fig. 4.3A). We propose a permissive role for AMPK and CaMKII signalling cascades in this 
phenomenon. The importance of these signalling pathways in muscle metabolism (Wright et al., 
2004) and initiating PGC-1α-dependent transcriptional programmes is well established (Wu et 
al., 2002;Zong et al., 2002). The transcriptional response to a single bout of exercise is linked to 
metabolic recovery and adaptation such as increased lipid oxidation, glucose sparing and 
glycogen synthesis during recovery from exercise (Mahoney et al., 2005). FOXO1A positively 
regulates fat metabolism and glycogen sparing through induction of LPL and PDK4 expression 
(Kamei et al., 2003;Furuyama et al., 2003), and influences PGC-1α expression (Kamei et al., 
2004). In transgenic mice overexpressing muscle-specific FOXO1A, PGC-1α mRNA levels are 
increased at rest suggesting that FOXO1A promotes PGC-1α gene expression in muscle 
(Kamei et al., 2004). The observed increase in PDK4 and FOXO1A expression following an 
acute bout of exercise is supported by other studies (Pilegaard et al., 2003;Russell et al., 
2005;Mahoney et al., 2005). FOXO1A expression was increased in an intensity-dependent 
manner immediately and 3 h after exercise similarly to the temporal pattern of PGC-1α and 
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PDK4 expression. Thus, FOXO1A may have important roles in the regulation of substrate 
utilization and the selected expression of PGC-1α target genes in an exercise context. 
Surprisingly, the effect of exercise intensity on skeletal muscle gene expression is poorly 
described. In human skeletal muscle, Kraniou et al. (2006) have shown no difference between 
GLUT4 mRNA induction whether 400 kcal of exercise was performed at either 40% or 80% 
VO2peak. However, Sriwijitkamol et al. (2007) have shown a tendency for higher PGC-1α and 
NRF-1 mRNA after 40 min at 70% VO2peak compared to 50% VO2peak. These results could be 
potentially confounded by the differences in total work completed. In addition, data from animal 
studies (Hildebrandt et al., 2003;Terada et al., 2005) has shown a tendency for an intensity-
dependent effect on mRNA and protein expression. Both the intensity and duration of exercise 
influence the magnitude of the increase in HKII, PDK4, UCP3 and LPL transcription during 
recovery (Hildebrandt et al., 2003). In terms of PGC-1α protein expression, Terada et al. (2005) 
compared responses to high (14x20 s with 14% BM attached) and low (2x3 h with 45 min rest) 
intensity swimming exercise in rats. Although actual energy expenditure during exercise was not 
controlled for or quantified, at 18 h after exercise PGC-1α protein content was increased by 
67% in LO, whereas in the HI trial protein content increased by 126%. However, this trend did 
not result in a statistically significant difference between the trials, so it was concluded that the 
intensity of exercise does not affect the subsequent protein content of PGC-1α. Clearly the 
effect of modulating metabolic stress through exercise intensity and the molecular mechanisms 
underlying altered gene expression warrants further investigation. 
Given the intensity-dependent effects on PGC-1α and FOXO1A, both of which target the PDK4 
gene (Furuyama et al., 2003;Wende et al., 2005;Araki & Motojima, 2006), the lack of an 
intensity-dependent response for PDK4 expression was unexpected. The regulation of PDK4 
mRNA in response to exercise has been linked to muscle glycogen content (Pilegaard et al., 
2005) and the faster rate of glycogen utilization during high intensity exercise would have been 
expected to elicit a greater response. PDK4 expression is increased during an 8 h fast with or 
without a bout of exercise (Vissing et al., 2005), and this effect is diminished when carbohydrate 
is provided during recovery (Pilegaard et al., 2005). In addition, in humans fasted for 48 h, 
FOXO1A mRNA, total protein expression and Ser256 phosphorylation were unaltered despite 
marked changes in whole body metabolism and the expression of PDK4 (Tsintzas et al., 2006), 
which suggests that the role of FOXO1A in regulating PDK4 is transient or lacks importance in 
the context of human skeletal muscle. 
Alternatively, the expression of the orphan nuclear receptor ERRα is regulated by PGC-1α 
(Schreiber et al., 2003) and is necessary for PDK4 expression (Wende et al., 2005;Araki & 
Motojima, 2006), in addition to PGC-1α-induced mitochondrial biogenesis (Schreiber et al., 
2003;Schreiber et al., 2004). ERRα is particularly important for the expression of genes 
regulating oxidative phosphorylation (Schreiber et al., 2003), fatty acid oxidation (Huss et al., 
2004) and mitochondrial DNA expression (Schreiber et al., 2004). ERRα may be a more 
important regulator of PDK4 expression than PGC-1α and the existing ERRα protein content 
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may be rate limiting. Moreover, PDK4 expression may be dependent on energy balance, rather 
than exercise itself, as the total energy expenditure was similar between trials.  
Despite the 10.2-fold increase in PGC-1α mRNA expression, the mRNA expression of 
transcription factors, including NRF-1, NRF-2 and ERRα, or the nuclear-encoded mitochondrial 
proteins COXIV, CPT1 and UCP3 targeted by PGC-1α were unaltered. The exercise challenge 
may not have been sufficient to activate transcription of these genes as previous studies have 
generally used a higher intensity (Pilegaard et al., 2005;Mahoney et al., 2005) or longer duration 
of exercise (Russell et al., 2005) resulting in greater total energy expenditure compared to the 
present study. Another possible explanation for the lack of observed change in PGC-1α-
associated gene targets may be that the signal transduction pathways activated by exercise 
resulted in increases rates of PGC-1α transcription or mRNA stability but did not necessarily 
affect PGC-1α protein content or function. Although it has generally been assumed that the 
exercise-induced increase in PGC-1α expression mediates an increase in mitochondrial 
biogenesis, Wright et al. (2007b) hypothesise that the initial phase of the adaptive increase in 
mitochondrial biogenesis induced by exercise is mediated by activation of existing PGC-1α 
protein rather than by the increase in PGC-1α expression. DNA binding of NRF-1 and NRF-2 to 
response elements on the cytochrome c and COXIV promoters, respectively, was markedly 
increased in response to exercise and occurred prior to an increase in PGC-1α protein (Wright 
et al., 2007b). NRF-1 and NRF-2 DNA binding activities are regulated by coactivation by PGC-
1α (Wu et al., 1999;Mootha et al., 2004). In addition, mRNA and protein levels of a number of 
mitochondrial constituents were increased prior to the increase in PGC-1α protein. Therefore, 
rather than an increase in PGC-1α mRNA being indicative of enhanced PGC-1α activity, 
measurement of the functional activity of existing PGC-1α protein and its associated 
transcription factors is necessary. Thus, while AMPK activation and increased calcium-
dependent signalling are known to acutely upregulate PGC-1α mRNA expression (Jager et al., 
2007;Wright et al., 2007a), their effects on its function as a transcriptional coactivator in vivo in 
the context of exercising skeletal muscle are not conclusively established. Together with the 
absence of an increase in ERRα, NRF-1 and NRF-2 mRNA, the nature of the present exercise 
challenge may have been insufficient to stimulate changes in the functional activity of these 
transcription factors. This would explain why changes in the expression of nuclear-encoded 
mitochondrial proteins were not observed. 
A novel observation of this study was the exercise-induced increase in RIP140 mRNA 
abundance. This corepressor specifically targets metabolic gene networks and has common 
nuclear receptor targets as PGC-1α, including ERRα (Powelka et al., 2006;Seth et al., 2007). 
RIP140 deletion is associated with an increase in TCA enzymes, oxidative phosphorylation and 
mitochondrial biogenesis (Powelka et al., 2006;Seth et al., 2007). Despite the increase in PGC-
1α expression, RIP140 may have repressed ERRα or other nuclear receptors and prevented 
the expression of related genes. We observed an exercise- but not intensity-dependent change 
in the expression of RIP140 mRNA (Fig. 4.3D), which suggests that RIP140 may play some role 
in the recovery or adaptation to a single bout of exercise. RIP140 has a repressor domain with 
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CtBP interaction motifs (White et al., 2008). CtBP is an NAD+ and NADH binding 
dehydrogenase, whose repressor function is increased during hypoxia by decreasing the 
NAD+/NADH ratio (Zhang et al., 2002). Exercise induces a similar redox response by increasing 
NADH (Sahlin et al., 1987) or decreasing NAD+ (Graham et al., 1978) and would therefore be a 
plausible stimulus for RIP140-mediated corepression. The subsequent increase in CtBP 
interaction with RIP140 would increase the repression of ERRα and mitochondrial biogenesis 
(Christian et al., 2006). The balance between PGC-1α coactivation and RIP140 corepression on 
gene expression and mitochondrial biogenesis during recovery from exercise remains to be 
determined.  
In conclusion, we report an exercise intensity-dependent increase in PGC-1α mRNA abundance 
that follows the activation pattern of the AMPK and CaMKII signalling cascades in human 
skeletal muscle. Despite the increase in PGC-1α mRNA abundance, PGC-1α target genes 
encoding mitochondrial proteins were unaltered. Increased RIP140 expression after exercise 
suggests that this corepressor potentially plays some role in exercise-induced alterations in 
gene expression during recovery. Exercise-induced increases in PDK4 and FOXO1A mRNA 
abundance may form part of a transcriptional response that contributes to exercise-induced 
alterations in skeletal muscle metabolism including glucose sparing and increased fat oxidation. 
Our results suggest that the early adaptive transcriptional response to a single bout of exercise 
is modulated by the intensity of the preceding exercise bout. 
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metabolic genes and transcriptional regulators in well-trained 
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5.1 Introduction 
The transcriptome response to a single bout exercise includes an upregulation of mRNAs 
involved in carbohydrate and lipid metabolism, oxidative phosphorylation and mitochondrial 
biogenesis (Pilegaard et al., 2000;Pilegaard et al., 2003;Russell et al., 2005;Mahoney et al., 
2005). Enhanced steady-state levels of gene transcripts due to repeated exercise bouts support 
the synthesis of protein components and provoke structural remodelling and functional 
adjustments in the long term (Fluck, 2006). For example, endurance-trained athletes with 
approximately two-fold higher VO2peak and muscle mitochondrial volume compared to sedentary 
individuals have elevated mRNA concentrations for genes encoding enzymes involved in 
oxidative phosphorylation (Puntschart et al., 1995). These elevations are in direct proportion to 
the higher mitochondrial content of the muscle. Therefore, regulation of gene expression at the 
transcriptional level is accepted as a key process in understanding the overall adaptive 
response to exercise. 
Training history is known to modulate the expression of mRNA in response to a single bout of 
exercise. Recently, it has been shown that short-term training elevates the resting steady-state 
level of mRNA for certain gene targets (Tunstall et al., 2002;Schmutz et al., 2006). In addition, 
there is accumulating evidence that the transcriptional response of metabolic factors may be 
different in trained compared to untrained muscle (Tunstall et al., 2002;Pilegaard et al., 
2003;Fischer et al., 2004;Lundby et al., 2006;Schmutz et al., 2006) or depending on the nature 
of exercise challenge relative to the training history (Coffey et al., 2006a). After a period of 
training, attenuated responsiveness of transcript levels to a single bout of endurance exercise 
has been reported (Fischer et al., 2004;Lundby et al., 2006;Schmutz et al., 2006). Both 
functional and structural adaptations are attenuated with ongoing training with the same relative 
intensity, which may be attributed to the attenuated transcriptional response in the trained state 
(Schmutz et al., 2006). However, the induction of certain genes during acute exercise prior to 
training may not necessarily be involved in the adaptive response to repeated exercise but 
merely reflect the nature of the stresses placed on the muscle (Choi et al., 2005;Keller et al., 
2007). Similarly, it has been suggested that some genes are involved in the restoration of 
homeostasis and therefore are induced during recovery from exercise, whereas other acutely 
responsive genes are not involved in the molecular basis of adaptation and hence are not 
responsive to exercise training (Mahoney et al., 2005). 
The metabolic and mitochondrial adaptations to regular exercise are under the control of an 
increasingly well-defined subset of transcription factors and their coregulators. As described in 
earlier chapters, transcriptional regulators of metabolism in skeletal muscle include PGC-1α, 
NRF-1, NRF-2, ERRα, FOXO1A, and RIP140, which subsequently coordinate of alterations the 
expression of genes involved in carbohydrate and lipid metabolism, oxidative phosphorylation 
and mitochondrial biogenesis (Handschin & Spiegelman, 2006;Freyssenet, 2007;Feige & 
Auwerx, 2007). These factors, apart from being crucial to the regulation of gene expression in 
response to cellular signals, can actually be primary targets for signal transduction pathways 
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(Gerhart-Hines et al., 2007;Jager et al., 2007). The contraction-induced activation of signal 
transduction pathways regulating skeletal muscle gene expression is modulated after a period 
of regular exercise training (McConell et al., 2005;Rose et al., 2007b) or depending on training 
status of the muscle (Yu et al., 2003). In general terms, at the same relative intensity of 
exercise, the activation of contraction-induced signalling pathways is reduced in response to 
training (Yu et al., 2003;McConell et al., 2005). This may be mediated by a reduction in the 
metabolic stress of subsequent exercise and/or an increase in the sensitivity of the energy 
sensing molecules to variations in energy homeostasis (Freyssenet, 2007). A blunted 
contraction-induced signalling response to acute exercise may in part explain the reduced 
transcriptional response to acute exercise observed in trained skeletal muscle. 
The purpose of this study was to examine the effect of acute exercise on the mRNA abundance 
of transcription factors and transcriptional coregulators in well-trained human skeletal muscle. 
As it has been reported that the signalling response to acute exercise in trained muscle may 
require a greater stimulus to elicit similar activation (Yu et al., 2003) and the transcriptional 
response is greater when muscle glycogen is lower (Pilegaard et al., 2002;Pilegaard et al., 
2005), we chose a 90 minute bout of cycle exercise expected to deplete muscle glycogen. 
Given the severity of the exercise stimulus, we hypothesised that the induced mRNA expression 
of selected gene targets would be qualitatively similar to those reported in untrained muscle. 
5.2 Materials and methods 
5.2.1 Experimental design 
Eight healthy, well-trained males volunteered to participate in the study (Table 5.1). Preliminary 
screening, the test for maximal oxygen uptake and verification of the power output required to 
elicit the desired exercise intensity were performed as described in chapter three. The 
experimental trial (Figure 5.1) took place at least seven days after the verification test and 
consisted of 90 min of cycling at 75% VO2peak, followed by one hour of recovery with minimal 
ambulation i.e. lying supine. To preclude the influence of circadian variation on any 
experimental variable, all experimental trials began between 0730 and 0930. Subjects were 
asked to abstain from caffeine and alcohol and refrain from physical activity of any nature for 24 
h prior to testing. Sweetened water (15 ml per kg BM) was provided immediately after exercise. 
On the day of the experimental trial, participants arrived at the Metabolic Physiology Research 
Unit after an overnight fast (>8 h) were requested to rest quietly in a supine position for 
approximately ten minutes. A resting muscle biopsy was taken (#1).  Exercise began 15 
minutes after the first biopsy. Cadence was maintained between 75-80 rpm throughout. Expired 
air was analysed for the first 15 min of exercise, between 35-45 min and again between 75-85 
min to verify exercise intensity. Approximately 20 min before the end of exercise, subjects briefly 
paused cycling while local anaesthetic was administered into the m. vastus lateralis. Exercise 
was continued within 2 min. Immediately at the end of exercise, a muscle biopsy (#2) was 
obtained from the anaesthetized area. A final muscle biopsy (#3) was taken 1 h after exercise. 
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Each biopsy was taken from the same leg but each site was at least 3 cm distal or proximal to 
the previous biopsy site. 
 
Table 5.1. Physical characteristics of participants 
      
    n=8 
   
Age (yr)  23.4±1.7 
Height (m) 1.84±2.4 
Mass (kg)  78.8±2.8 
BMI (kg•m-2) 23.2±0.5 
Body fat (%) 9.4±1.1 
VO2peak (L•min-1) 4.57±0.10 
      
   
 
Biopsies
-15 min 0 min 90 min 150 min
O/N Fast
Exercise at 73% VO2peak for 90 minPrep Bed rest
Pre + 0 h + 1 h
 
Figure 5.1. Schematic of experimental design 
 
5.2.2 Statistical analysis 
One-way ANOVA, with post-hoc pair-wise comparisons using Fisher’s least significant 
difference, was used determine the effect of exercise on the variables of interest. 
5.3 Results 
5.3.1 Energy expenditure and substrate utilisation 
Average total energy expenditure for 90 min of exercise was 1439 ± 33 kcal (Table 5.2). The 
percentage contribution of CHO and fat to total energy expenditure during exercise was 73.0 ± 
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2.8% and 27.0 ± 2.8%, respectively. Muscle glycogen content was decreased by exercise by 
76% (149.6 ± 10.9 vs. 36.3 ± 12.1 mmol•kg dry weight-1, p<0.05; Fig. 5.2). 
 






Total EE (kcal) 1439±33 
Rate of EE (kcal•min-1) 16.0±0.4 
Exercise intensity (%VO2peak) 72.5±1.8 
Exercise time (min) 90 
RER 0.92±0.01 
CHO oxidation rate (g•min-1) 2.9±0.1 
Total carbohydrate oxidized (g) 261±9 
Rate of fat oxidation (g•min-1) 0.49±0.05 
Total fat oxidized (g) 44.1±4.5 
Rate of glycogen utilization (mmol•kg-1 dw•min-1) 1.26±0.12 
Plasma lactate at termination (mM) 2.92±0.38 
































































Figure 5.2 Muscle glycogen concentrations. Values are mean±SE. *** significantly different from Pre 
(p<0.001); ** significantly different from Pre (p<0.05). 
5.3.2 Contraction-activated signalling cascades 
ACCβ phosphorylation, as a surrogate marker of AMPK activity, was increased (p<0.001) both 
immediately after exercise and after 1 h of recovery (Fig. 5.3). Exercise resulted in a 5.8- and 
6.4-fold elevation in phosphorylated ACCβ protein immediately after and 1 h after exercise, 
respectively. 




























































Figure 5.3 Phosphorylated ACCβ protein, normalised to GAPDH protein content. Representative blots for 
each protein are included. Values are mean±SE. *** significantly different from Pre (p<0.001). 
5.3.3 Gene expression 
No increase in mRNA expression for any gene target was observed immediately after exercise 
(Fig. 5.4). Expression of ERRα mRNA was reduced by 34% (p<0.05) immediately after exercise 
but returned to a value similar to pre-exercise values after 1 h of recovery (Fig. 5.4E). PGC-1α 
mRNA expression in response to exercise increased by 4.0-fold after 1 h of recovery (p<0.001; 
Fig. 5.4A). Similarly, FOXO1A mRNA was elevated 3.9-fold 1 h after exercise (p<0.05; Fig. 
5.4B). The expression of PDK4 mRNA was increased by 11.1-fold at the same time point 
(p<0.05; Fig. 5.4C). Sirt1 mRNA was increased by 55% (p<0.05), whereas RIP140 tended to 
increase (49%, p<0.1), both at 1 h after cessation of exercise (Fig. 5.4F & D, respectively). The 
expression of NRF-1, NRF-2, CREB and GLUT4 mRNA was unaffected by exercise at the time 
points investigated (Table 5.3). 





































































































































































































































































































Figure 5.4. mRNA expression of selected transcriptional regulators and metabolic genes, (A) PGC-1α, (B) 
FOXO1A, (C) PDK4, (D) RIP140, (E) ERRα, and (F) Sirt1. Values are mean±SE, normalised to 18S rRNA. 
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Table 5.3. mRNA expression of selected gene targets unaltered by exercise. Values are mean±SE, 
normalised to the housekeeper gene 18S. 
          
  Pre + 0 h + 1 h 
     
NRF-1  0.94±0.15 0.71±0.08 1.11±0.28 
NRF-2  0.74±0.12 0.89±0.11 0.87±0.23 
CREB  0.87±0.14 0.76±0.10 1.08±0.26 
GLUT4  1.00±0.21 0.67±0.13 1.03±0.23 
          
     
5.4 Discussion 
Activation of contraction-induced signal transduction pathways and elevations in mRNA of 
selected genes after a single bout of exercise are reduced after a period of regular exercise 
training (McConell et al., 2005;Schmutz et al., 2006). We demonstrate that acute exercise of a 
sufficient stimulus induces qualitatively similar signalling and transcriptional responses to those 
observed in untrained muscle. Acute exercise-induced activation of AMPK-dependent signalling 
and increased mRNA expression of transcriptional (PGC-1α, FOXO1A) and metabolic (PDK4) 
regulators is conserved in muscle of men with a prolonged history of training. In addition, as we 
have previously shown in untrained muscle, acute exercise induces an increase in mRNA 
expression of the transcriptional corepressor RIP140. Finally, we are the first to report that the 
mRNA abundance of Sirt1, a class III HDAC and known regulator of PGC-1α-associated 
transcriptional regulation, is increased during recovery from exercise. 
AMPK is a key regulator of contraction-induced alterations in gene expression (Jorgensen et al., 
2006). Pharmacological activation of AMPK induces similar effects to chronic exercise, resulting 
in increased expression of genes encoding mitochondrial and metabolic proteins and promoting 
mitochondrial biogenesis through PGC-1α-dependent pathways (Bergeron et al., 2001;Zong et 
al., 2002). Due to technical limitations, we were unable to measure AMPK phosphorylation in 
this experiment. However, exercise resulted in an approximately six-fold increase ACCβ 
phosphorylation that was present immediately after exercise and remained up to 1 h into 
recovery (Fig 5.3). We conclude that the magnitude of this increase represents a significant 
increase in AMPK activity based on several lines of evidence. Firstly, although small (less than 
two-fold) but significant increases in ACCβ phosphorylation have been previously reported 
coincident with unaltered AMPK activity, this has been attributed to transient fluctuations in 
AMPK activity and the fact the ACCβ phosphorylation is an extremely sensitive indicator of 
relative AMPK activity (Park et al., 2002;Chen et al., 2003;Sriwijitkamol et al., 2007). Secondly, 
AMPK activity has been reported to be ablated in response to acute exercise after a period of 
training when exercise is conducted at the same absolute exercise intensity as prior to training 
(McConell et al., 2005). However, when trained and untrained men exercise at approximately 
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the same relative intensity, AMPK activity is attenuated in trained muscle compared to untrained 
but is still significantly elevated above basal values (Yu et al., 2003;Nielsen et al., 2003). Finally, 
the reduction in AMPK activity in trained muscle is in part explained by a reduction in the degree 
of muscle energy imbalance (McConell et al., 2005). After a period of exercise training, the 
same cellular rate of mitochondrial oxidative phosphorylation is attained with a lower rate of 
oxidative phosphorylation per mitochondrion for any absolute workload in muscle fibres with 
elevated mitochondrial content (Dudley et al., 1987). ATP and creatine phosphate 
concentrations decrease to a smaller degree, and the free ADP concentration increases to a 
lesser extent in cells with elevated mitochondrial contents at the same absolute work rate 
(Dudley et al., 1987;Green et al., 1991). Better preservation of free ADP lowers the rate of AMP 
formation, ultimately decreasing the activation of AMPK and its upstream activators. However, 
in well-trained men, a similar, but shorter (60 min), exercise protocol has previously been shown 
to activate AMPK despite PCr and ADP concentrations and the AMP/ATP ratio being 
unchanged (Wojtaszewski et al., 2003). 
A single bout of exercise is known to transiently activate transcription and increase the mRNA 
abundance of many metabolic genes and transcription factors during recovery (Pilegaard et al., 
2003;Russell et al., 2005). The transcriptional response to a single bout of exercise in the 
untrained state is linked to metabolic recovery and adaptation such as increased lipid oxidation, 
glucose sparing and glycogen synthesis during recovery from exercise (Mahoney et al., 2005). 
Exercise training-induced skeletal muscle adaptation is mediated by the accumulation of 
repeated transient elevations in mRNA (Fluck, 2004). However, the transcriptional response to 
a single bout of exercise in the trained state is less well described. In the present study, the 
increased expression of selected gene targets was qualitatively similar to those reported in 
untrained muscle in experiment I. mRNA abundance of PGC-1α, FOXO1A and PDK4 was 
markedly and rapidly elevated in response to a single bout of exercise (Fig. 5.4). The induction 
of FOXO1A and PDK4 is consistent with the initiation of a transcriptional response encoding 
proteins that may serve to reestablish metabolic homeostasis through coordinated changes in 
substrate metabolism (Mahoney et al., 2005). FOXO1A is known to positively regulate fat 
metabolism and glucose sparing through the induction of LPL and PDK4 gene transcription 
(Kamei et al., 2003;Furuyama et al., 2003) and fat transport by enhancing FAT/CD36 
expression in the plasma membrane (Bastie et al., 2005). FOXO1A binds directly to the PDK4 
promoter (Kwon et al., 2004) and overexpression of inducible FOXO1A in C2C12 cells increases 
PDK4 expression, leading to decreased pyruvate dehydrogenase activity and glycolytic flux 
(Bastie et al., 2005). The pyruvate dehydrogenase complex is the key step regulating the 
complete oxidation of glucose proceeding from glycolysis to the Kreb cycle. Inactivation of this 
complex by PDK4 shuts down the conversion of pyruvate to acetyl CoA, resulting in allosteric 
inhibition of glycolysis and suppression of glucose oxidation leading to the diversion of imported 
glucose to storage (Sugden & Holness, 2006). PGC-1α-associated induction of PDK4 
expression is mediated by the activity of ERRα and FOXO1A (Furuyama et al., 2003;Wende et 
al., 2005;Araki & Motojima, 2006). Induction of ERRα and subsequent binding to the PDK4 
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gene promoter in a complex with PGC-1α is induced by PGC-1α and results in increased PDK4 
expression, a pathway in which ERRα is indispensable (Wende et al., 2005). Therefore it is 
likely that the upregulation of transcription of these genes by acute exercise is induced to initiate 
these processes. 
Recently the relationship between the acute transcriptional response and nature of training 
adaptation has been questioned (Mahoney & Tarnopolsky, 2005;Timmons et al., 2005b). Direct 
comparison between ‘acute’ and ‘chronic’ transcriptomes does not demonstrate a link between 
acute exercise responses and the chronic phenotype shift associated with endurance exercise 
training (Keller et al., 2007). In addition, repeated exercise training reduces the magnitude of the 
increase in mRNA of certain genes in response to an acute exercise bout (Fischer et al., 
2004;Lundby et al., 2006;Schmutz et al., 2006). This has been attributed to elevated resting 
mRNA levels and increased sensitivity of the response (Schmutz et al., 2006). However, 
Timmons et al. (2005) have reported that the cluster of mitochondrial and metabolic regulatory 
genes that are activated after a single bout of exercise are not elevated after training. The basal 
mRNA abundance of COXIV and LPL was increased indicating that training did result in 
quantitative adaptations in mitochondrial and lipid metabolism (Timmons et al., 2005b). 
Moreover, the steady-state mRNA abundance of PDK4 and UCP3 was downregulated by 
training, despite the fact that these genes are robustly increased after a single bout of exercise 
(Pilegaard et al., 2000;Schrauwen et al., 2002;Pilegaard et al., 2003;Mahoney et al., 2005). 
Taken together, acutely responsive genes are involved in the restoration of homeostasis but, if 
not involved in the molecular basis of adaptation, are not responsive to exercise training 
(Mahoney & Tarnopolsky, 2005). 
Support for this hypothesis has been shown by Cartoni et al. (2005), who have found marked 
increases in mRNA encoding regulators of mitochondrial biogenesis (PGC-1α, ERRα, NRF-2, 
COXIV) in the muscle of trained cyclists during recovery from a 10 km time-trial. This suggests 
that even in muscle with highly adapted mitochondrial phenotype (Wittwer et al., 2004), a 
sufficient exercise stimulus can induce a transcriptional response designed to coordinate further 
alterations in mitochondrial phenotype. We have not observed an increase in mRNA for ERRα, 
NRF-1 or NRF-2, but it cannot be ruled out that an increase occurred outside of the time frame 
measured. ERRα and NRF-2 mRNA abundance has been previously shown to be elevated 
after 2 and 24 h of recovery, respectively (Cartoni et al., 2005). In addition, it is not possible to 
ascertain the molecular mechanisms regulating this transcriptional response (e.g. DNA binding, 
posttranslational modifications), nor is it possible to definitively conclude that these alterations in 
mRNA are coupled to a functional metabolic response. 
Recent evidence has implicated the nuclear receptor corepressor RIP140 in the regulation of 
metabolic homeostasis by acting on specific gene targets also regulated by the transcriptional 
coactivator PGC-1α (Christian et al., 2006). Advances in the understanding of the regulation of 
PGC-1α in skeletal muscle metabolism have recently identified the class III HDAC, Sirt1, as a 
key regulator of PGC-1α functional activity by deacetylating PGC-1α protein (Lagouge et al., 
2006;Gerhart-Hines et al., 2007). The effect of acute exercise on Sirt1 or RIP140 is unknown. In 
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the present study, a single bout of exercise resulted in an increase in both RIP140 and Sirt1 
mRNA abundance after 1 h of recovery (Fig. 5.4). The functional implications for this finding are 
unknown at present but suggest that muscle contraction regulates Sirt1 and RIP140 expression 
at a transcriptional level, which may be manifested as an alteration in protein content with 
repeated bouts of training. The subsequent role in skeletal muscle metabolism or adaptation to 
acute exercise or chronic training remains to be investigated. 
We have previously shown that the expression of RIP140 is increased immediately and 3 h after 
exercise in untrained men (experiment I). This corepressor specifically targets metabolic gene 
networks and has common nuclear receptor targets as PGC-1α, including ERRα (Powelka et 
al., 2006;Seth et al., 2007). RIP140 deletion is associated with an increase in TCA enzymes, 
oxidative phosphorylation and mitochondrial biogenesis (Powelka et al., 2006;Seth et al., 2007). 
Control of RIP140 repressive activity is largely under the control of posttranslational 
modifications including phosphorylation and acetylation (White et al., 2008). Phosphorylation of 
RIP140 results in greater HDAC recruitment and enhanced repression (Gupta et al., 2005), 
whereas acetylation of RIP140 prevents CtBP recruitment and relieves transcriptional 
repression (Vo et al., 2001). Therefore it is likely that cellular signal transduction cascades can 
regulate its activity but acute exercise-induced effects are entirely unexplored at this time. 
Sirt1 is capable of direct physical interaction with PGC-1α, deacetylating the PGC-1α protein 
and increasing its transcriptional activity (Nemoto et al., 2005;Gerhart-Hines et al., 2007). 
Activation of Sirt1 by resveratrol treatment enhances both the whole-body aerobic capacity and 
the endurance running performance, with a concomitant increase in the mitochondrial oxidative 
capacity of the skeletal muscle (Lagouge et al., 2006). Ectopic PGC-1α expression increases 
ERRα expression and increases mitochondrial gene expression, including respiratory chain 
(cytochrome c, COXV) and lipid metabolism (MCAD, CPT1 and PDK4) genes, an effect that 
was largely prevented by knocking down Sirt1 (Gerhart-Hines et al., 2007). Given the 
importance of Sirt1 to PGC-1α-dependent transcriptional programmes, intuitively Sirt1 may play 
a role in exercise-mediated transcriptional regulation. This has yet to be confirmed, but we show 
that Sirt1 mRNA abundance is elevated during recovery from acute exercise. Only one previous 
study has examined the regulation of Sirt1 by exercise. In rodent muscle, acute exercise 
increased Sirt1 protein content by 18% 2 h after cessation of exercise, an effect that was not 
observed at 0, 1, 18 or 24 h after exercise (Suwa et al., 2008). In addition, two weeks of 
endurance training in the same animals increased Sirt1 protein content by 19% at rest. Although 
the effect of exercise on Sirt1 functional activity remain to be examined, this data and our 
results suggests that exercise modulates the expression of Sirt1, which may in turn play a role 
in exercise-mediated metabolic adaptations (Suwa et al., 2008). 
The regulation of both Sirt1 and RIP140 activity is influenced by the cellular redox state via the 
NAD+/NADH ratio (Rodgers et al., 2008;White et al., 2008). Fluctuations in this ratio are known 
to occur during exercise (Robergs et al., 2004) and are potential contraction-induced metabolic 
signals (Hawley & Zierath, 2004). This suggests that these factors can be modulated by 
contraction-induced mechanisms with possible downstream effects on gene expression 
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(Freyssenet, 2007). The repressive function of RIP140 is mediated by the presence of four 
repression domains which recruit HDACs leading to increased repression (Wei et al., 2000). 
The recruitment of HDACs is mediated by the binding of CtBP, an NAD+/NADH-dependent 
dehydrogenase. Therefore changes in cellular redox potential may affect RIP140 repressive 
activity mediated by CtBP acting as a sensor of redox state (White et al., 2008). Sirt1 enzymatic 
activity is directly affected by fluctuations in NAD+ as well as the ratio of NAD+/NADH. Thus, the 
redox state of the cell, controlled by the activity of different metabolic pathways, modulates Sirt1 
activity (Rodgers et al., 2008). NAD+/NADH ratio has also been reported to increase during 
submaximal and maximal exercise (Graham & Saltin, 1989), whereas Green et al. (1992) have 
shown a progressive decline in NAD+/NADH ratio during 60 min of exercise at 67-76% VO2peak. 
A decrease in the NAD+/NADH ratio increases CtBP-dependent repression (Zhang et al., 2002), 
which suggesting that acute exercise would increase the repressive function of RIP140. 
Conversely, an increase in the NAD+/NADH ratio increases Sirt1-mediated PGC-1α 
deacetylation (Lagouge et al., 2006), which in theory would mean that acute exercise would 
increase the transcriptional activity of PGC-1α.The relationships between NAD+/NADH ratio and 
these transcriptional regulators may be tissue- or stimulus-specific (Freyssenet, 2007). In 
addition, it may be that the NAD+/NADH concentrations in the particular cellular compartments 
(i.e. cytosolic vs. mitochondrial redox) are more important in their regulation than those that 
have been routinely measured during exercise. Clearly, several lines of investigation are 
required to fully elucidate the potential influence of these novel regulators on exercise-mediated 
metabolic adaptation. 
In summary, given a sufficient stimulus, the activation of AMPK and increase in mRNA 
abundance of exercise-responsive genes is conserved in well-trained skeletal muscle in 
response to a single bout of exercise. The exercise-induced increases in PGC-1α, FOXO1A 
and PDK4 are qualitatively similar to those seen in untrained muscle. This coordinated induction 
of several genes may form part of a transcriptional response that contributes to exercise-
induced alterations in skeletal muscle metabolism including glucose sparing and increased fat 
oxidation in the post-exercise period (Kimber et al., 2003). This is consistent with the coupling of 
the induction of a transcriptional response to exercise specifically to a functional metabolic 
demand. We also report that the mRNA abundance of the novel transcriptional regulators, 
RIP140 and Sirt1, is increased during recovery from exercise suggesting that these factors are 
exercise-responsive and may play a role in the acute and/or adaptive response to exercise. 
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6.1 Introduction 
A single bout of exercise generates transient increases in mRNA abundance for a multitude of 
genes that typically peaks 3-12 h after cessation of exercise but generally returns to basal levels 
within 24 hours (Pilegaard et al., 2000;Pilegaard et al., 2003;Mahoney et al., 2005;Yang et al., 
2005a;Schmutz et al., 2006). These include coordinated induction of the expression of genes 
involved in carbohydrate metabolism (HKII, PDK4, GLUT4), lipid metabolism (CPT1, MCAD, 
LPL), oxidative phosphorylation (cytochrome c, COXIV) and mitochondrial biogenesis (Tfam). 
Accumulation of these transcripts with repeated exercise sessions may be the molecular 
mechanism underlying the functional adaptations to exercise training including proteins involved 
in mitochondrial ATP production (Holloszy, 1967), mobilisation, transport and oxidation of fatty 
acids (Bonen et al., 1999), glucose transport and glycogen synthesis (Houmard et al., 1995). 
Comparison of highly-trained and sedentary individuals (Puntschart et al., 1995;Schmitt et al., 
2003;Wittwer et al., 2004), or longitudinal studies of previously untrained individuals 
commencing training (Tunstall et al., 2002;Russell et al., 2003;Short et al., 2003;Schmutz et al., 
2006) support this contention. In trained athletes, elevations in transcript expression of proteins 
involved in lipid and mitochondrial metabolism are in proportion to the augmented mitochondrial 
volume density and elevated VO2peak compared to untrained controls (Puntschart et al., 
1995;Schmitt et al., 2003). Similarly, exercise training elevates steady-state mRNA abundance 
of genes encoding proteins involved in lipid transport and oxidation and mitochondrial 
metabolism when compared to pre-training levels (Tunstall et al., 2002;Schmutz et al., 2006). 
Exercise training for as few as fourteen days results in qualitatively similar adaptations to those 
observed after more prolonged training. These include an increase in maximal oxygen uptake, 
and when exercise was performed at the same absolute intensity after training, smaller 
decreases in high-energy phosphates, a reduction in exercising RER, muscle glycogen 
utilisation and blood lactate accumulation, and concomitant increase in lipid utilisation was 
observed (Green et al., 1991;Green et al., 1992;Mendenhall et al., 1994;Phillips et al., 1996a). 
Spina et al. (1996) have shown that seven to ten days of training for 2 h/d at 60-70% VO2peak is 
sufficient to induce mitochondrial adaptation, as measured by citrate synthase and β-HAD 
activity coincident with an increase in maximal oxygen consumption. In addition, molecular 
events underlying these training adaptations in this time frame are observed at mitochondrial 
(Spina et al., 1996), metabolic (Green et al., 1991), intracellular signalling (McConell et al., 
2005) and transcriptional (Pilegaard et al., 2003) levels. The transient but robust increase in 
mRNA expression of transcription factors and transcriptional coregulators (e.g. PGC-1α, NRF-2, 
ERRα, FOXO1A) after acute exercise suggests a role in the adaptation to chronic exercise 
(Pilegaard et al., 2003;Cartoni et al., 2005;Mahoney et al., 2005). However, the effect of 
exercise training on the expression of these factors during short-term training is not clearly 
defined. Six weeks of endurance training leads to steady-state elevations of mRNA encoding 
PGC-1α and PPARα (Russell et al., 2003), an effect that was not present after nine days of 
training (Tunstall et al., 2002). The transcriptional response to acute exercise therefore is likely 
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to stimulate mitochondrial biogenesis (Wright et al., 2007b), but the accumulation of these 
transcripts or the time course of these changes remains to be confirmed. 
The purpose of this study was firstly to examine whether proposed accumulation of mRNA 
underlying muscular adaptation after repeated bouts of exercise training (Fluck, 2006) is evident 
after fourteen days of training. We hypothesised that an increase in steady-state mRNA content 
of selected genes would be consistent with those that are reported to be transiently elevated 
after a single bout of exercise. The second purpose of this study was to examine the continuity 
between alterations in mRNA and translational changes in protein content during training. The 
final purpose of this study was to examine the time course of adaptation at both the 
transcriptional and translational level over the course of fourteen consecutive days of training. 
6.2 Materials and methods 
6.2.1 Experimental design 
Eight healthy, sedentary males volunteered to participate in the study (Table 6.1). Preliminary 
screening, the test for maximal oxygen uptake and verification of the power output required to 
elicit the desired training intensity were performed as described in chapter three. Seven days 
after the test to verify the power output required for training, the training phase commenced. 
The experimental design (Fig. 6.1) consisted of participants cycling for 60 min per session at 
~80%VO2peak on fourteen consecutive days. Muscle biopsies were taken on the morning prior to 
the first training session, and on five other mornings throughout the training period. A test for 
maximal oxygen uptake was performed 48-72 hours after the last training session to measure 
training-induced changes in VO2peak. 
Table 6.1. Physical characteristics of participants. Values are mean±SE. *** significant difference to Pre-
training (p<0.001) 
      
    n=8 
   
Age (yr)  23±2 
Height (m)  1.79±0.03 
Mass (kg)  75.3±3.0 
BMI (kg•m-2) 23.6±0.9 
Body fat (%) 13.3±2.2 
Pre-training VO2peak (L•min-1) 2.81±0.15 
Post-training VO2peak (L•min-1) 3.28±0.12*** 
∆ VO2peak (%) 17.5±3.8 
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6.2.2 Training programme 
The training phase consisted of fourteen exercise training sessions performed on fourteen 
consecutive days, beginning on day 0 (Fig. 6.1). Each training session was supervised and 
performed in the Human Performance Laboratory at Dublin City University. Each training 
session was 60 min in duration at an intensity equivalent to 80% of pre-training VO2peak. Plain 
water was allowed for consumption ad libitum throughout each session. Training sessions for 
each individual took place at the same time of day ± 1 h to preclude any influence of circadian 
variation on the response to individual training sessions. Expired air was collected for 5 min on 
three occasions during each session; 15-20 min, 35-40 min, 55-60 min. From this, VO2 was 
monitored as the measure of exercise intensity and the power output was adjusted accordingly 
to elicit the target exercise intensity. Heart rate (Polar Vantage NVTM; Polar, Port Washington, 
NY) and rating of perceived exertion (Borg, 1998) were recorded at 5 min intervals during 
exercise. The target oxygen uptake was increased by 10% after seven sessions to ensure the 
training stimulus increased commensurate with the expected increase in VO2peak. Using similar 
protocols, Gulve & Spina (1995) and Spina et al. (1996) have shown 9-10% increases in VO2peak 
after seven to ten days of cycle ergometer training. 
6.2.3 Muscle biopsies 
Six muscle biopsies were taken throughout the training programme. On the morning of day 0, 
participants reported the Metabolic Physiology Research Unit after an overnight (>8 h) fast and 
were requested to rest quietly in a supine position for approximately 15 min. A resting muscle 
biopsy was taken (#1, baseline, day 0). On the morning of day 1, participants reported again 
after an overnight fast and rested quietly as before. A second muscle biopsy was taken (#2, day 
1). The biopsy was taken 16 h after the cessation of the last exercise training session. This 
pattern was repeated for biopsies #3, #4, #5 and #6, which were taken on the morning of days 
3, 7, 10 and 14 respectively, i.e. 16 h after training sessions 3, 7, 10 and 14. Biopsies #1, #2 
and #6 were taken from the left leg; biopsies #3, #4 and #5 were taken from the right leg. A 
fresh incision was made for each biopsy and was 3 cm proximal or distal to a previous biopsy 
site. 
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Figure 6.1. Schematic of the experimental design 
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6.2.4 Dietary control 
For the three days prior to day 0, participants were required to keep a record of all food and fluid 
consumed. Participants were then asked to repeat this pattern of intake throughout the training 
phase to reduce the variability in metabolic responses that have been due to day-to-day 
variation in dietary intake. 
Participants were weighed to the nearest 0.1 kg in minimal clothing prior to and immediately 
after each training session to determine fluid loss induced by each session. Each participant 
was then provided with a volume of plain water equivalent to 150 % of the difference in body 
mass i.e. for every kg of body mass lost during the session, 1.5 L of water was provided. At this 
time, each participant was given two cereal bars (Nutrigrain, Kellogg’s, UK) for consumption 
with the bolus of fluid. This provided 50 g of CHO, 3 g of protein and 7 g of fat immediately after 
each session. 
6.2.5 Statistical analysis 
One-way ANOVA with post-hoc pair-wise comparisons using Fisher’s least significant 
difference, was used determine the effect of exercise training on variables of interest with serial 
measurements. A paired t-test was used to determine the differences between pre- and post-
training VO2peak scores. 
6.3 Results 
6.3.1 Training log and aerobic capacity 
Each participant completed his full complement of fourteen days of exercise training as 
described, indicating 100% compliance. The specifics of exercise intensity and energy 
expenditure are described in the training log (Table 6.2). 
Exercise training resulted in 17.8±3.5% increase in VO2peak compared to pre-training values 
(Table 6.1). Average exercise intensity of the fourteen training sessions was 80.5±1.9% of the 
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Table 6.2. Training log 
                  
                  
         
 Session 1 2 3 4 5 6 7 
 
   
     
VO2 (L•min-1) 2.17±0.08 2.20±0.08 2.24±0.11 2.21±0.12 2.18±0.13 2.15±0.07 2.20±0.10 
EE (kcal)  650±24 661±25 672±34 662±39 653±38 646±20 661±30 
% PRE VO2peak 77.5±1.8 78.9±2.2 79.8±2.0 78.4±1.8 77.3±1.3 77.2±1.9 78.6±1.2 
%POST VO2peak 66.1±1.3 67.4±2.0 68.4±2.4 67.2±2.6 66.4±2.8 65.9±1.2 67.2±1.6 
                  
         
         
                  
                  
         
 Session 8 9 10 11 12 13 14 
 
 
       
VO2 (L•min-1) 2.20±0.14 2.27±0.13 2.38±0.13 2.35±0.14 2.33±0.11 2.39±0.08 2.35±0.13 
EE (kcal)  659±41 681±38 715±39 706±43 699±33 717±25 705±38 
% PRE VO2peak 77.9±1.6 80.1±1.9 84.8±2.2 83.4±1.1 83.2±2.9 85.7±2.6 83.7±1.9 
%POST VO2peak 66.8±2.7 67.4±3.1 72.7±2.9 71.6±2.8 71.1±2.5 73.1±1.9 71.6±2.1 
                  
         
         
                 
                 
         
  Sessions 1-7 Sessions 8-14 Sessions 1-14  
 
 
       
VO2 (L•min-1) 2.19±0.10 2.32±0.12 2.26±0.11  
EE (kcal)  658±0.30 697±37 677±33  
% PRE VO2peak 78.2±1.7 82.7±2.0 80.5±1.9  
%POST VO2peak 66.9±2.0 70.6±2.6 68.8±2.3  
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6.3.2 Gene expression 
The expression of genes encoding proteins involved in mitochondrial metabolism and 
transcriptional control of mitochondrial biogenesis is shown in Figure 6.2. Steady-state 
expression of PGC-1α mRNA increased above pre-training values at days 3 and 7 (48%, 
p<0.05; 31%, p<0.1) but returned to values similar to day 0 thereafter (Fig. 6.2A). ERRα mRNA 
expression was elevated at day 3 (p<0.05) and remained elevated up to day 14 (44-63%, 
p<0.05; Fig. 6.2B). COXIV mRNA tended to be elevated after 1 and 3 days (~40%, p<0.1) and 
continued to be elevated up to day 14 (60-85%, p<0.05; Fig. 6.2E). NRF-1 and PPARδ mRNA 
were elevated after 1 day of training (51% and 68%, respectively; p<0.05) but returned to values 
similar to pre-training values thereafter (Fig. 6.2C & D). No change was observed in UCP3 
mRNA, although a tendency (p=0.108) existed for elevated expression after 1 day of training 
(Fig. 6.2F).  
The expression of genes encoding proteins involved substrate selection and metabolism is 
shown in Figure 6.3. Steady-state mRNA expression of FOXO1A (2.7-fold, p<0.05) and PDK4 
(8.7-fold, p<0.001) was elevated after 1 day of training but were not different to pre-training 
values at any time point (Fig. 6.3A & B). CPT1 mRNA expression was highest after 3 days of 
training (2.0-fold greater than day 0, p<0.05), tended to remain above pre-training values at 
days 7 and 10 (both 54%, p<0.1) and was still elevated by 75% of pre-training values at day 14 
(p<0.05; Fig. 6.3C). GLUT4 mRNA expression was markedly reduced after one training session 
(-51%, p<0.05) but returned to pre-training levels after day 3 and remained unchanged until day 
14. 
One training session induced an increase in mRNA expression for RIP140 (2.1-fold, p<0.001), 
CREB (43%, p<0.05) and Sirt1 (2.1-fold, p<0.001), after which values returned to pre-training 
levels for the remainder of the training period (Fig. 6.4A, B & C). However, CREB mRNA tended 
to remain elevated and after 14 days of training remained 30% above pre-training levels (p<0.1; 
Fig. 6.4C). 
6.3.3 Protein content 
No significantly measurable change was observed in protein content of PGC-1α (Fig 6.5A), 
FOXO1A (Fig.6.5C), PDK4 (Fig. 6.6B) or CPT1 (Fig. 6.6C). ERRα tended to be elevated after 
days 10 and 14 compared to pre-training protein content (~70%, p<0.1; Fig. 6.5B). HKII protein 
content (Fig. 6.6B) was elevated by day 7 (2.9-fold, p<0.05), peaked at day 10 (4.1-fold, 
p<0.001) and remained elevated at day 14 (3.1-fold, p<0.05). COXIV protein content tended to 



























































































































































































































































































































































































Figure 6.2. mRNA expression of genes encoding proteins involved in mitochondrial metabolism and 
transcriptional regulation of mitochondrial biogenesis, (A) PGC-1α, (B) ERRα, (C) NRF-1, (D) PPARδ, (E) 
COXIV, and (F) UCP3. Values are mean±SE, normalised to GAPDH mRNA. *** significantly different to 
Day 0 (p<0.001); ** significantly different to Day 0 (p<0.05); * significantly different to Day 0 (p<0.1). 
 
















































































































































































































































Figure 6.3. mRNA expression of genes encoding proteins involved in substrate selection and metabolism, 
(A) FOXO1A, (B) PDK4, (C) CPT1, (D) GLUT4. Values are mean±SE, normalised to GAPDH mRNA. *** 
significantly different to Day 0 (p<0.001); ** significantly different to Day 0 (p<0.05); * significantly different 
to Day 0 (p<0.1). 
 
 



















































































































































































Figure 6.4. mRNA expression of genes encoding proteins involved in regulation of PGC-1α expression and 
corepression of transcription  (A) RIP140, (B) CREB, (C) Sirt1. Values are mean±SE, normalised to 
GAPDH mRNA. *** significantly different to Day 0 (p<0.001); ** significantly different to Day 0 (p<0.05); * 
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Figure 6.5. Protein content of (A) PGC-1α, (B) ERRα, and (C) FOXO1A, normalised to GAPDH protein 
content. Representative blots for each protein are included. Values are mean±SE. * significantly different 
to Day 0 (p<0.1). 
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Figure 6.6. Protein content of (A) HKII, (B) PDK4, (C) CPT1, and (D) COXIV, normalised to GAPDH 
protein content. Representative blots for each protein are included. Values are mean±SE. *** significantly 
different to Day 0 (p<0.001); ** significantly different to Day 0 (p<0.05); * significantly different to Day 0 
(p<0.1). 
6.4 Discussion 
A single bout of exercise generates a robust but transient increase in the quantity of mRNA for a 
multitude of genes, which are thought to contribute to the recovery from and adaptation to acute 
exercise (Pilegaard et al., 2003;Cartoni et al., 2005;Mahoney et al., 2005). A widely accepted 
hypothesis is that training adaptation is mediated largely by these pulses of elevated mRNA 
abundance after individual exercise bouts within a training program leading to long-term 
increases in protein abundance that culminate in physiological adaptations (Mahoney & 
Tarnopolsky, 2005;Fluck, 2006). In the present study, we tested this contention by examining 
the time course of alterations in mRNA and protein abundance in response to short-term 
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training. However, the results are equivocal in their support. With regard to alterations in mRNA 
abundance of selected genes, there are three broad patterns to emerge: (i) no increase in 
mRNA, (ii) an increase after one exercise session but a return to baseline levels thereafter, or 
(iii) an increase after three exercise sessions that is sustained or increases further throughout 
the training period. Similarly for protein content, two distinct patterns are evident: (i) no change 
in protein content during training, (ii) an increase in protein content evident after seven days of 
training that is sustained until the end of the training period. 
An incremental accumulation of mRNA of genes encoding regulators of mitochondrial 
biogenesis (PGC-1α, ERRα), lipid transport (CPT1) and mitochondrial metabolism (COXIV) was 
observed during the fourteen day training program. This was evident as an increase above 
baseline values after three sessions (Figs 6.2A, B & E, 6.3C). These genes have been 
previously shown to robustly increase after a single bout of exercise (Pilegaard et al., 
2000;Cartoni et al., 2005), and our results indicate an accumulation effect with repeated 
exercise bouts. This suggests that transcriptional activation of these genes plays some role in 
the adaptation to exercise. The regulation of mitochondrial biogenesis and metabolic gene 
expression in skeletal muscle is under control of a well-defined set of factors including PGC-1α 
and ERRα (Schreiber et al., 2003;Huss et al., 2004;Wende et al., 2005;Araki & Motojima, 2006). 
PGC-1α acts as a transcriptional coactivator for a large number of transcription factors 
regulating the expression of metabolic and mitochondrial genes (Handschin & Spiegelman, 
2006). Altering the transcriptional activity of PGC-1α affects physiological responses that equip 
the cell to meet the energy demands of a changing environment including augmentation of 
mitochondrial biogenesis, cellular respiration rates and energy substrate uptake and utilisation 
(Wu et al., 1999;Michael et al., 2001;Lin et al., 2002;St-Pierre et al., 2003;Wende et al., 
2005;Rohas et al., 2007;Wende et al., 2007). Overexpression of PGC-1α in rodent skeletal 
muscle produces a phenotype remarkably similar to endurance trained muscle and improves 
exercise performance (Wende et al., 2007;Calvo et al., 2008). The expression of the orphan 
nuclear receptor ERRα is regulated by PGC-1α (Schreiber et al., 2003) and is necessary for 
PGC-1α-induced mitochondrial biogenesis (Schreiber et al., 2004). ERRα is particularly 
important for the expression of genes regulating oxidative phosphorylation (Schreiber et al., 
2003), fatty acid oxidation (Huss et al., 2004) and mitochondrial DNA expression (Schreiber et 
al., 2004). Therefore, this pathway in association with other factors such as the NRFs is 
proposed as critical to exercise-induced skeletal muscle adaptations (Baar, 2004;Hood et al., 
2006;Arany et al., 2008).  
Despite the accumulation of PGC-1α mRNA, no measurable change was observed in PGC-1α 
protein content whereas an increase in ERRα mRNA levels preceded an elevation in ERRα 
protein content. The discrepancies are difficult to explain. The half-life of PGC-1α protein is 
approximately 2.3 h (Puigserver et al., 2001) and it is possible that the sampling times for 
biopsies missed any increases in protein content induced by exercise. Alternatively, it may be 
that the existing PGC-1α protein content is sufficient and exercise-induced PGC-1α-dependent 
adaptations are regulated by posttranslational modification of existing PGC-1α (Wright et al., 
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2007b). However, PGC-1α protein content has recently been shown to be increased by ~16-
23% in human skeletal muscle during the first 24 h of recovery from an exhaustive bout of 
exercise (Mathai et al., 2008). In addition, PGC-1α mRNA and protein content have been 
previously shown to be elevated by six weeks of endurance training (Russell et al., 
2003;Burgomaster et al., 2008), which suggests that the steady-state increase in PGC-1α 
protein content during endurance training may occur after the fourteen days monitored in this 
experiment. The increase in both ERRα mRNA and protein content suggests that ERRα is 
critical to exercise-induced adaptations in skeletal muscle. To our knowledge, this is the first 
experiment to report such results in the context of exercise training. Given the established 
function of ERRα, this regulation is likely to be at the level of the expression of genes regulating 
oxidative phosphorylation, lipid metabolism and angiogenesis (Schreiber et al., 2003;Huss et 
al., 2004;Arany et al., 2008).  
The increases in CPT1 and COXIV expression are supportive evidence for ERRα-related 
adaptation in the present study. PGC-1α- and ERRα-dependent regulation of CPT1 expression 
has been established (Huss et al., 2004;Gerhart-Hines et al., 2007). Regulation of fatty acyl-
CoA entry into the mitochondria by CPT1 has been identified as a rate-limiting step in the 
oxidation of fatty acids (McGarry & Brown, 1997). The activity of CPT1 is higher in muscle from 
trained compared to untrained humans (Berthon et al., 1998;Jong-Yeon et al., 2002) and this 
was strongly correlated with citrate synthase activity and VO2peak (Berthon et al., 1998). In 
addition, a period of training in previously sedentary individuals results in an increase in CPT1 
activity (Bruce et al., 2006). An increase in CPT1 mRNA after short- and long-term training has 
also been observed (Tunstall et al., 2002;Russell et al., 2003), and in endurance-trained 
compared to sedentary muscle (Schmitt et al., 2003). The relationship between an increase in 
CPT1 mRNA and enzymatic activity after exercise training is not established, but in rodent liver 
under pathological stress, alterations in CPT1 mRNA are reflected by changes in enzymatic 
activity (Mynatt et al., 1994). Evidence for possible PGC-1α/ERRα-associated mitochondrial 
adaptation is supported by the progressive increases in both COXIV mRNA and protein content 
(Figs. 6.2E & 6.6D). COXIV is a nuclear-encoded subunit of the cytochrome c oxidase complex, 
which is the terminal enzyme of the respiratory chain responsible for establishing a 
transmembrane proton gradient that is used to produce ATP (Scarpulla, 2008). COX assembly 
and activity is dependent on COXIV (Li et al., 2006), and COXIV expression is often used as a 
representative marker of mitochondrial biogenesis (Hood, 2001). Exercise training-induced 
changes in COX activity and COXIV protein are reported (Carter et al., 2001;Short et al., 
2003;Gibala et al., 2006). At the mRNA level, COXIV mRNA is elevated (~85%) in endurance-
trained compared to sedentary individuals (Puntschart et al., 1995), whereas endurance training 
resulted in a ~70% increase in COXIV mRNA after six or sixteen weeks (Russell et al., 
2003;Short et al., 2003). In vitro results data have shown that COXIV induction by PGC-1α 
depends, at least partly, on ERRα function (Schreiber et al., 2004). In response to physical 
activity or inactivity, COXIV expression is well correlated with PGC-1α (Short et al., 
2003;Timmons et al., 2005a). PGC-1α-dependent regulation of COXIV expression is likely to be 
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mediated by coactivation of NRF-2 (Wu et al., 1999;Wright et al., 2007b), by virtue of the 
presence of an NRF-2 binding site in the COXIV promoter region (Scarpulla, 2008). Acute 
exercise increases NRF-2 DNA binding to COXIV (Baar et al., 2002;Wright et al., 2007b). In 
addition, an exercise-induced PGC-1α-associated increase in COXIV protein illustrates the 
effective coordination of transcriptional regulation of both the nuclear- and mitochondrial 
genomes described by Hood (2001). However, it has recently been shown in muscle-specific 
PGC-1α knockout mice that exercise training-induced increases in nuclear- (δ-ALAS) and 
mitochondrial-encoded (COXI) proteins are not dependent on PGC-1α, despite an apparent 
regulation of basal protein expression of these targets by PGC-1α (Leick et al., 2008). This is 
interpreted as either PGC-1α is not involved in the training-induced adaptive response in 
skeletal muscle, or that as of yet undetermined compensatory factors or mechanisms modulate 
the response when PGC-1α is absent (Leick et al., 2008). Similarly, in the present study it is not 
possible to ascertain whether the training-induced increase in COXIV is due to a PGC-1α 
coactivation of ERRα and NRF-2 or a combination of other factors in the present experiment. As 
such, the current data can only demonstrate coincidence, but not causality.  
A cluster of genes, which have previously shown to be upregulated by an acute bout of exercise 
(experiments I and II) (Pilegaard et al., 2003;Russell et al., 2005;Cartoni et al., 2005), were 
increased after one exercise session but returned to and remained at basal levels thereafter 
(Figs 6.2, 6.3, 6.4). These included mRNA of genes encoding transcription factors (NRF-1, 
FOXO1A, CREB, PPARδ), the transcriptional corepressor RIP140, Sirt1 and PDK4. This 
suggests that that these genes are not involved in adaptation and respond to exercise for 
different reasons (Mahoney & Tarnopolsky, 2005). For example, PDK4 mRNA has consistently 
been shown to increase robustly during recovery from acute exercise (Pilegaard et al., 
2005;Mahoney et al., 2005;Yang et al., 2005a). However, using microarray analysis, Timmons 
et al. (2005) reported that steady-state levels of PDK4 mRNA are robustly downregulated after 
six weeks of endurance training. Moreover, Keller et al. (2007) have compared microarray data 
from acute and chronic exercise studies and concluded that little direct connection is evident 
between acute upregulation of transcripts and chronic accumulation of transcripts. This 
suggests that acutely responsive genes are involved in restoring muscle cell homeostasis 
during the recovery period after exercise or are part of a generalized stress response that is 
triggered in “uninitiated skeletal muscle” before a more specific response can be “fine-tuned” 
throughout the training period (Mahoney & Tarnopolsky, 2005). However, even in well-trained 
muscle, we have shown that acute exercise can transiently increase the expression of 
FOXO1A, PDK4 and RIP140 among others (experiment II) suggesting that the acute response 
of these particular genes is conserved but does not result in transcript accumulation. This is 
supported by data from Nordsborg et al. (2003) who showed an apparent downregulation of 
PDK4 mRNA expression at rest after six weeks of high intensity training. However, acute 
exercise still induced an increase, albeit blunted, in PDK4 mRNA after training. Therefore, it is 
likely that (i) genes that are not elevated after exercise training may still be involved in 
adaptation and/or homeostatic recovery, and (ii) acutely responsive genes do not necessarily 
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participate in training adaptation. Regarding transcription factor expression, without any 
measurement of protein function it is not possible to rule out a role for these factors in the 
adaptation to exercise. Acute exercise studies demonstrate that the transcript expression of 
these genes is responsive to exercise. However, it may be that the expression (mRNA and/or 
protein) is not as important as functional activity of these targets in the regulation of exercise-
induced alterations in skeletal muscle metabolism. The well established roles for NRF-1 in 
mitochondrial gene regulation (Wu et al., 1999), FOXO1A in substrate metabolism (Bastie et al., 
2005) and Sirt1 in PGC-1α-associated metabolic regulation (Gerhart-Hines et al., 2007) suggest 
that these factors are likely to have a role in the shift in skeletal muscle phenotype after exercise 
training. 
Given the lack of change in mRNA abundance, the protein content for FOXO1A and PDK4 was, 
as might be expected, unaltered by exercise training (Fig. 6.5C & 6.6B). Conversely, mRNA 
does not always need to accumulate to affect a training-induced increase in its protein product. 
Rather, repeated transient pulses of mRNA can lead to an increase in protein product. Kraniou 
et al. (2004) have shown a 3.6-fold increase in GLUT4 protein content after seven consecutive 
days of training, in the absence of any change in mRNA abundance. This is despite the fact that 
GLUT4 transcription and mRNA is elevated during recovery from acute exercise (Neufer & 
Dohm, 1993;Kraniou et al., 2000;Kraniou et al., 2006). In the present study, we did not observe 
a change in GLUT4 mRNA during training, despite the fact that similar training has been 
previously shown to result in elevations in GLUT4 protein content (Houmard et al., 1995;Kraniou 
et al., 2004). Although we did not measure HKII mRNA in the present study, HKII protein was 
markedly elevated after seven days of training and remained elevated thereafter (Fig. 6.6A). 
Acute endurance exercise leads to a transient increase in HKII transcription and mRNA levels in 
human skeletal muscle (Pilegaard et al., 2000;Pilegaard et al., 2002), whereas HKII activity 
increases after a period of exercise training (Baldwin et al., 1973;Green et al., 1983;Spina et al., 
1996;Phillips et al., 1996b). In addition, increases in HKII mRNA levels correlate well with an 
increase in HKII protein content and activity (Osawa et al., 1995;Koval et al., 1998). The 
increased HKII protein content may reflect the need for an increased glucose phosphorylation, 
both during and after exercise, thus ensuring substrate availability for glycolysis during exercise 
and for glycogen synthesis in the recovery period (Connett & Sahlin, 1996). An increase in the 
ability and capacity to store glycogen in muscle is robust adaptation to exercise training 
(Holloszy & Coyle, 1984). 
In summary, adaptations to chronic exercise training are well established (Holloszy & Coyle, 
1984). However, few studies have focussed on the transcriptional regulation of these 
adaptations despite the widely held view that transcriptional mechanisms underlie the 
remarkable plasticity of skeletal muscle (Booth & Baldwin, 1996;Williams & Neufer, 1996;Hood 
et al., 2006;Fluck, 2006). We have demonstrated divergent effects of exercise training on 
mRNA and protein expression for a range of transcriptional regulators and metabolic and 
mitochondrial targets. These findings suggest that the regulation of gene expression by exercise 
is gene-specific. Improvements in mitochondrial function require an increase in the proteins that 
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participate in the generation of a dynamic mitochondrial network. We show an increase in the 
mRNA abundance of the transcriptional coactivator PGC-1α and the PGC-1α partner ERRα. 
Notably, this is the first study to report changes in ERRα protein levels following exercise 
training. Furthermore, there is an increase in COXIV mRNA and protein, a PGC-1α target gene 
and marker of mitochondrial biogenesis. These data are consistent with the concept that initial 
signalling events associated with acute exercise induce transient pulses of increased mRNA 
abundance that eventually lead to an increase in protein content and enzyme activity, and that 
with longer term training there are increases in mRNA abundance for some, but notably not all, 
mitochondrial and metabolic proteins (Hood, 2001;Mahoney & Tarnopolsky, 2005;Fluck, 2006). 
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The goal of this body of work was to investigate alterations in skeletal muscle gene expression 
under various experimental conditions. In the series of experiments reported, the findings were 
as follows 
(i) divergent exercise intensities during acute isocaloric bouts of exercise modulate the 
magnitude of the transcriptional response to exercise such that coincident with 
greater kinase activation during exercise, larger increases in mRNA abundance 
occur during recovery from high intensity exercise 
(ii) the induction of mRNA after acute exercise in trained muscle is qualitatively similar 
to untrained muscle and may induce a transcriptional programme coupled to a 
functional metabolic response in the post-exercise period 
(iii) the transcriptional response to acute exercise is linked to either the restoration of 
metabolic homeostasis or adaptation to repeated exercise bouts 
(iv) these findings are recapitulated during exercise training, where accumulation of 
mRNA and corresponding protein are present for some, but not all, acutely 
responsive genes 
The initial course of signalling events and their interactions with regulators of the transcriptional 
response remain elusive. However, the ensuing transcriptional response in skeletal muscle is 
specific in terms of its character and time course is response to acute exercise and exercise 
training. Our results illustrate the well-described phenomenology of skeletal muscle plasticity 
and suggest that transcript level adjustments underlie modulation of skeletal muscle metabolism 
and phenotype by regular exercise. 
7.1 Contraction-mediated regulation of skeletal muscle gene expression 
7.1.1 Modulation of the exercise-induced signal modulates gene expression during 
recovery 
The activation of AMPK, CaMKII and p38 MAPK pathways are strongly linked to metabolic and 
mitochondrial adaptation in skeletal muscle (Long et al., 2004;Fluck, 2004;Chin, 
2005;Jorgensen et al., 2006). The metabolic milieu and the multiple extra- and intramuscular 
stimuli during contraction make it extremely difficult to isolate the exact contribution of each 
signalling pathway to measured changes in gene expression. Moreover, it has become 
increasingly apparent that these pathways, in broad terms, demonstrate some degree of 
dependence, cross-talk and redundancy in their regulation of metabolism (Hurley et al., 
2005;Wright et al., 2007a). Conclusive data demonstrating continuity between activation these 
pathways to consequent alterations in gene expression is currently lacking in exercising human 
skeletal muscle. The mechanistic evidence is largely based on animal or cell-based 
experiments using pharmacological activation or inhibition of these kinases and/or knockout of 
signal pathway components and examining the downstream effects on gene expression. 
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Using divergent exercise intensities as a novel integrative approach to investigate the effect of 
altering metabolic stress (and consequently, signalling kinase activation), we hypothesised that 
altering the metabolic stress of an acute exercise bout would be reflected by corresponding 
alterations skeletal muscle gene expression. In experiment I, we have demonstrated an 
intensity-dependent activation of intracellular signalling kinases, and differential responses in 
mRNA expression of selected gene targets. In short, greater kinase activation of AMPK and 
CaMKII at the higher exercise intensity coincided with greater elevations in mRNA abundance 
of some (PGC-1α, FOXO1A, PPARδ) but not all gene targets (PDK4, RIP140) during recovery 
from high intensity exercise. However, the continuity between the activation of these kinases 
and the alterations in functional activity of transcriptional regulators regulating the expression of 
these genes was not established. 
That the molecular signature of a single bout of exercise is sensitive and specific to the 
functional and metabolic demand imposed has been previously demonstrated in experiments 
that altered these demands by innovative means. Differential regulation of exercise-induced 
mRNA expression has been observed in studies that have reduced the muscle glycogen 
content (Keller et al., 2001;Pilegaard et al., 2002), fed carbohydrate during exercise (Civitarese 
et al., 2005), varied carbohydrate supply during recovery (Cluberton et al., 2005;Pilegaard et al., 
2005), suppressed circulating FFA prior to exercise (Watt et al., 2004), or exercised the muscle 
under ischemia (Norrbom et al., 2004). The divergent responses between metabolic genes and 
transcriptional coregulators to these interventions (Russell et al., 2005;Civitarese et al., 2005) 
suggests that the regulation of their expression on a gene-specific basis is sensitive to and 
dependent on specific signals. In some cases, the exercise-induced signal activation has been 
modulated under similar experimental conditions (Wadley et al., 2006;Akerstrom et al., 2006), 
which suggests that alterations in the activity of signal transduction pathways may underlie this 
transcriptional phenomenon. However, this has not been directly examined. Our results suggest 
that experimental manipulation of the exercise challenge modulates skeletal muscle gene 
expression, coincident with the differential activation of signal transduction pathways. 
The intensity of exercise can be relatively easily modulated and quantified in a laboratory 
setting. Although we have only used two exercise intensities in our model, it would be possible 
to examine a variety of intensities between 30% and 90% VO2peak, with a view to investigating 
the linearity of the signalling and transcriptional responses to acute exercise. This assumes 
each exercise bout is isocaloric, as the duration of an acute bout of exercise is known to 
modulate gene expression when exercise is performed at the same intensity (Hildebrandt et al., 
2003), presumably due to variation in energy expenditure. 
This model would not be able to fully delineate the respective contributions of each signalling 
cascade. However, clearer relationships may be established between kinase activation and 
gene expression given the established intensity-dependent activation of these kinases 
(Wojtaszewski et al., 2000;Widegren et al., 2000;Rose et al., 2006). For instance, during low 
intensity exercise, we observed minimal activation of AMPK and CaMKII but a robust elevation 
in mRNA abundance of PGC-1α was still observed during recovery.  
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7.1.2 Posttranslational modifications induced by exercise-induced signals 
The lack on data demonstrating continuity between the contraction-induced signal activation 
and the regulation of gene expression reflects the fact that the majority of exercise-related 
studies on transcriptional regulation in humans have been descriptive rather than mechanistic. 
A network of nuclear receptors, transcription factors and coregulators are the key factors linking 
alterations in dietary, metabolic and endocrine pathways to the control of target gene 
expression (Feige & Auwerx, 2007). Their functional activity is regulated through spatial and 
temporal control of their expression and activity in response to metabolic cues. Accumulating 
evidence suggests that this regulation is controlled at the level of posttranslational modification 
of the existing transcriptional regulator protein. That these regulatory pathways are each 
modulated by exercise suggests that they could play some role in exercise-mediated metabolic 
regulation. For example, the regulation of PGC-1α functional activity can occur at the level of 
direct phosphorylation by p38 MAPK (Puigserver et al., 2001) or AMPK (Jager et al., 2007), or 
by acetylation status mediated by NAD+/NADH-dependent control of Sirt1 and GCN5 activity 
(Rodgers et al., 2005;Lerin et al., 2006). Similarly, the regulation of FOXO1A activity can occur 
at the level of phosphorylation (Biggs III et al., 1999) and acetylation (Nakae et al., 2006). 
However, these mechanisms have not been investigated in an exercise context. 
7.1.3 Untrained vs. trained muscle 
The differences in exercise duration, energy expenditure and biopsy timing between 
experiments I and II make it impossible to directly compare the transcriptional response to 
exercise in the untrained and trained state. However, the general pattern of mRNA induction 
during recovery in either experiment is qualitatively similar. A rapid and robust increase in 
mRNA abundance of the PGC-1α, FOXO1A and PDK4 is consistent with a transcriptional 
response initiated to program a metabolic response in the recovery period after exercise that 
restores homeostasis through coordinated changes in substrate metabolism (Mahoney et al., 
2005) as discussed in earlier chapters.  
Studies comparing the effect of training history or short-term training on the transcriptional 
response to acute exercise have generally concluded that the magnitude of the response is 
blunted for most genes (Nordsborg et al., 2003;Fischer et al., 2004;Lundby et al., 2006;Schmutz 
et al., 2006). Nordsborg et al. (2003) have suggested that possible that the mRNA changes 
during recovery from exercise would be the same in the trained and untrained state, if exercise 
had been carried out at the same relative, instead of the same absolute, workload. However, 
these effects in other studies were irrespective of whether the acute exercise bout after a period 
of training was conducted at the same relative or absolute exercise intensity. Conversely, our 
results suggest that irrespective of the training status of the muscle, it is likely that if the 
metabolic perturbation is sufficient, an appropriate transcriptional response is induced. In the 
case of glycogen-depleting exercise in experiment II, the appropriate transcriptional response in 
this case is likely to be similar, but not limited, to the one described above, i.e. sparing of 
glycogen precursors for glycogen resynthesis and increased lipid oxidation. Regarding the 
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extent of metabolic perturbation, it is worth remembering that the exercise challenge was more 
than three-fold higher in terms of calories expended during the respective bout in the trained 
compared to untrained experiments. Duration of exercise (and thus, total energy expenditure) 
has been previously shown to regulate the transcription of UCP3, PDK4 and HKII when 
exercise intensity is similar (Hildebrandt et al., 2003). These data are consistent with the notion 
that the muscle adapts appropriately and specifically to metabolic stress. 
7.1.4 Continuity between effects of acute and chronic exercise on gene expression 
Apart from the restoration of homeostasis, the transcriptional response to a single bout of 
exercise is hypothesised to increase mRNA abundance of factors that later play a role in 
adaptation to exercise (Mahoney et al., 2005). However, after an acute bout of exercise no 
measurable increase was observed in mRNA abundance of a number of genes known to 
regulate mitochondrial metabolism and regulate gene expression in skeletal muscle, i.e. ERRα, 
NRF-1, NRF-2. Despite this apparent lack of upregulation after acute exercise, we still observed 
an accumulation of ERRα transcript abundance during training, laterally reflected by an 
increase in ERRα protein content. Conversely, FOXO1A transcript abundance was rapidly and 
robustly increased after acute exercise, but neither mRNA nor protein content was altered 
during exercise training. 
A generalised hypothesis regarding the role of transcriptional regulation in governing skeletal 
muscle plasticity and exercise training adaptation is widely proposed (Booth & Baldwin, 
1996;Hood, 2001;Mahoney & Tarnopolsky, 2005;Fluck, 2006). Initial signalling events 
associated with acute exercise induce transient pulses of increased mRNA abundance for 
selected genes. These transcripts gradually accumulate with repeated stimulation due to the 
repetitive effect of exercise training. This accumulation of transcript abundance eventually leads 
to an increase in protein content and enzyme activity of the encoded targets. The functional 
consequences of these events are manifested as a training adaptation such as enhanced 
capacity to produce ATP from aerobic means during exercise. 
The results reported herein add to our understanding of this framework. Rather than there being 
a linear relationship between mRNA expression during recovery from exercise with a gradual 
accumulation of transcript abundance during training, and a consequent increase in protein 
content, regulation must be considered on a gene-specific basis. There are several possible 
effects of acute and chronic exercise on any given gene that may be surmised from our data: 
(i) robust and transient increase in mRNA abundance during recovery from a single 
bout of exercise consistent with role in homeostatic restoration; no change with 
exercise training and unlikely to have a role in the adaptation to training 
(ii) robust and transient increase in mRNA abundance during recovery from a single 
bout of exercise, which results in gradual accumulation of transcript expression 
consistent with role in adaptation to exercise training 
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(iii) no change in mRNA abundance during recovery from a single bout of exercise, but 
gradual accumulation of transcript expression evident during training consistent with 
role in adaptation to exercise training 
(iv) robust increase in mRNA abundance after one exercise session as part of a 
generalized stress response that is triggered in uninitiated skeletal muscle before a 
more specific response can be fine-tuned throughout the training period 
7.2 Gene-specific regulation by exercise 
7.2.1 PDK4 as a case study  
PDK4-mediated inhibition of PDH via phosphorylation in muscle represents a mechanism for 
conserving carbohydrate substrates by gradually limiting the entry of glycolytic products into the 
mitochondria for oxidation and thereby conserving tricarboxylic acids for gluconeogenesis 
(Sugden & Holness, 2006). During recovery from exercise, skeletal muscle is characterized by a 
dramatic increase in insulin action and glycogen synthase activity, both of which promote the 
rapid resynthesis of muscle glycogen (Price et al., 1994;Nielsen et al., 2001). Partitioning of 
exogenous glucose towards glycogen resynthesis is of high metabolic priority during immediate 
post-exercise recovery, and is supported reduced PDH activity and increased fat oxidation 
(Kimber et al., 2003). 
Expression of PDK4 is highly sensitive to alterations in metabolic status such as acute exercise, 
fasting and high-fat/low-carbohydrate diets (Pilegaard et al., 2000;Peters et al., 2001;Pilegaard 
et al., 2003;Tsintzas et al., 2006). This is because skeletal muscle PDK4 expression increases 
in situations where carbohydrate availability and insulin levels are decreased and free fatty 
acids are increased (Sugden & Holness, 2006). In other words, during metabolic states in which 
there is a perceived deficit in whole body glucose availability. Irrespective of training status, we 
observed a marked increase in PDK4 mRNA abundance during recovery from a single bout of 
exercise (experiments I and II). An increase in PDK4 mRNA has been shown to correlate with 
an increased level of PDK4 protein, which increases PDK activity, reducing PDH activity (Peters 
et al., 2001;Tsintzas et al., 2006). 
The induction pattern of PDK4 mRNA in response to metabolic perturbation illustrates the highly 
specific nature of the transcriptional response to a stimulus. Elevations in PDK4 mRNA are 
greater when the duration of exercise is extended at same exercise intensity (Hildebrandt et al., 
2003). Lowering muscle glycogen increases PDK4 mRNA at rest and augments the exercise-
induced effects (Pilegaard et al., 2002). Carbohydrate ingestion during exercise ablates the 
exercise-induced increase in PDK4 mRNA during recovery (Civatarese et al., 2005(Cluberton et 
al., 2005). Similarly, high carbohydrate feeding during recovery from exercise blunts the post-
exercise increase in PDK4 mRNA compared to low carbohydrate intake (Pilegaard et al., 2005). 
Fasting (48 h) induces an upregulation in PDK4 mRNA expression, and additionally reduces 
PDH activity coincident with an increase in PDK4 protein expression in human skeletal muscle 
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(Tsintzas et al., 2006). This response was reversed by refeeding with a CHO-rich diet. Without 
addressing factors regulating PDK4 gene expression (Pilegaard & Neufer, 2004;Sugden & 
Holness, 2006), taken together these results demonstrate that PDK4 mRNA is induced in 
response to acute or sustained perturbation to metabolism that require a shift in fuel partitioning, 
but is rapidly reversed when exogenous fuel is supplied. 
A robust increase in PDK4 mRNA expression induced by a single bout exercise of exercise 
would be expected to be recapitulated by an accumulation in mRNA and latterly protein content 
during training. However, this is not the case. Timmons et al. (2005) reported steady-state 
levels of PDK4 mRNA robustly downregulated after six weeks of endurance training, whereas 
we found no change in PDK4 mRNA or protein content after fourteen days of training. After six 
weeks of high intensity training, acute exercise still induced an increase in PDK4 mRNA, 
despite an apparent downregulation of PDK4 mRNA abundance at rest (Nordsborg et al., 
2003). This suggests that PDK4 is one gene that is acutely responsive to exercise but does not 
participate in the adaptive response to exercise training. This type of transcriptional regulation 
has previously been proposed by Mahoney & Tarnopolsky (2005), and should be considered in 
any discussion of the relevance of an acute exercise-induced increase in expression of a given 
gene to a training-induced adaptation. 
7.2.2 Transcription factors and transcriptional coregulators  
A single bout of exercise increases the mRNA abundance of several transcription factors and 
transcriptional coregulators during recovery (Pilegaard et al., 2003;Russell et al., 2005;Cartoni 
et al., 2005). The relevance of this phenomenon to the adaptive response to exercise training is 
not established. Intuitively, the induction of expression of regulators of mitochondrial gene 
expression and mitochondrial biogenesis by acute exercise may play a role in adaptation given 
the established effects of exercise training on mitochondrial adaptations (Holloszy & Coyle, 
1984;Fluck, 2004). 
We did not observe a change in transcript abundance of several transcription factors such as 
ERRα, NRF-1, NRF-2, MEF2 and CREB during recovery from acute exercise. Experimental 
design differences in factors such as timing of biopsies, exercise duration, or probe/primer 
design to name a few, cannot be ruled out as explanation for the discrepancy between studies. 
In the training study, the mRNA expression of several transcription factors was elevated 16 h 
after one session of exercise but returned to pre-training values thereafter for the remainder of 
the training period. Protein content for PGC-1α and FOXO1A was unaltered by training but 
ERRα protein increased during training. The increase in COXIV mRNA and protein content 
throughout the training period indicates that some adaptation at the level of mitochondrial 
metabolism/biogenesis had occurred. 
Training-induced alterations in expression of transcription factors and coregulators are not well 
described. However, PPARα and PGC-1α mRNA and protein content have been previously 
shown to be elevated by six weeks of endurance training (Russell et al., 2003;Burgomaster et 
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al., 2008). Similarly, ten weeks of exercise training resulted in a 50% increase in PGC-1α 
mRNA (Mortensen et al., 2007), whereas sixteen weeks of aerobic training increased the mRNA 
abundance of PGC-1α, NRF-1, and Tfam (Short et al., 2003). 
At present, the generalised response of transcription factors to training and their precise role in 
exercise-mediated metabolic adaptation is unknown beyond a coincidental rise in mRNA and/or 
protein expression during training. What relevance this increase in expression has regarding 
functional activity is unknown. In some cases, it may be that the existing transcription factor or 
coregulator protein content is sufficient and exercise-induced adaptations are regulated by 
posttranslational modification of existing protein, thereby modifying its functional activity. This 
has been proposed in the case of exercise-induced PGC-1α-associated mitochondrial 
biogenesis (Wright et al., 2007b). One report currently in press (Mathai et al., 2008) has shown 
a ~20% increase in PGC-1α protein content in human skeletal muscle during 24 h of recovery 
from a single bout exhaustive exercise. PGC-1α knockout in skeletal muscle reduces the acute 
exercise-induced expression of mitochondrial gene targets (Leick et al., 2008). Together these 
results suggest PGC-1α expression is induced by exercise consistent with a role in acute 
exercise-induced transcriptome response, whereas PGC-1α is not mandatory for the exercise 
training-induced response of the same gene targets (Mathai et al., 2008).  
7.3 Technical considerations 
7.3.1 Timing of muscle biopsies 
Given the rapid kinetics of contraction-induced signalling, posttranslational modifications, 
transcriptional activation, mRNA stability/half-life, and protein stability/half-life, studies that 
involve only single time point measurements may not be conclusive due to lack of time course 
data. Studies on skeletal muscle metabolism require the excision of muscle tissue, generally 
through means of a muscle biopsy. Although relatively painless, the invasive nature of the 
procedure reduces the number of volunteers willing to participate in experiments. This is one of 
the major difficulties in in vivo experiments in exercise metabolism. Our experimental designs 
have employed multiple muscle biopsies in an attempt to achieve adequate temporal resolution 
regarding the molecular responses to exercise. 
However, it cannot be discounted that a lack of observed effects in the mRNA or protein 
expression of selected targets was simply due to the timing of biopsies. For example, the 
increase in PGC-1α mRNA reported during recovery from exercise can be seen 1 h after 
exercise (Russell et al., 2005) and remains elevated up to 8 h into recovery (Vissing et al., 
2005). In contrast, increased mRNA abundance of CPT1 or COXIV may not be manifested until 
24 h after exercise (Cartoni et al., 2005;Pilegaard et al., 2005). Therefore, in the acute exercise 
studies (experiments I and II), a lack of observed effects may be attributed to the timing of 
muscle biopsies. 
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In the training study, biopsies were taking in the fasted state, 16 h after the previous exercise 
bout. Again the kinetics of mRNA and protein stability cannot be discounted. However, we were 
interested in steady-state changes in gene expression and, as such, this design satisfied our 
aim. In addition, it is possible that accumulations in mRNA and protein content may have 
occurred later than the fourteen days of training measured here. Endurance training, employing 
an appropriate duration per day, frequency per week, and submaximal intensity per exercise 
bout, can produce an increase in mitochondrial content, usually ranging from 50 to 100% within 
six weeks, reaching a new, higher steady-state mitochondrial content (Holloszy & Coyle, 
1984;Hood, 2001). Similarly, previous studies investigating PGC-1α protein content have shown 
changes in protein content after six weeks of training (Russell et al., 2003;Burgomaster et al., 
2008). The nature of training adaptations is that individual components follow distinct time 
courses (Saltin et al., 1977;Phillips et al., 1996b), a fact that may be reflected by divergent 
responses of mRNA and protein content of specific targets.  
7.3.2 mRNA and protein kinetics in skeletal muscle in response to contractile activity   
The relationship between morphometric estimation of muscle mitochondrial volume density and 
biochemical changes in tissue oxidative capacity are highly correlated (Reichmann et al., 1985). 
Therefore, mitochondrial content is generally estimated by the change in maximal activity, 
measured under optimal conditions in vitro, of a typical marker enzyme (e.g. citrate synthase, 
SDH) or by the change in the protein content of a single protein (e.g. cytochrome c, COX).  
The approximate six week time period required to achieve a new steady-state mitochondrial 
content in response to endurance training clearly does not reflect the early molecular events 
that ultimately lead to the measurable morphological changes (Hood, 2001). A change in 
mitochondrial protein content is measurable at much earlier time points. Mitochondrial proteins 
turn over with a half-life of approximately one week after the onset of a new level of muscle 
contractile activity (Booth, 1977;Henriksson & Reitman, 1977;Terjung, 1979), whereas 
enzymatic activities are elevated after as little as two days of stimulation (Reichmann et al., 
1985). 
A chronic increase in the contractile activity of skeletal muscle can stimulate translation of 
mitochondrial proteins from the existing pool of mRNAs, before the increase in mRNA content 
takes place (Freyssenet et al., 1996). In chronically stimulated muscle, elevations in citrate 
synthase activity were observed before an increase in citrate synthase mRNA after eight days, 
but increases in citrate synthase mRNA were subsequently followed by a larger increase in 
citrate synthase activity up to fifty-two days (Seedorf et al., 1986). However, the mRNA 
expression and enzymatic activity of LDH, a cytosolic enzyme, increased in an identical manner 
to one another in the same time frames. 
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7.3.3 Relationship of alterations in mRNA to functional consequences 
Increments in mRNA abundance are often referred to as increases in gene expression. This is 
technically incorrect, because increased gene expression and its associated 
phenotypic/functional manifestations do not take place until there is an increase in the 
concentration of the protein encoded by the gene (Baar et al., 2002). Gene expression can be 
controlled at various points beyond transcription, so the extent to which a protein will increase in 
response to an adaptive stimulus cannot always be predicted from the increase in mRNA. In 
skeletal muscle, expression of mRNA does not always accurately reflect the abundance of 
proteins and can give no information regarding their posttranslational modifications (Hojlund et 
al., 2008). 
For example, in order for PDK4 to alter fuel partitioning, it must phosphorylate PDC, thereby 
inactivating it. It is incorrect to say that an increase in PDK4 mRNA expression leads to sparing 
of glucose. There is no evidence that this mRNA change results in altered PDK4 protein content 
nor is there any evidence that its enzymatic activity, i.e. leading to phosphorylation of PDC, is 
increased. A more conservative statement is that a transcriptional response was induced that 
may form part of a metabolic response that contributes to glucose sparing and increased fat 
oxidation. 
The observation that a specific mRNA was significantly increased following exercise indicates a 
regulatory effect of muscle contractions upon that mRNA level. However, the finding that 
subsequently the protein level does not change may demonstrate that acute exercise does not 
necessarily mediate a detectable increase in protein content at the translational level. 
Alternatively, the temporal resolution provided by muscle biopsies may be a confounding factor. 
Clearly, consideration and further investigation of the continuity between contractile activity-
induced alterations in transcriptional regulation, protein synthesis and functional adaptation is 
required. 
7.3.4 Measurement of PGC-1α protein content by immunoblot techniques 
Measurement of protein content in these experiments is limited to those currently available from 
commercial sources. It must be acknowledged by this author that determination of PGC-1α 
protein content in human skeletal muscle has been an ongoing issue in this field for the past 12-
18 months, something that has been widely acknowledged at conference proceedings. As such, 
there are currently doubts about the validity of certain commercially available antibodies, e.g. 
one commercially available PGC-1α antibody is known to identify an immunoreactive protein 
band in the tissue of PGC-1α-null mice (AV Chibalin, personal communication). The PGC-1α 
antibody used in the current experiments (PGC-1α H-300, sc-13067, Santa Cruz Biotechnology) 
was chosen on the basis of its use in previously published papers (Taylor et al., 2005;Akimoto 
et al., 2005;Hancock et al., 2008). The molecular weight of the immunoreactive protein band 
targeted by this antibody is approximately 75 kDa (Fig. 6.5A), as opposed to the predicted 92-
105 kDa molecular weight of the full-length protein. Aside from assurances from the vendor as 
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to specificity of the antibody, and speculation on the cause of the discrepancy between the 
measured and expected molecular weight (posttranslational cleavage, splice variants, relative 
protein charge), there is little else under the control of the end user. However, it is carefully 
acknowledged that this issue must be resolved prior to publication of these results in a peer-
reviewed publication. 
7.4 Future directions  
7.4.1 Establishing the mechanisms regulating exercise-induced gene transcription 
The signalling and transcriptional responses to acute exercise have become increasingly well 
defined, but the direct link between these responses remains elusive in vivo. As discussed in 
other sections, transcription factors and their coregulators are responsible for integrating 
intracellular signals into functional consequences through their control of gene expression.  
Only a few experiments have directly measured functional activity or associated changes of 
transcriptional regulators after exercise. In rodents, for example, the DNA binding activity of 
NRF-1 and NRF-2 to promoter regions of mitochondrial genes is increased by acute exercise 
(Baar et al., 2002;Wright et al., 2007b), an effect thought to be mediated by PGC-1α and 
indicative of stimulation of mitochondrial biogenesis by exercise. However, mechanistic data 
such as this remains unreported in humans. In humans, limited data does suggest acute 
exercise can alter the functional activity of transcription factors. A single bout of exercise has 
been shown to increase GEF (McGee et al., 2006) and MEF2 (Yu et al., 2001;McGee et al., 
2006) DNA binding activities, which may in part explain GLUT4 gene regulation by exercise.  
Future studies in humans that aim to establish the mechanisms of exercise-induced 
mitochondrial biogenesis should focus on (i) establishing the effect of exercise on the functional 
activity of transcriptional factors and their coregulators, (ii) demonstrating continuity between 
activation of signal transduction pathways and the functional activity of these factors, and (iii) 
the regulation of translational mechanisms that translate these robust changes in mRNA 
expression to functional protein and enzymatic activity. 
For example, p38 MAPK and AMPK phosphorylation sites modulating functional activity have 
been identified on the PGC-1α protein (Puigserver et al., 2001;Jager et al., 2007). If an 
exercise-induced increase in the activity of these kinases does in fact alter PGC-1α activity, one 
or more of these sites should be phosphorylated by exercise. The ability to examine these 
mechanisms is of course limited by the availability of methodologies such as, in this case, a 
primary antibody directed towards these sites. 
7.4.2 Novel pathways/posttranslational modifications 
We report the first data to demonstrate regulation of RIP140 and Sirt1 mRNA expression by 
acute exercise and exercise training, although a functional role in skeletal muscle metabolism or 
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adaptation to acute exercise or chronic training remains to be investigated. RIP140 has been 
proposed as a metabolic counterbalance to the effects of PGC-1α in regulation of metabolic 
homeostasis by acting on specific gene targets in common with PGC-1α (White et al., 2008). 
The role of corepression in an exercise context has not been investigated. Sirt1 is a key 
regulator of skeletal muscle metabolism by regulating PGC-1α functional activity by its 
acetylation status (Lagouge et al., 2006;Gerhart-Hines et al., 2007). The growing body of 
evidence linking posttranslational modifications of factors, such as PGC-1 and FOXO1A among 
others, to metabolic regulation is worthy of investigation in the regulation of exercise-induced 
metabolic regulation. 
As discussed in earlier chapters, the regulation of both Sirt1 and RIP140 activity is influenced by 
the cellular redox state via the NAD+/NADH ratio (Rodgers et al., 2008;White et al., 2008). 
Fluctuations in this ratio are known to occur during exercise (Robergs et al., 2004) and are 
potential contraction-induced metabolic signals (Hawley & Zierath, 2004). This suggests that the 
functional activity of these factors, rather than the expression, can also be modulated by 
contraction-induced mechanisms with possible downstream effects on gene expression. The 
role of cellular redox state in metabolic regulation at a transcriptional level requires further 
investigation in the context of exercise. 
7.4.3 Identification of novel therapeutic targets 
The identification of novel therapeutic targets if often cited as a meaningful outcome from 
studies on the molecular biology of exercise. However, the question should be asked “what 
does the identification of novel therapeutic targets really mean”? 
Exercise as well as being a metabolic stressor and physiological stimulus to muscle plasticity 
also has the desirable outcome of ameliorating, short of ablating, metabolic dysfunction through 
favourable alterations in glycemic control, lipid profile and mitochondrial function. Alterations 
mediated by increases in exercise-mediated glucose disposal, possible clearing of lipid 
metabolism by-products/intermediaries, lipid oxidation, energy expenditure and mitochondrial 
biogenesis and oxidative phosphorylation gene expression. Exercise training alters substrate 
metabolism of working muscle but also the metabolic status of the resting muscle and improves 
metabolic flexibility. It seems logical to suggest that the induction of exercise-like responses in 
skeletal muscle through whatever means could be a panacea for the ills of metabolic 
dysfunction. Although targeting kinases activated by exercise may be one way to enhance the 
metabolic profile of a diseased muscle, the suitability of protein kinases as drug targets is 
debated (Coghlan & Smith, 2005). Currently, there are discrepancies between the exercise-
induced alterations in gene expression and pharmacologically-induced effects (Jorgensen et al., 
2005). 
Alternatively, the molecular genetic signature from acute exercise and training has been 
proposed as useful in predicting successful rehabilitation with a given disorder (Mahoney & 
Tarnopolsky, 2005). These authors suggest that transcriptome signatures could be used as a 
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standard by which to compare the exercise response from a variety of patient populations to 
identify which components of the response are altered by the disease in question. For example, 
insulin-resistant subjects have reduced responses of nuclear-encoded mitochondrial genes to 
exercise, and this could contribute to the origin and maintenance of mitochondrial dysfunction 
(De Filippis et al., 2008) 
Genes that respond most robustly to exercise are regulatory genes (e.g. transcription factors, 
transcriptional coactivators), not effector genes (e.g. components of the electron transport 
chain, β-oxidation). According to Mahoney & Tarnopolsky (2005), therapeutically, it is 
advantageous to target genes that assert widespread effects on the multitude of cellular events 
that compose adaptation (e.g. mitochondrial biogenesis and elevated fat oxidation and glucose 
transport) as opposed to targeting individual genes within a given facet of adaptation. 
7.4.4 Further investigations with the current tissue samples 
There are several lines of enquiry that we intend to pursue with the remaining samples from this 
series of experiments, with a view to maximising the amount of knowledge garnered from 
human biopsy samples. Currently, there is both cDNA and whole muscle lysate available for 
most if not all experimental time points, which provides us with the means for further 
investigation to improve our current data set and investigate further as novel targets emerge. 
 Firstly as described above, methodological issues concerning the measurement of PGC-1α 
protein content must be addressed. Subject to confirmation of a commercially available and 
suitably validated PGC-1α antibody, or acquisition of an aliquot of antibody from the 
Spiegelman lab (Dana Farber Cancer Institute, Harvard Medical School, Boston MA), we will 
examine the protein content in samples from the training study. In addition, in light of a recent 
publication demonstrating rapid upregulation of PGC-1α protein during recovery from acute 
exercise (Mathai et al., 2008), we will return to the acute exercise samples from experiments I 
and II to investigate this observation in our samples. 
Secondly, using the stored aliquots of whole muscle lysate, it will be po=ssible to investigate 
posttranslational modifications and protein-protein interactions under the experimental 
conditions described. We are currently developing a method to examine acetylation status by 
immunoprecipitating the protein of interest and probing for immunoreactive bands with an 
acetylated lysine antibody (#9441, Cell Signaling Technology). When optimised, this method will 
provide the first reported data on the effect of acute and regular exercise on the acetylation 
status of PGC-1α, RIP140 and FOXO1A. In addition, we intend to examine the colocalisation of 
PGC-1α and RIP140 in complex with transcriptional regulators such as NRF-1, NRF-2 and 
ERRα to investigate the role of transcription factor complex formation in the adaptive response 
to both acute exercise and exercise training. 
Thirdly, given the role of AMPK in the regulation of skeletal muscle gene expression (section 
2.6.2.2) and the robust activation by exercise, it is unsurprising that it has been implicated in the 
adaptive response to exercise training (Jorgensen et al., 2006). However, at present it is 
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unclear which AMPKα isoform is involved in the adaptation to training. Numerous studies have 
demonstrated that the α2 isoform is responsive to acute endurance-type exercise 
(Wojtaszewski et al., 2000;Fujii et al., 2000). However, the α1, but not α2 subunit, has been 
shown to be increased by exercise training (Frosig et al., 2004). Given that the exercise 
training-induced response of several metabolic and mitochondrial genes is similar between wild-
type and α2 AMPK knockout mice (Jorgensen et al., 2007) but AMPK is required for 
mitochondrial biogenesis and the exercise-mimetic effects of β-GPA (Zong et al., 2002), this 
suggests that AMPK isoform-specific regulation of training-induced responses remain to be 
investigated. With this in mind, we intend to measure the protein expression of the respective 
AMPK α-isoforms to explore this further. 
Finally, allowing for the kinetic considerations and sample timing described in section 7.3 and 
further to the contention of Baar et al. (2002) (see section 7.3.3), we acknowledge that it would 
improve our results considerably to couple the measurement of mRNA abundance to alterations 
in protein content for each gene of interest. Currently, we are endeavouring to provide 
corresponding protein content measurements for each reported mRNA abundance, i.e. 
matching the transcript to the respective protein. For example, in experiment I, considering the 
mRNA abundance of PGC-1α, FOXO1A, PDK4 and RIP140 is robustly increased during the 
first 3 h of recovery from exercise, it will be interesting to examine the effect of the 
corresponding protein content during the same time period and up to 19 h after exercise.  
7.5 Practical relevance 
We have only measured a small number of genes in the context of a single bout of exercise but 
extrapolation of the intensity-dependent effect on the expression of selected genes after 
isocaloric exercise suggests that exercise training at a higher intensity for a shorter duration 
may promote greater magnitude of adaptations. This remains to be confirmed in an exercise 
training experiment. Previous research on rodents (Terada et al., 2005) and humans (Gibala et 
al., 2006;Burgomaster et al., 2008) suggest that shorter duration, but higher intensity, training is 
at least as effective as more traditional endurance-type training in terms of the degree of 
adaptation. In a human study (Gibala et al., 2006), during two weeks of training (six sessions) 
the total training volume for the high intensity group was only 10% that of the endurance training 
group (i.e. 150 vs. 1500 kcal). In terms of total training time, commitment over two weeks was 
2.5 h for the high intensity group, whereas the endurance group performed continuous exercise 
each training day for a total of 10.5 h. Training adaptations in terms of maximal oxygen uptake 
and muscle oxidative capacity were not different between groups. Therefore, intense interval 
training is a time-efficient strategy to induce rapid muscle and performance adaptations 
comparable to traditional endurance training. 
Our acute exercise results support the contention that reduced duration, high intensity exercise 
is as effective as traditional training (Coyle, 2005b;Baar, 2006). The stimulus for adaptation, 
particularly in terms of substrate metabolism and mitochondrial biogenesis, may be greater 
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when the intensity of the exercise training is higher. This study may provide a molecular insight 
into findings that first established this principle over a quarter of a century ago (Dudley et al., 
1982): “for the same adaptive response, the length of daily exercise necessary to bring about 
the change becomes less as the intensity of training increases”. 
The most commonly cited reason for not exercising is a “lack of time” (Godin et al., 1994). 
Training at higher intensities provides an alternative to current exercise prescriptions for time 
pressed individuals (Gibala & McGee, 2008). The price for the effectiveness and time-efficiency 
of training at a higher intensity is that it is very hard to get people to exercise at a high intensity 
for any period of time (Baar, 2006). It remains to be determined which populations, depending 
on age, health status, and psychology, are mostly likely to adhere and benefit from high 
intensity training. 
Finally, we chose to limit the caloric expenditure of the exercise bout within a physiologically 
relevant range consistent with industry exercise guidelines (ACSM, 1998). High intensity sprint 
training does not utilize as many calories as longer duration endurance exercise (Gibala & 
McGee, 2008). This means that the efficacy of this type of training is reduced if the goal of 
training weight loss. However, high intensity endurance exercise may expend sufficient calories, 
require less time commitment and result in more pronounced cellular adaptations than low 
intensity recreational exercise. 
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